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SUMMARY
The present work has investigated the species differences and 
mechanisms involved in hepatic peroxisome p ro life ra tio n .
The s u ita b ility  of primary hepatocyte cultures as an in v itro  model fo r  
th is  phenomenon was determined. The effects  of a range o f peroxisome 
p ro life ra to rs  on cultured ra t hepatocytes were both q u a lita tiv e ly  and 
q u an tita tive ly  s im ilar to the e ffects  observed in the l iv e r  of the ra t  
lH  vivo.
A species difference in the hepatic response to o ra lly  administered 
d i- ( 2-ethyl hexyl)phthalate (DEHP) was demonstrated in the ra t and the 
marmoset. This species difference phenomenon was fu rther investigated  
using primary guinea pig and marmoset hepatocyte cu ltures. Peroxisome 
p ro !ite ra tio n  as seen in ra t hepatocytes was not observed in guinea pig 
or marmoset hepatocytes with any agent tested. S im ila rly , peroxisome 
p ro life ra tio n  was not observed in cultured human hepatocytes. These 
observations are suggested to in fe r  an inherent difference in 
s e n s itiv ity  of the guinea pig, marmoset and human hepatocyte to 
peroxisome p ro life ra tio n .
The mechanism by which DEHP e l ic i ts  peroxisome p ro life ra tio n  in the ra t  
l iv e r  has been investigated. The metabolites of DEHP produced by 
Co -1-oxidation of the monoester (m etabolite IX [m ono-(2-ethyl- 
5-hydroxy hexyl phthalate] and metabolite VI [m ono-(2-ethyl-5 oxo 
hexyl phthalate]) were shown to be potent peroxisome p ro life ra to rs  in  
cultured ra t hepatocytes. These metabolites produced a tran s ient 
increase in in tra c e llu la r  neutral l ip id  in cultured ra t hepatocytes. 
Metabolite Vis was fu rther shown to in te rfe re  with hepatic l ip id  
metabolism, causing an in h ib itio n  of mitochondrial medium chain acyl 
carn itine  oxidation s p e c ific a lly . Hence i t  is  proposed th a t the 
species difference in peroxisome p ro life ra tio n  is due to differences in  
response of guinea p ig , marmoset and human hepatocytes to the 
accumulation of in tra c e llu la r  l ip id .
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CHAPTER I 
INTRODUCTION
1.1 PEROXISOMES
1.1.1 MICROBODIES AND PEROXISOMES
'Microbodies' were f i r s t  described in the cytoplasm of the mouse 
proximal kidney tubule by Rhodin (1958). The concurrent developments 
in c e ll fractionation  techniques provided the evidence that microbodies 
were indeed biochemically d is tin c t organelles (de Duve e t al_, 1960; 
Beaufay e t a^, 1964; Baudhuin e ta V , 1965a ,^; de Duve and Baudhuin, 
1966). 'Microbody' is  a morphological term which is  used loosely and 
encompasses a number of biochemically re lated organelles -  peroxisomes, 
microperoxisomes, glyoxysomes, glycosomes and hydrogenosomes. 
Microbodies from a ll  sources have a s im ilar morphological appearance 
but d if fe r  in th e ir  content of enzymes and metabolic pathways.
The term 'peroxisome' was coined by de Duve (1965) to indicate the 
function of th is  organelle in hydrogen peroxide (^ C ^ ) metabolism, and 
is applied to microbodies containing catalase and at lea s t one 
^C^-generating fla v in  oxidase. Other catalase-positive microbodies 
are the glyoxysomes and microperoxisomes, whereas glycosomes and 
hydrogenosomes are catalase-negative. The nomenclature associated 
with microbodies is  summaried below:
Though microbodies per se are ubiquitous organelles the c e lls  o f higher 
animals contain only peroxisomes (and microperoxisomes). Furthermore, 
only ra t l iv e r  peroxisomes have been investigated in d e ta il.  The 
description of peroxisome morphology, enzyme p ro file  and function th a t 
follows is thus confined to ra t l iv e r  peroxisomes. However, several 
reviews on microbody morphology and function are availab le  (de Duve, 
1983; de Duve and Baudhuin, 1966; Masters and Holmes, 1977; Hruban 
and Rechcigl, 1969; de Duve, 1978; Bock e t al_, 1980; T o lb ert, 1981; 
Tolbert and Essner, 1981; Leighton and Lazo, 1982).
MICROBODIES
CATALASE-POSITIVE
*  PEROXISOMES
*  MICROPEROXISOMES
*  GLYOXYSOMES
CATALASE-NEGATIVE *  HYDROGENOSOMES 
GLYCOSOMES
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1.1.2 PEROXISOME MORPHOLOGY
Peroxisomes are located in the cytoplasm of the ce ll and are spherical
in shape. The size varies depending on the tissue from 0.1 -  1.5 fim
in diameter and ra t l iv e r  peroxisomes are approximately 0.5 j^m in
diameter. Peroxisomes are bounded by a single membrane which has a
trilam in ar structure, the thickness and composition of which is  s im ilar  
to the endoplasmic reticulum (Donaldson e t a l ,  1972). However, more 
recently i t  has been shown that the polypeptide composition of these 
membranes are e n tire ly  d iffe re n t (Lazarow e t al_, 1982). The membrane 
is highly permeable to a number of small molecules such as sucrose, 
H2O2 , NAD+ and inorganic ions (de Duve and Baudhuin, 1966; van 
Veldhoven e t al_, 1983). The peroxisomal membrane has frequently been 
observed to show continu ities with the smooth endoplasmic reticulum  
(SER) (Hruban e t :a]_, 1963; Novikoff and Shin, 1964; Reddy and Svoboda,
1971) and i t  has been proposed th a t peroxisomes do not e x is t as free  
organelles w ithin the ce ll but are always attached to the endoplasmic 
reticulum (Novikoff and Shin, 1964). I t  is  of in te res t in th is  respect 
that peroxisomes are not evenly d istributed  w ithin the ce ll but occur 
in clusters (Novikoff and Shin, 1964).
The most d is tin c tiv e  morphological feature of normal ra t l iv e r  
peroxisomes is  the c rys ta llin e  'core' or 'nucleoid' which is  easily  
visable w ithin the granular m atrix. The presence of the core was 
believed to be associated with insoluble urate oxidase (Baudhuin e t al_, 
1965a , Tsukuda e t al_, 1971; A fze liu s , 1965). In support of th is  
peroxisomes of human l iv e r  which lack urate oxidase a c t iv ity  are devoid
of nucleoid structures (de Duve and Baudhuin, 1966). In contrad iction ,
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however, monkey kidney exhibits no detectable urate oxidase a c t iv ity  
but the peroxisomes do contain nucleoids (Tischer e t  al_, 1968). More 
recently studies have indicated th a t other peroxisomal enzymes are also 
associated with the core (Hayashi e t al_, 1971; 1973; 1976; 1981). 
Nucleoids have not been reported in tissues other than l iv e r  and 
kidney; fo r example, microbodies are completely devoid of nucleoid 
structures in ra t brown adipose tissue (Ahlabo and Barnard, 1971). I t  
is  suggested that such populations be termed 'microperoxisomes'
(Novikoff and Novikoff, 1972). However, u n til such microbodies are 
shown to contain an oxidase a c tiv ity  as in the microperoxisomes of the
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guinea pig i n t e s t i n e  iconnocx ec  aj_, l y / ^ i  iney  snouia De lermea 
'ca ta lase-positive  microbodies'. This is  an important d is tin c tio n  as 
some catalase positive microbodies have been shown to lack such oxidase 
a c tiv ity  (Bock e t al ,^ 1975) and as such are not 'peroxisomes' according 
to the concept of de Duve and Baudhuin (1966). Whether micro­
peroxisomes are progenitors of true peroxisomes or biochemically 
d is tin c t organelles is not known.
The typical morphological appearance of ra t l iv e r  peroxisomes is shown 
in Figure I . 1.
1 .1 .3  PEROXISOME BIOGENESIS
The mechanisms involved in the biogenesis of peroxisomes w ithin the 
ce ll remain a matter of uncertainty. The e a r lie s t model of peroxisome 
biogenesis (de Duve and Baudhuin, 1966) suggested that peroxisomes 
arose as 'buds' from the endoplasmic reticulum , s p lit t in g  o ff  to form 
discrete organelles (Figure 1 .2 ) . The peroxisomal proteins were 
assumed to be synthesised on membrane bound ribosomes, cotranslation - 
a lly  released into the lumen of the endoplasmic reticulum and thus 
delivered in to the developing peroxisome 'buds'. This model was based 
largely  on the morphological observation of numerous continu ities  
between peroxisomal and endoplasmic reticulum membranes (Novikoff and 
Shin, 1964) and evidence for the transfer of labelled  catalase from 
the rough endoplasmic reticulum to the peroxisome (Higashi and Peters, 
1963). Ingeneous experiments using pulse la b e llin g  techniques 
revealed f i r s t ly  that peroxisomes are destroyed at random and do not 
have a fixed life tim e  (Poole et aT, 1969) and secondly that the size of 
the peroxisome is not an index of e ith e r age or stage of growth (Poole 
e t _al_, 1970). These observations argued against the theory of 'growth 
and ripening' proposed by de Duve and Baudhuin (1966) and suggested 
that i f  the peroxisomes did grow as 'buds' from the endoplasmic 
reticulum , that they must reach th e ir  fin a l size w ithin a very short 
time (1 hour).
To explain these observations Poole e t al_ (1970) proposed the 
p o ss ib ility  "that peroxisomes do not ex is t as independent individuals  
but continuously or in te rm itten tly  exchange m aterial with one another".
FIGURE 1.1
ELECTRON MICROGRAPH OF RAT LIVER SHOWING THE
MORPHOLOGICAL FEATURES OF PEROXISOMES
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The peroxisome is  c learly  distinguishable from other cytoplasmic 
organelles by its  size [0.1 -  1 .5 /j diam eter), single lim itin g  
membrane and central nucleoid. Continuities with the endoplasmic 
reticulum are visable.
FIGURE 1.2
PROPOSED MODELS OF PEROXISOME BIOGENESIS
a) 'Budding' from endoplasmic reticulum
b) Peroxisomal reticulum
New peroxisomes form from pre-existing ones, and proteins are incorporated 
post tra n s la tlo n a lly .
From Lazarow e t a l , 1980.
Poole suggested that this exchange of material took place e ith e r by 
fusion or fiss ion  of p artic les  or by attachment to the endoplasmic 
reticulum .
Both of the above models were based on the supposition that peroxisomes 
arise from the endoplasmic reticulum , and enzymes synthesised by 
membrane bound ribosomes are discharged in tra lu m ina lly  in to  the 
peroxisomes. Experiments using radio labelled  tracers to follow  the 
synthesis of peroxisomal enzymes did not confirm th is . In the 
experiments of Higashi and Peters (1963) the e a r lie s t  peak of 
ra d io a c tiv ity  in catalase from leucine was found in the rough 
endoplasmic reticulum fraction  suggesting synthesis by membrane-bound 
ribosomes. The purity of the catalase antibody used in these early  
studies has been much questioned. I t  has been shown subsequently th a t 
catalase can be synthesised by free polysomes (Sakamoto and 
Higashi,1973) and that catalase, urate oxidase and a number of other 
peroxisomal polypeptides are synthesised exclusively by free ribosomes 
and not by membrane-bound ribosomes (Goldman and B lobel, 1978; Lazarow 
e t al_, 1982). In fu rther support of these observations large amounts 
of catalase apomonomer and other peroxisomal polypeptides are found in 
the cytosol a fte r  la b e llin g  (Lazarow and de Duve, 1973; Lazarow e t 
an, 1982).
The obligatory passage of such proteins across the peroxisomal membrane 
poses an in teresting  problem. 'Cotranslational tran s fe r' where 
passage across the membrane is t ig h tly  coupled to tran s la tion  and 
proceeds only during synthesis of the protein , has been ruled out fo r  
catalase and urate oxidase (Goldman and Blobel, 1978; Lazarow e t al_, 
1982). Evidence in support o f . 'p o s t.tran s la tio n a l' uptake of catalase  
is  provided by Lazarow and de Duve (1973). The catalase tetram er is  
assembled intraperoxisomally following the uptake of haem and the 
apomonomer from the cytoplasm. I t  is  however e n tire ly  feas ib le  th a t 
other proteins may enter the peroxisome by d iffe re n t routes.
Lazarow et al_ (1980) have proposed a th ird  model of peroxisome 
biogenesis to encompass th is  more recent data. Lazarow has suggested 
that peroxisomes may indeed be interconnected with each other, e ith e r  
permanently or tran s ie n tly , to form a 'peroxisomal reticulum* th a t is
never in continuity with the endoplasmic reticulum. This model 
implies that peroxisomes are not constructed from scratch but by 
fiss ion  from old peroxisomes or budding from the peroxisomal reticulum . 
Newly synthesised proteins are added to the pre-existing  peroxisomal 
mass e ith er by post translational uptake or by cotranslational uptake 
in specialised parts of the reticulum (Figure 1 .2 ). The peroxisomes 
are able to exchange th e ir  contents by d iffu s io n .
In conclusion, no single model of peroxisomal biogenesis has emerged 
that explains completely a ll of the experimental data on the synthesis 
and incorporation of peroxisomal enzymes. The 'peroxisomal re ticu lu m ', 
however, is  compatible with most of th is  data. I t  is c lear that 
peroxisomal enzymes are synthesised by free ribosomes and may enter the 
peroxisomes by post translational uptake. The method of specific  
entry and retention of these enzymes by the peroxisome is  not known. 
Nothing is known of the mechanisms contro lling  the biogenesis of 
peroxisomes and peroxisomal proteins. The biogenesis of peroxisomes 
and packaging of peroxisomal enzymes appears to be a unique and at 
present elusive process.
1 .1 .4  PEROXISOMAL ENZYMES
Despite the s im ilar morphological appearance of microbodies from a ll 
sources the enzyme content and associated pathways appear to be 
variable and dependent on the tissue. Only ra t l iv e r  peroxisomes have 
been examined in great deta il and in most tissues the enzymne 
complement and thus functional ro le of microbodies is not known.
De Duve and Baudhuin (1966) described the peroxisome as an organelle  
important in the metabolism of H2O2 . De Duve's terminology was based 
on the id e n tific a tio n  of catalase and the H202-generating oxidases, 
urate oxidase, D-amino acid oxidase and L<*-hydroxy acid oxidase as 
specific  peroxisomal enzymes. However, i t  has now become c lear th a t 
the enzyme composition and hence metabolic function of the peroxisome 
is  fa r more complex than f i r s t  an tic ipated . The enzyme complement of 
ra t l iv e r  peroxisomes (to  date) is  shown in Table I . 1.
TABLE 1.1 
ENZYMES OF RAT LIVER PEROXISOMES
REFS
1. ENZYMES OF H202 METABOLISM
CATALASE 1 ,2 ,3
D-AMINO ACID OXIDASE 1 ,2 ,3
URATE OXIDASE 1 ,2 ,3
L-<*-HYDROXYACID OXIDASE 4,5
(GLYCOLATE OXIDASE)
POLYAMINE OXIDASE 6
2. DEHYDROGENASES -NAD/NADP
GLYCER0L-3-PH0SPHATE DEHYDROGENASE {NAD) 7
NADH-GLYCOLATE REDUCTASE 8
ISOCITRATE DEHYDROGENASE (NADP) 9
ACYL-DHAP*: NADPH OXIDOREDUCTASE 10
ALDEHYDE DEHYDROGENASE (NAD/NADP) 11
3. TRANSFERASES
CARNITINE ACETYL TRANSFERASE 12
CARNITINE OCTANOYL TRANSFERASE 12,13
ACYL-CoA': DHAP* ACYL TRANSFERASE 10
GLYOXYLATE AMINOTRANSFERASE 8
4. OTHERS
NADH-CYTOCHROME C REDUCTASE 14
PALMITOYL-CoA' B-OXIDATION SYSTEM 15,16
ACYL-CoA' SYNTHETASE 17
EPOXIDE HYDROLASE 18
*DHAP = Dihydroxy acetone phosphate
'CoA = Coenzyme A
9.
TABLE 1.1
(Continued)
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1.1 .5  METABOLIC FUNCTIONS OF PEROXISOMES
The f i r s t  attempt at defining the functional ro le of the peroxisome 
w ithin the ce ll was made by de Duve and Baudhuin (1966). The 
'peroxisome concept' recognised that the incorporation of 
H202- 9enerating  oxidases and large amounts of catalase w ithin the same 
organelle was lik e ly  to be 'b io lo g ic a lly  m eaningful'. The peroxisome 
was envisaged as an organelle th a t played a central ro le  in H202 
metabolism (Figure 1 .3 ).
Since the recognition of the peroxisome as a biochemically d is tin c t  
organelle the enzymes located s p e c ific a lly  w ithin the peroxisome have 
enumerated rap id ly . Apart from the H202~generating oxidase and 
catalase o r ig in a lly  described, the peroxisome (ra t  l iv e r )  has now been 
shown to contain a variety  of NAD(P) linked dehydrogenases, 
transferases and (o f p a rtic u la r in te re s t to the phenomonon of 
peroxisome p ro life ra tio n ) a fa tty  acid B-oxidation system. I t  is  
obvious th a t the peroxisome is  capable of playing a more varied ro le  in 
metabolism that was f i r s t  thought. For many peroxisomal enzymes the 
function is  not known, whereas fo r others a ro le  in metabolic pathways 
within the peroxisome has been id e n tif ie d . These metabolic pathways and 
postulated functions in the intermediary metabolism of the l iv e r  are 
discussed in more deta il below.
1 .1 .5 .1  HYDROGEN PEROXIDE DISPOSAL
The ro le  of the peroxisome in in tra c e llu la r  H202 disposal was f i r s t  
discussed by de Duve and Baudhuin (1966). Though H202 i t s e l f  is  not 
very cytotoxic i t  is  capable o f producing highly reactive species such 
as s ing let oxygen or hydroxyl rad ica ls . Thus i t  is  lik e ly  that 
catalase plays an important ro le  in maintaining low levels of c e llu la r  
H2O2 , and p a rtic u la rly  in degrading H2O2 formed by the peroxisomal 
fla v in  oxidases. However, other H202-generating oxidases e x is t 
outside the peroxisome eg xanthine oxidase, and monoamine oxidase and 
H202 may also be formed by microsomal and mitochondrial enzyme systems. 
The H202 generated by such systems must e ith er (1) d iffuse in to  the 
peroxisome or (2 ) be degraded by catalase released from the peroxisome
FIGURE 1.3 
PEROXISOME CONCEPT OF DE DUVE
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from de Duve and Baudhuin,1966
2H20
or (3) be removed by other non-peroxisomal enzymes, eg glutathione  
peroxidase. I t  is  a t present unclear whether catalase per se is 
released from the peroxisome into the cytosol under normal conditions. 
During subcellular fractionation  studies catalase has frequently been 
detected in the cytosol (Leighton e t a l ,  1975; Baudhuin e t al_, 1964; 
Lazarow and de Duve, 1973) but i t  is  suggested that th is  is  merely an 
arte fac t caused by leakage from peroxisomes damaged during the 
homogenisation process (Beaufay e t aT, 1964; Leighton e t al_, 1968). In 
contradiction to th is  several authors suggest, c it in g  both h isto - 
chemical staining and antibody sta in ing , that extraperoxisomal forms of 
catalase do e x is t. I t  is  possible that newly synthesised catalase, 
which is located in large amounts in the cytosol, though immuno- 
lo g ic a lly  reactive may not contain haem and is  thus not l ik e ly  to be 
enzymatically ac tive . This may explain the detection of extra - 
peroxisomal catalase using antibody staining techniques. However, the 
histochemical diami nobenzidine (DAB) stain u tilis e s  the peroxidatic  
reaction o f catalase and presumably requires a haem-containing enzyme 
(Roels, 1976; Roels et al_, 1977). Convincing evidence for the 
existence of m ultip le (and extraperoxisomal) forms of catalase has been 
accumulated (Holmes and Masters, 1972; Jones and Masters, 1975). 
Clearly th is  discrepancy needs to be resolved i f  the ro le and 
effic iency  of catalase in maintaining low c e llu la r  H2O2 leve ls  is  to be 
determined.
1 .1 .5 .2  FATTY ACID OXIDATION
The existence of a non-mitochondrial B-oxidation pathway was f i r s t  
described in the glyoxysomes of castor bean endosperm (Cooper and 
Beevers, 1969). This prompted the search for th is  pathway in other 
microbodies and the existence of a fa tty  acid B-oxidation pathway in 
ra t l iv e r  peroxisomes was demonstrated by Lazarow and de Duve (1976). 
The individual enzymes of the peroxisomal B-oxidation pathway have been 
id en tifie d  (Lazarow, 1978; Osumi and Hashimoto, 1979) and though 
comparable in function to the mitochondrial enzymes both the enzymes 
and the pathways are d is tin c tly  d iffe re n t (Figure 1 .4 ).
FIGURE 1.4
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MITOCHONORIAL SYSTEM PEROXISOMAL SYSTEM
R -C H j-C H , -C O -SC oA fa t ly  acyl Co A
fla v o p ro t tm
r«5D ira tary  
2 ~ * ( p )------------3 ^ ^ ------f ia » o o fo t» in . H ,
H ,0  1/2 0 ,
3 ~ ®
r ts o i fo to r y
cnam
M ,0  1/2 0 ,
d«nydrog«nas»
R -C H .C H -C O -S C o A
hj0 n |
R -C H O H -C H ,-C O -S C o A  
NAO*-
NAOM.
R -C O -C H ,-C O -S C o A  
CoASH^
R -C O -S C oA  
>
C H ,-C O -S C oA
2 -u n ta tu ra t« d  acyl Co A
hydratas*
3 -  A ydro i y •  acyiCoA
ddhydro^dflOM
3 -o .y -a cy lC o A
j thioiddd
acylC oA
a c tty lC o A
f l-C H , -C H , .  CO-SCoA
- f la » o a ro t*m   » H t 0  .1 /2  0 ,
v  i  fc a ia T o f i
f ta»oo ro i»m  Hj
B -C H .C H -C O -S C o A  
-H ,0
R -C H O H -C H ,-C O -S C o A  
- H A D ’
'^ -♦ N A O H  .  H*
R -C O -C H ,.C O -S C o A  
^ C o A S H
R .C O -S C oA
C H ,-C O -S C o A
COFACTOR REQUIREMENTS FOR PEROXISOMAL AND MITOCHONDRIAL FATTY ACYL-CoA 
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from Mannaerts and Debeer, 1981.
Peroxisomal B-oxidation is d iffe re n t from mitochondrial B-oxidation in 
several important aspects:
1. The f i r s t  enzyme in the mitoch ondrial pathway, fa tty  acyl CoA 
dehydrogenase, transfers electrons to the mitochondrial electron  
transport chain (by way of electron transport flavoprotein ) and is
thus coupled to ATP formation. The f i r s t  enzyme in the 
peroxisomal pathway, fa tty  acyl CoA oxidase, delivers electrons
d ire c tly  to oxygen forming H2O2 -
2. As peroxisomal B-oxidation is not coupled to a phosphorylation
system i t  is  insensitive to in h ib ito rs  of mitoch ondrial 
resp iration (and B-oxidation) eg cyanide.
3. Peroxisomal enoyl-CoA hydratase and 3-hydroxy acyl CoA 
dehydrogenase are believed to form a bifunctional prote in . These 
are separate enzymes in the mitochondrial pathway.
4. The peroxisomal B-oxidation system demonstrates a d iffe re n t chain
length s p e c ific ity  to the mitochondrial system and does not 
oxidise acyl CoAs with chain lengths of less than 7 carbon atoms 
at a s ig n ifica n t rate  (Lazarow, 1978).
5. The cofactor requirements of peroxisomal and mitochondrial
B-oxidation in v itro  d if fe r  dram atically (Figure 1 .4 ) .
The fa te  of the products of peroxisomal B-oxidation (Cg-Cg acyl CoA, 
acetyl CoA, NADH) is not fu lly  understood. The re-oxidation of NADH 
may be coupled to other peroxisomal enzyme reactions as o r ig in a lly  
proposed by de Duve and Baudhuin (1966) (Figure 1 .5 ). A lte rn a tiv e ly  
NADH may be reoxidised extraperoxisomally as the peroxisomal membrane 
is permeable to NAD+ (Van Veldhoven et al ,^ 1983). The fa te  of the acyl 
CoAs generated by peroxisomal B-oxidation is also unclear. The 
peroxisomal membrane is not permeable to CoA and i t  is  suggested th a t 
the peroxisome contains its  own in traorganellar pool of th is  cofactor. 
(Van Broekhoven et a1_, 1981). Removal of the acyl CoAs in tact 
generated by B-oxidation would severely deplete the peroxisomal pool of
FIGURE 1.5
POSSIBLE PATHWAYS FOR THE REOXIDATION OF NADH IN THE PEROXISOME
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CoA, and hence lim it  the peroxisomal B-oxidation pathway. As th is is  
not the case i t  is  logical to assume th a t the CoA used in the th io lase  
reaction is continually recycled. Evidence for th is  is provided by 
the observation that though carn itine  does not stim ulate the rate of 
peroxisomal pal mi toy! CoA oxidation, when measured in the presence of 
carn itine  the acetyl units formed are in the form of acetyl carn itine  
(Thomas e t al_, 1980). This reaction is  presumably performed by the 
carn itine  acyl transferases located in the matrix of the peroxisome 
(Markwell e t al_, 1973; 1977; Lazarow, 1978).
A second discrepancy in th is  pathway is  the s ite  of activation  of the 
fa tty  acid to the corresponding CoA ester. I f  the fa tty  acid is  
activated outside the peroxisome using extraperoxisomal CoA and 
transferred into the peroxisome then CoA would accumulate w ithin the 
organelle. Evidence available does suggest that peroxisomal acyl CoA 
synthetase is  located on the cytosolic side of the peroxisomal membrane 
and that extraperoxisomal CoA is  u t ilis e d  (Van Broekhoven e t al_, 1981). 
I t  is  possible that a membrane c a rr ie r  may be involved (Appelkvist and 
D allner, 1980) which serves to transport the acyl group across the 
peroxisomal membrane in a manner analagous to the mitochrondrial 
carn itine  transport system, thus serving to keep separate the 
peroxisomal and cytosolic CoA pools. Figure 1.6 il lu s tra te s  a 
possible mechanism for the maintenance of the peroxisomal CoA pool 
during B-oxidation.
Numerous attempts have been made at determining the re la tiv e  importance 
of peroxisomal and mitochondrial B-oxidation using in v itro  systems.
The variation  in  experimental design has yielded very d iffe re n t  
estimates and the flu x  of fa tty  acids through these two pathways i_n 
vivo is not known. A number o f investigators (Mannaerts e t al_, 1979; 
Osumi and Hashimoto, 1979; Thomas et al_, 1980) claim th a t the 
peroxisomal B-oxidation pathway is of minor importance in the l iv e r  i_n 
vivo, while others (Lazarow, 1978; Krahling e t al_, 1978; Neat e t al_, 
1981; Kondrup and Lazarow, 1982) suggest i t  is of considerable 
importance accounting for up to 40% of the metabolism of palm itate .
POSSIBLE MECHANISM FOR MAINTENANCE OF PEROXISOMAL COENZYME A POOL
DURING B-OXIDATION
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I t  should be noted that the re la tiv e  contribution of these two pathways 
to fa tty  acid oxidation is  l ik e ly  to vary with substrates of d iffe re n t  
chain lengths. Peroxisomes have l i t t l e  or no capacity to metabolise 
fa tty  acids of chain lengths less than 7 carbons (Lazarow, 1978 and 
Inestrosa et al_, 1979) and thus do not contribute to th e ir  oxidation  
in the l iv e r .  Furthermore peroxisomes from the liv e rs  of rats fed 
high fa t  diets are able to metabolise very long chain fa t ty  acids 
(Osmundsen e t al_, 1979; Osumi and Hashimoto, 1979) and i t  is  suggested 
that such fa tty  acids which are poor substrates for mitochondrial 
oxidation may be chain shortened f i r s t  by the peroxisome, fo r fu rth er  
metabolism by the mitochondrial pathway (Bremer, 1977; Osmundsen e t 
al;, 1979).
In summary the peroxisome contains an enzyme pathway fo r the 
B-oxidation of fa t ty  acids which is d is tin c t from the mitochondrial 
pathway. The re la tiv e  contribution of the peroxisomal pathway to the 
oxidation of fa t ty  acids by the l iv e r  is not known. The substrate 
s p e c ific ity  of the peroxisomal pathway suggests i t  plays a ro le in the 
metabolism of fa t ty  acids which are poorly metabolised by the 
mitochrondrial pathway, or simply shortens fa tty  acids for subsequent 
mitochondrial metabolism. I t  is not known whether these pathways 
operate simultaneously or are independent of each other. The dual 
lo ca lisation  of fa tty  acid oxidation in the l iv e r  remains a mystery.
I . 1 .5 .3  PURINE METABOLISM
The pathway of catabolism of purine nucleotides is indicated below:
The major s ite  of purine catabolism in mammals is the l iv e r .  Through 
evolution some of these enzymes have been deleted and a llan to in  or uric  
acid form the major excretion products in higher animals. In man, fo r  
example, the end product of purine catabolism is the insoluble uric  
acid, whereas in rodents, such as the ra t ,  which possess urate 
oxidase a c tiv ity  the more soluble a llan to in  is  produced.
Though urate oxidase a c tiv ity  is  located w ithin the peroxisomes, the 
other enzymes of th is  pathway such as xanthine oxidase are not. The 
location of urate oxidase (a H2O2 generating oxidase) w ith in  the 
peroxisome is  agreeable with the 'peroxisome concept'. However, 
xanthine oxidase which also produces H2O2 is  located in the cytosol.
The presence of peroxisomal urate oxidase is not essential fo r the 
catabolism of purine nucleotides in mammals, but the p rec ip ita tio n  of 
uric acid in the kidney of man (gout) is  perhaps an indication of its  
d e s ira b ility .
PURINE NUCLEOTIDES
Various catabolic enzymes
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I . 1 .5 .4  GLYOXYLATE METABOLISM
Glycolate is  believed to be formed in various metabolic pathways in 
mammals. Its  oxidation to glyoxylate, by glycolate oxidase, and 
fu rther reactions involving glyoxylate are compartmentalised w ith in  the 
peroxisome in the animal c e l l .  The pathways involving glyoxylate in 
the peroxisome are described in Figure 1.7 . Glyoxylate may also be 
formed by the deamination of glycine by D-amino acid oxidase.
Glycolate oxidase, which is an isozyme of L«x-hydroxy acid oxidase, also 
oxidises glycolate to oxalic acid which due to its  in s o lu b ility  is  an 
undesirable end product. Glyoxylate may also be transaminated to 
glycine by the peroxisomal amino transferases which show a high 
s p e c ific ity  fo r glyoxylate as the amino receptor. Despite the 
in tr ic a te  network of reactions involving glyoxylate the function and 
significance of such a pathway is not known.
1.2 PEROXISOME PROLIFERATION IN RODENTS
1.2.1 HEPATIC PEROXISOME PROLIFERATION
In 1965 Hess e t aT described the effects  of the hypo!ipidaemic drug 
c lo fib ra te  on the liv e r  of the male r a t ,  reporting hepatomegaly 
p ro life ra tio n  of smooth endoplasmic reticulum and an increase in the 
number of hepatic microbodies. Since th is  discovery a number of other 
hypo!ipidaemic drugs have been shown to produce s im ilar e ffec ts  on the 
rodent l iv e r .  Perhaps more in te re s tin g ly , a number of miscellaneous 
compounds, encompassing a wide range of chemical structures, have also 
been shown to e l ic i t  hepatic peroxisome p ro life ra tio n  in rodents.
Table 1.2 summarises the chemical agents and physiological stresses 
where an increase in the number of peroxisomes in the rodent l iv e r  has 
been reported. For many of the agents lis te d  an increase in the 
number of hepatic peroxisomes has been determined by subjective  
examination of electron micrographs. We were ourselves however unable 
to detect peroxisome p ro life ra tio n  in rodents treated with 
phenobarbital, endotoxaemia or ethionine using biochemical enzyme 
markers. Q uantitative morphometric analysis has confirmed th a t
FIGURE I .7
GLYOXYLATE PATHWAY IN RAT LIVER PEROXISOMES
glycolate
glyoxylate
glycine
GO
A T
DA AO
COOH
I
c h 2oh
I GO
COOH
I
CHO
r l tAT DAAO
COOH
I
c h n h 2
GO
COOH
>  I
COOH
oxalate
glycolate oxidase
aminotransferase 
D-amino acid oxidase
22.
TABLE 1.2
RODENT HEPATIC PEROXISOME PROLIFERATORS
HYPOLIPIDAEMIC DRUGS
AT-308 (1)
BEZAFIBRATE (2)
BR-931 (3)
CETABEN (4) 
CIPROFIBRATE (5) 
CLOFIBRATE (6 )
DG 585 (5)
DH 6463 (5)
FENOFIBRATE (7) 
GEMFIBRIZOL (8 )
LK-903 (9)
METHYLCLOFENAPATE (10) 
NAFENOPIN (11) 
PROCETAFEN (12)
S-8527 (13)
SaH-42,348 (14) 
SIMFIBRATE (15) 
TIADENOL (16)
TIBRIC ACID (17) 
WY-14,643 (17)
PLASTICISERS AND RELATED COMPOUNDS
DI-(2-ETHYL HEXYLlPHTHALATE (20)
D I- ( 2-ETHYL HEXYL)SEBACATE (21) 
2-ETHYL HEXANOIC ACID (21)
2-ETHYL HEXANOL (20)
2-ETHYL HEXALDEHYDE (21)
D I- ( 2-ETHYL HEXYL1ADIPATE (21) 
MONO-(2-ETHYL HEXYLlPHTHALATE (20)
PHYSIOLOGICAL/PATHOLOGIC STRESS
CHEMICALLY-INDUCED DIABETES (22) 
COLD ADAPTATION (23)
ENDOTOXAEMIA (24)
GENETIC OBESITY (25)
HIGH FAT DIETS (26) (27) 
HYPERTHYROIDISM (28)
PARTIAL HEPATECTOMY (29) 
RIBOFLAVIN DEFICIENCY (30) 
STARVATION (31)
VITAMIN E DEFICIENCY (32) (33)
MISCELLANEOUS COMPOUNDS
ACETYL SALICYLIC ACID (34)(19) 
CARBON TETRACHLORIDE (18) 
DIMETHRIN (35)
ETHIONINE (36)
HALOTHANE (37)
HYPOGLYCAEMIC DRUGS (38) 
ISOPRENALINE (39) 
PERFLUORODECANOIC ACID (40) 
PHENOBARBITAL (41)
PHENOXY ACETIC ACID HERBICIDES 
(421(43)
TRICHLOROETHYLENE (44)
TABLE 1.2
(Continued)
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"peroxisome pro lifera tion" is associated with an increase in the 
numerical density of peroxisomes within the l iv e r  cell cytoplasm (Moody 
and Reddy, 1976; Reddy et a l ,  1982a; Lalwani et al_, 1983a ) .
Peroxisome p ro life ra tio n  is not an "all or nothing" phenomenon and the 
extent of p ro life ra t io n  varies dramatically with d if fe re n t  agents and 
with d if fe ren t doses of the same agent. The hypo!ipidaemic drugs in 
general are the most potent p ro lite ra to rs  (on an equivalent dose 
basis), causing the largest increases in peroxisomal volume density, 
whereas acetyl s a lic y l ic  acid and the industria l p iastic isers  are 
comparatively weak pro lite ra tors  (Figure 1 .8 ) .
In general, following administration of a high dose of a peroxisome 
p ro l i te ra to r ,  the l iv e r  weight and numbers of peroxisomes increase 
gradually reaching a plateau level which is maintained for the duration 
of treatment, and then decline to normal levels following removal of 
the inducer. The time course of these events varies for d i f fe re n t  
agents (Hess et al_, 1965; Moody and Reddy, 1976, 1978a ) .
1 .2.2 HEPATIC EFFECTS OF PEROXISOME PRQLIFERATORS
I . 2.2.1 PEROXISOME-SPECIFIC EFFECTS
Early studies on the enzyme changes associated with peroxisome 
p ro lite ra t io n  concentrated on the few marker peroxisomal enzymes known, 
in particu lar catalase. Catalase a c t iv ity  has been shown to be 
induced by a l l  peroxisome pro lite ra to rs  but to a small degree only 
M - f o l d ) .  This increase in no way para lle ls  the sometimes enormous 
increases in peroxisome numbers and is a poor indicator of the degree 
of peroxisome p ro l ife ra t io n . A second enzyme closely involved in 
l ip id  metabolism, carn itine acyl transferase, was shown to be 
s ig n if ican tly  enhanced following c lo f ib ra te  treatment (Solberg et aj[,
1972). Subsequently analysis of the subcellular d istr ibu tion  of this  
enzyme revealed i ts  loca lisation  partly  within the peroxisome. Though 
the carn itine  pal mi toy! transferase is located only in the
FIGURE 1.8
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mitochondrion and endoplasmic reticulum, part of the carn itine  
octanoyl- and acetyl-transferase a c t iv ity  is located within the 
peroxisome (Markwell e t al ,^ 1973; 1976). Though the peroxisomal 
carnitine acyl transferase is s ig n if ican tly  enhanced following  
c lo fib ra te  treatment the greatest changes in this enzyme a c t iv i ty  are 
in the mitochondrial compartment (Kahonen, 1976; Markwell e t al_, 1977). 
For th is  reason the e ffec t on this enzyme a c t iv ity  w i l l  not be 
considered here as 'peroxisome-specific', although i t  is  frequently  
used as an indicator of peroxisome p ro life ra t io n .
The discovery of a fa t ty  acid B-oxidation pathway in ra t  l iv e r  
peroxisomes (Lazarow and de Duve, 1976) was of particu lar in teres t in 
the l ig h t  of the association of peroxisome p ro life ra t io n  with 
hypo!ipidaemic drugs. This peroxisomal B-oxidation pathway was shown 
to be s ig n if ic an tly  enhanced by c lo f ib ra te  (Lazarow and de Duve, 1976) 
and supports the hypothesis that peroxisome p ro life ra t io n  and the 
concommitent hypolipidaemia are indeed related events. The induction 
of the peroxisomal B-oxidation pathway specifica lly  appears to be 
common Nto peroxisome pro lite ra to rs  and has been shown not only for the 
hypo!ipidaemic drugs (Lazarow and de Duve, 1976; Berge and Bakke, 1981; 
Lazarow, 1980; Hayashi e t al_, 1981) but also for the p lastic isers  
(Osumi and Hashimoto, 1978), various physiological stresses (Neat e t  
cH, 1980; Is h i i  e t al_, 1980a; Murphy e t al_, 1979; Reddy e t  al_, 1981) 
and for a number of miscellaneous compounds ( Is h i i  and Suga, 1979; Bone 
e t al_, 1982; Kawashima et al_, 1984). Induction of peroxisomal 
B-oxidation is used as a biochemical marker for peroxisome 
p ro life ra t io n . Unlike the consistent small changes observed in 
catalase a c t iv ity  the degree of induction of peroxisomal B-oxidation  
re flec ts  the increase in peroxisome numbers. Though the f i r s t  enzyme 
of the peroxisomal pathway, acyl CoA oxidase, is the rate l im it in g  
enzyme the a c t iv i t ie s  of a l l  the pathway enzymes are induced (Osumi and 
Hashimoto, 1979 and Inestrosa et al_, 1979).
A marked increase in a polypeptide of molecular weight 80,000 (PPA-80) 
was noted in subcellular fractions from the l ive rs  of rats treated with 
c lo fib ra te  (Reddy and Kumar, 1977). PPA-80 has consistently been found
to be associated with peroxisome pro life ra tio n  in the rodent l iv e r  
( Is h i i  and Suga, 1979; Is h i i  e t al_, 1980a; Lalwani e t  al ,^ 1981a ; 
Kawashima e t al_, 1984; Reddy e t al_, 1981). Extensive investigations  
by Reddy's group have indicated that th is  protein may represent the 
bifunctional enoyl CoA hydratase/3 hydroxyacyl CoA dehydrogenase of the 
peroxisomal B-oxidation pathway (Osumi and Hashimoto, 1979; Reddy et  
al_, 1981).
Detailed studies on other peroxisomal enzymes are lacking. Many 
investigators have noted a decrease or no change in the specific  
a c t iv ity  of the classical peroxisomal oxidases-urate oxidase D-amino 
acid oxidase etc -  following administration of peroxisome prol ife ra to rs  
(Azarnoff and Svoboda, 1966; Markwell et al_, 1977; Is h i i  e t  a^, 1980; 
Berge and Bakke, 1981). Urate oxidase a c t iv ity  has been shown to be 
enhanced s lig h t ly  following administration of hypo!ipidaemic agents 
(Moody and Reddy, 1978a ; Svoboda, 1978; Hayashi et £ [ ,  1981; Pollard  
and Brindley, 1982). Other peroxisomal enzymes which have been shown 
to be enhanced s lig h tly  by hypo!ipidaemic agents include D-amino acid 
oxidase (Hayashi e t a l ,  1981; Svoboda, 1978) and dihydroxyacetone 
phosphate acyl transferase (Pollard and Brindley, 1982).
I . 2 .2 .2  OTHER HEPATIC EFFECTS
A variety o f  s truc tu ra lly  and pharmacologically d if fe re n t  chemical 
agents e l i c i t  p ro life ra t io n  of peroxisomes in the l iv e r  of rodents.
This organelle induction alone appears to link  these agents 
toxicologically  a t present. I t  would appear that th is  p ro l ife ra t io n  
is ,  without exception, associated with an increase in the peroxisomal 
capacity for the oxidation of fa t ty  acids. C lofibrate  and the 
hypolipidaemic drugs have been shown to produce a number of e ffects  on 
the l iv e r  which are not confined to the peroxisome or peroxisomal 
enzymes. A thorough search of the l i te ra tu re  has revealed that many 
of these effects are common to peroxisome p ro lite ra to rs  in general.
The effects of peroxisome pro litera tors  on the rodent l iv e r  are 
summarised in Table 1.3.
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As already mentioned carn itine acyl transferase a c t iv ity  is enhanced 
dramatically in the l ive rs  of rodents treated with peroxisome 
p ro lite ra to rs . However, the long-, medium- and short-chain carn itine  
acyl transferases (carn itine  palmitoyl transferase (CPT), carn itine  
octanoyl transferase (COT) and carn itine acetyl transferase (CAT) 
respectively are not enhanced equally. Without exception, CAT and COT
3
are enhanced fa r  more than the CPT (Moody and Reddy, 1978 'Markwell e t  
aT, 1977). Part of the CAT and COT is  located within the peroxisome 
and this a c t iv ity  is markedly enhanced concommitant with peroxisome 
p ro lite ra t io n . However, the greatest induction in this a c t iv i ty  
occurs in the mitochondrial compartment (Markwell e t £1_, 1977;
Kahonen, 1976).
The a c t iv i t ie s  of three additional non-peroxisomal enzymes involved in 
l ip id  metabolism are also enhanced by peroxisome p ro lite ra to rs :  
cytochrome P450-mediated 1 auric acid hydroxylase, long chain acyl-CoA 
hydrolase and fa t ty  acyl-CoA desaturase. Further indications of an 
e ffec t of these agents on l ip id  metabolism is suggested by the increase 
in Coenzyme A, carn itine  and fa t ty  acid binding protein in the l iv e r  of 
animals treated with these agents.
The compilation of th is data has uncovered three important facts:
1. The effects of these various agents on the l iv e r  are markedly 
s im ilar , not only in the p ro l ife ra t io n  of peroxisomes but also in 
the p ro f i le  of changes in other hepatic enzymes and constituents.
2. The in i t i a l  overall e f fec t  on the l iv e r  produced by the
administration of chemicals is not q u a lita t iv e ly  d if fe re n t  to that  
observed in certain types of physiological stress.
3. The p ro fi le  of effects on the l iv e r  is strongly indicative  of a
perturbation of hepatic l ip id  metabolism.
1.2 .3  EXTRA-HEPATIC PEROXISOME PROLIFERATION
Though p ro life ra t io n  of peroxisomes appears to be a common observation 
in the l iv e r  of rodents, i ts  occurrence in extrahepatic tissues is not 
well characterised. The sparse data available on peroxisome 
pro life ra tio n  in extrahepatic tissues probably re flects  the lim ited  
investigation rather than the r a r i ty  of the occurence (Table 1 .4 ) .  The 
role of peroxisomes and peroxisomal fa t ty  acid metabolism in 
extrahepatic tissues is not known.
1-3 SPECIES DIFFERENCES IN HEPATIC PEROXISOME PROLIFERATION
As already noted p ro l ife ra t io n  of peroxisomes in the l iv e r  of rodents 
is a common observation. Early studies by Svoboda e t al_ (1967) 
suggested that c lo fib ra te  did not e l ic i t -h e p a t ic  peroxisome 
p ro life ra tio n  in a number of non-rodent species. Subsequently a 
s ign if ican t amount of data has accumulated suggesting that peroxisome 
p ro lite ra t io n  is a species-specific phenomenon and does not occur in 
a ll  species.Table 1.5 summarises this data. Although many of these 
studies were lim ited in scope and u t i l is e d  only a few animals, the data 
strongly suggests a species difference in response to peroxisome 
p ro lite ra to rs . Reddy et (1984) however have suggested that  
peroxisome pro lite ra tio n  is not specific to rodents but can be induced 
in other species a t s ig n if ican tly  higher doses, that is i t  is  a 
dose-dependent rather than species-specific phenomenon. In the l ig h t  
of the suggestion that hepatic peroxisome pro!itera tors  as a class are 
carcinogenic (Reddy et a l , 1980) th is  species difference phenomenon is  
of great importance. I f  peroxisome p ro life ra t io n  is e n t ire ly  a 
species-specific phenomenon then extrapolation of the carcinogenic 
hazard to species not exhibiting peroxisome p ro life ra t io n  is  
questionable. S im ilarly  i f  peroxisome p ro life ra t io n  is a 
dose-dependent phenomenon as suggested by Reddy then each species must 
be considered indiv idually  in i ts  quantitative response to a r e a l is t ic  
exposure level of the agent.
PEROXISOME PROLIFERATION IN EXTRAHEPATIC RODENT TISSUES 
TISSUE COMPOUND REF
KIDNEY CLOFIBRATEb 1,12
METHYL CL0FENAPATEa>b 2,11
ACETYL SALICYLIC ACIDb 3
PARATHYROID HORMONEb 4
NAFENOPIN3 5
BR931a,b 11
PROCETOFEN3,6 11
RMI 14,514b 13
INTESTINE CLOFIBRATE6 6,12
NAFENOPIN3 , 7,5
DUODENUM NAFENOPIN3 , 15 5
MUSCLE NAFENOPIN3 , b 5,8
BROWN FAT COLD ADAPTATION3 9
HEART CLOFIBRATE3 10
HIGH FAT DIETS3 10
NAFENOPIN3 5
HARDERIAN GLAND NAFENOPIN3 5
TESTES NAFENOPIN3 5
ADRENALS NAFENOPIN3 5
LUNG NAFENOPIN3 5
CEREBELLUM NAFENOPIN3 5
THYMUS NAFENOPIN3 5
SEMINAL VEHICLE NAFENOPIN3 5
3 Stimulation of peroxisomal B oxidation enzymes 
Increase in peroxisome volume density
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TABLE 1.4
(Continued)
REFERENCES
( I )  Azarnoff and Svoboda, 1966; (2) Reddy et al_, 1975^; (3) Hruban et
al_, 1966; (4) Engfeldt et al_, 1958; (5) Leighton and Lazo, 1982; (6)
Svoboda, 1976; (7) Psenicnik and Pipan, 1977; (8) Behrens et al.,
1983; (9) Nedergaard 'et al_, 1980; (10) Norseth and Thomassen, 1983;
( I I )  Lalwani et a l ,  1981; (12) Small e t a l , 1981; (13) Svoboda, 1978.
TABLE 1.5
HEPATIC PEROXISOME PROLIFERATION IN NON-RODENT SPECIES
AGENT SPECIES RESPONSE REF
CIPROFIBRATE CAT + 1
CHICKEN + 1
CYNAMOLGUS MONKEY + 1
PIGEON + 1
RHESUS MONKEY + 1
CLOBUZARIT DOG _  2
MARMOSET MONKEY _  2
CLOFIBRATE CHICKEN __ 3
DOG + 3
MARMOSET MONKEY -  4
RABBIT -  3
RHESUS MONKEY -  4,5
SQUIRREL MONKEY -  3
DEHP MARMOSET -  6
FENOFIBRATE RHESUS MONKEY - 5
CLOZIC DOG -  7
MARMOSET -  7
no peroxisome p ro life ra t io n
+ peroxisome pro life ra tio n
(1) Reddy e t a]_, 1984; (2) Orton et aV, 1984; (3) Svoboda et a l ,  
1967; (4) Holloway et a l , 1982a ; (5) Blane and P in aro li ,  1980;
REFERENCES
(6) Mitchell e t a l , 1985; (7) Holloway et a l , 1982^.
Data available on peroxisome p ro life ra t io n  in human l iv e r  is lacking.
A small number of studies have been carried out on human l iv e r  biopsies 
from patients receiving hypolipidaemic drugs. Table 1.6 summarises 
this data. The peroxisome response was in general assessed merely by 
subjective examination of electron micrographs without any quantitative  
morphometric analysis. Evidence is also available suggesting that  
peroxisome pro !ite ra tion  occurs in man in certain pathological 
conditions, and notably in conditions where fa t ty  in f i l t r a t io n  of the 
l iv e r  is symptomatic.
Despite the inadequacy of the above-mentioned studies the data suggests 
that peroxisome p ro life ra t io n  may occur in the l iv e r  of man. However, 
whether the degree of this p ro lite ra t io n  is comparable with .that 
observed in rodent l iv e r  is not known. I t  is questionable whether a
1.2 fold increase in peroxisomal volume in human l iv e r  following  
c lo fib ra te  administration is  b io log ica lly  meaningful (Hanefeld e t al_, 
1983) when compared to the enormous increases observed in the rodent 
l iv e r .
1-4 PEROXISOME PROLIFERATION AND HEPATOCARCINOGENESIS
Reddy et al_ (1980) suggested that rodent hepatic peroxisome 
pro lite ra tors  constitute a novel class of chemical carcinogens. This 
hypothesis was based on the observation that a number of hypol ipidaemic 
drugs had been shown to produce tumours in the live rs  of rodents. I t  
has since become evident that a number of other hypolipidaemic drugs 
and other peroxisome pro lite ra tors  have been shown to enhance the 
incidence of hepatocellular carcinomas in rodents. Table 1.7 
indicates the peroxisome pro lite ra tors  for which hepatocarcinogenicity 
in rodents has been demonstrated. I t  does not necessarily ensue that  
the other agents do not induce hepatocarcinogenesis but rather that no 
data is availab le . I t  is c lear that a good correlation exists between 
hepatic peroxisome p ro life ra tio n  and hepatocarcinogenesis in rodents.
TABLE 1,6
HEPATIC PEROXISOME PROLIFERATION IN MAN
CHEMICALLY INDUCED:
AGENT RESPONSE REF
ALCOHOL TOXICITY + 1,2
CLOFIBRATE + 3,4
FENOFIBRATE -  5 ,6 ,7
GEMFIBRIZOL - 8
LIDOFLAZINE + 9
NOT CHEMICALLY INDUCED:
CAUSE RESPONSE REF
DIABETES MELLITUS + 2
HEPATITIS (VIRAL) + 10,11,12
LEPTOSPIROSIS + 13
LIPODYSTROPHY + 14
OBESITY + 2
REYES SYNDROME + 15
REFERENCES
(1) Rubin and Lieber, 1967; (2) Petersen, 1977; (3) Hanefeld e t al_,
1980; (4) Hanefeld e t aV, 1983; (5) Bliimcke e t al_, 1983; (6) Gariot
e t al_, 1983; (7) Blane and P in aro li,  1980; (8) de la  Ig les ia  e t a l ,
1981; (9) Verheyen et al_, 1975; (10) Dancygier, 1983; (11) Sternlieb
and Quintana, 1977; (12) Schaffner, 1966; (13) Brito e t a l , 1970;
(14) Harbour et a l , 1981; (15) Schubert et a l , 1972.
TABLE 1.7
CORRELATION OF HEPATOCARCINOGENESIS WITH AGENTS CAUSING 
HEPATIC PEROXISOME PROLIFERATION IN RODENTS
AGENT HEPATOCARCINOGEN REF
BEZAFIBRATE +*- 1
BR-931 + 2
CIPROFIBRATE + 22
CLOFIBRATE + 4,5
FENOFIBRATE +* 3
GEMFIBRIZOL +- 6
METHYL CLOFENAPATE + 7
NAFENOPIN + 8,9
TIBRIC ACID + 2
Wy-14,643 . + 10,11
DI-(2-ETHYL HEXYL)PHTHALATE + 12
DI-(2-ETHYL HEXYL)ADIPATE +- 13
ETHIONINE + 14,15
PHENOBARBITAL + 17,18
STREPT0Z0T0CIN2 + 19,20
TRICHLOROETHYLENE +- 21
pro !ife ra tion  in rodents; however, the chemical per se has 
carcinogenic potential
TABLE 1.7
(Continued)
REFERENCES
(1) Fahimi e t a]_, 1982; (2) Reddy £ t  aT_, 1980; (3) Reddy and Lalwai,
1983; (4) Reddy and Qureshi, 1979; (5) Svoboda and Azarnoff, 1979;
(6) Fitzgerald e t al_, 1981; (7) Reddy et al_, 1982^; (8) Reddy et a l ,
1976; (9) Reddy and Rao, 1977; (10) Reddy et a l ,  1979; (11) Lalwani
■et al., 1981b; (12) NTP, 1982; (13) NTP, 1981; (14) Popper e t  a l , 1953
(1 5 ) -Farter, 1956; (17) Thorpe and Walker, 1973; (18) Peraino e t a l ,
1973; (19) Weisburger et al_, 1975; (21) NTP, 1976; (22) Rao e t ali,
1984.
In teres ting ly , the evidence available suggests that peroxisome 
p ro lite ra to r  carcinogens do not act via a d irect genotoxic mechanism.
A variety of short term in v itro  tests have been used to assay the 
genotoxic potential of these agents. The most common in v itro  tes t is  
the Salmonella typhimurium assay which measures DNA damage as base pair  
substitution or frame s h if t  mutations of h istid ine-requiring  strains of 
Salmonella to histidine-independent mutants (Ames et a l , 1975). Where 
tested the peroxisome p ro lite ra to rs  are negative, that is do not 
s ig n if ican tly  increase the number of mutations, in the Salmonella test  
(Warren e t al ,^ 1980; Fitzgerald et al_, 1981; Warren et al_, 1982; 
Kozumbo et al_, 1982; Reddy et al_, 1982^). A second widely used vn 
v itro  te s t ,  the lymphocyte [ 2H] thymidine assay, measures DNA damage as 
a suppression of the rate of [ 2H] thymidine incorporation into  
replicating DNA in p ro life ra t in g  eukaryotic ce lls  (Painter, 1978; 
Warren, 1978). Peroxisome prol ite ra to rs  have consistently proven to be 
"non-genotoxic" in this assay (Warren e t £ [ ,  1980; Warren e t al_,
1982). A further complementary indicator of genotoxic potential is 
the amount of binding of an agent to DNA following in vivo 
administration (Lutz, 1979). Neither the hypolipidaemic drugs 
c lo fib ra te  or fenofibrate (Von Daniken e t al_, 1981) nor the 
plastic isers  DEHP or DEHA (Von Daniken e t  al_, 1984) have demonstrated 
any such covalent binding to DNA. The only indication of any 
interaction of these agents with c e l lu la r  DNA is provided by the 
induction of s is te r  chromatid exchanges (SCE). SCEs are reciprocal 
changes of chromosomal material between s is ter chromatids (Stetka and 
Wolff, 1976). C lofibrate and the phenoxyacetic acid herbicides have 
been shown to induce SCEs in v itro  ( in  CHO c e lls )  (Linnainmaa, 1984). 
However, no dose-related effects were obtained, the induction was very 
weak and the results concluded to indicate the absence of a DNA 
damaging e f fe c t .  DEHP has also been shown to induce SCEs in CHO ce lls  
(P h i l l ip s 'e t 'a r t ,  1982).
The available evidence suggests that peroxisome p ro life ra to r  
carcinogens do not act via a mechanism which involves a primary 
genotoxic event. The lack of d irec t genotoxic a c t iv i ty  has led Reddy 
and coworkers to propose that an in d irec t mechanism may account fo r  the
observed carcinogenicity of these agents: peroxisome p ro life ra t io n
leads to an imbalanced increase in the peroxisomal F^C^-generating 
oxidases and catalase resulting in an increase in the steady state  
levels of H2O2 within the l iv e r  c e l l .  This increased H2O2 may lead to 
increased levels of reactive oxygen species within the c e l ls .  The 
sustained increase in H2O2 and reactive oxygen species is presumed to 
potentiate the carcinogenic process (Reddy et art, 1980; Warren et a l , 
1982). In support of this hypothesis ^ 2  has been shown to produce 
DNA damage in mammalian ce lls  in v it ro  (Stich et a l , 1978; Mehlo Fihlo  
et al_, 1984; Hoffman and Meneghini, 1979) and lipofuscin pigment has 
been shown to accumulate in the l iv e r  of animals treated with 
peroxisome pro life ra tors  (Reddy et a t ,  1982).
Despite the attractiveness of this hypothesis l i t t l e  evidence in  
support of i t  has been forthcoming. I t  is also of consideration that  
the p ro f i le  of hepatic changes brought about by the various peroxisome 
pro life ra tors  is remarkably s im ilar (Table 1.3) and any of these 
concurrent events could equally be related to the carcinogenic a c t iv i ty  
of these agents. Further elucidation of the mechanisms and changes 
involved in peroxisome p ro lite ra t io n  is essential to our understanding 
of the role of this process, i f  any, in hepatocarcinogenesis.
1.5 AIMS AND OBJECTIVES
The aims of this work were twofold: f i r s t l y ,  to gain a more thorough
understanding of hepatic peroxisome p ro life ra t io n  in rodents, in 
p articu lar by understanding the mechanisms by which chemicals e l i c i t  
this e f fe c t ,  and secondly, to establish whether a "species difference"  
in sens it iv ity  to peroxisome p ro life ra t io n  exists and i f  so to 
understand the mechanistic basis for th is  d ifference, and provide a 
better estimate of the hazard of such agents to man.
The objectives of this work were:
1. To investigate the potential of primary ra t  hepatocyte cultures as 
an i_n v itro  system for the study of peroxisome p ro l i fe ra t io n .
Using primary hepatocyte cultures from various species including 
man, to investigate whether a species difference in s e n s it iv ity  
exists.
To investigate the mechanism(s) by which these agents e l i c i t  
peroxisome pro life ra tio n  in the rodent l i v e r .
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CHAPTER I I  
METHODS
I I . l  ANIMALS
Adult male Aider!ey Park rats (Wistar-derived) weighing 160 -  250 g 
were used. Rats were housed in stainless steel wire-bottomed cages, 
subjected to a l ig h t  cycle of 0600 -  1800 and were allowed food (PCD 
p e lle t  d ie t ,  BP N utr it ion , Witham, UK) and water ad l ib itu m . For 
oral dosing studies animals were administered the chemicals, dissolved 
in corn oil (5 ml/kg) by gavage. Control animals received corn oil  
alone. Rats were k i l le d  by cervical dislocation or inhalation of 
excess diethyl ether as stated.
Adult male Alderley Park guinea pigs (Duncan and Hartley) weighing 
4 0 0 - 5 0 0  gm were used. The animals were housed in pairs and fed and 
dosed as above. Guinea pigs were k i l le d  by cervical dislocation or 
inhalation of excess diethyl ether.
Adult male marmoset monkeys (C a l l i th r ix  jaccus) weighing 200 -  400 g 
were supplied by the Marmoset Breeding Unit, ICI PLC, Pharmaceuticals 
Division, Alderley Park, Macclesfield, Cheshire UK. The animals were 
housed singly and fed a standard d ie t (Mazuri Primate D ie t ) ,  fru it .- in -  
season and malt bread once daily  and were allowed water ad 1ibiturn. 
Vitamin supplements were supplied twice weekly in the d ie t .  Marmosets 
were administered DEHP (2 g/kg) by gavage. DEHP was not suspended in 
corn o il due to the lim ited volume which could be administered to the 
monkey by this route. Marmosets were k i l le d  by inhalation of excess 
carbon dioxide or by a single intraperitoneal in jection of penta- 
barbitone (60 mg Saggatal, May and Baker, Dagenham, UK) as stated.
Human l iv e r  biopsies (Manchester Royal Infirmary) were obtained from 
brain-dead renal transplant donors a f te r  compliance with ethical and 
legal requirements.
I I . 2 MATERIALS
C lofib ric  acid was supplied by Pharmaceuticals Division, ICI PLC, 
Alderley Park, Macclesfield, UK. D i-(2 -ethyl hexyl)phthalate (DEHP), 
mono-(2-ethyl hexyl) phthal ate and 7“^C  DEHP (48.6 mCi/mmol) were 
supplied by Petrochemicals and Plastics D ivision, ICI PLC, Wilton,
Middlesbrough, UK. Metabolites of DEHP were prepared from the urine 
of rats dosed o ra lly  with 7“^ C  DEHP by Dr J C Lhuguenot (Lhuguenot et  
a l , 1985). These metabolites were isolated by preparative HPLC and 
id en tif ied  by GC/MS and were mono-(3-carboxy-2-ethyl propyl)phthalate  
(metabolite I ) ,  mono-(5-carboxy-2-ethyl pentyl)phthalate  
(metabolite V ) , mono-(2-ethyl-5-oxohexyl)phthalate (metabolite VI) and 
mono-(2- ethyl-5-hydroxy hexyl)phthalate (metabolite IX ) .
Metabolite Vis refers to a chemically synthesized metabolite VI which 
was prepared by Mr D Moore, Biochemical Toxicology Section, Central 
Toxicology Laboratory, ICI PLC, Alderley Park, Macclesfield, Cheshire, 
UK. 1"^C palmitic acid (58 mCi/mmol), 1“^C  palmitoy!-Coenzyme A 
(50-60 mCi/mmol) and l ' ^ C  1 auric acid (15-30 mCi/mmol) were obtained 
from Amersham International PLC, Amersham, UK.
Liebowitz L15 culture medium, tryptose phosphate broth, foetal bovine 
serum, trypan blue dye and phenol red indicator were obtained from Flow 
Laboratories, Irv in e ,  UK. Collagenase (Type I )  supplied by Cooper 
Biomedical, was obtained from Lome Laboratories, Berkshire, UK.
Dispase (from Bacillus polymyxa Grade I I )  was obtained from Boehringer- 
Mannheim, East Sussex, UK. Hyaluronidase (from bovine testes, Type 
1-S), deoxyribonuclease I (from bovine pancreas, type I I I )  and Fibro- 
nectin (from human plasma) were obtained from Sigma Chemical Company, 
Poole, UK.
*Optiphase MP' s c in t i l la n t  was obtained from Fisons PLC, S c ie n t if ic  
Equipment Division, Loughborough, UK. Carbogen (95% 02/5% CO2 ) was 
obtained from 'A ir  Products', Walkden, UK.
All other chemicals were of the highest available purity  and were 
obtained from Sigma Chemical Company, Poole, UK, Aldrich Chemical 
Company, Gillingham, Dorset, UK, or B rit ish  Drug Houses, Liverpool, UK.
H  .3 ISOLATION OF HEPATOCYTES
Hepatocytes were isolated from ra t ,  guinea pig and marmoset l iv e r  by in 
situ perfusion with collagenase (Rao et £ [ ,  1976; with modifications) 
and from human l iv e r  slices by incubation with collagenase/dispase 
containing solution. Collagenase alone was in s u ff ic ie n t  to digest 
marmoset and human l iv e r  tissue and consequently the methods vary. 
Figure I I . 1 summarises the procedures used.
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FIGURE I I . 1
FLOW DIAGRAM FOR ISOLATION OF HEPATOCYTES FROM THE LIVER OF
DIFFERENT SPECIES
RAT, GUINEA PIG
KRHB x 10 MIN
MARMOSET
I
■ \ * ■ N
KRRB, x 10 MIN PBS x 10 MIN
>
EGTA x 10 MIN
i
HUMAN LIVER BIOPSY
IN SITU PERFUSION IN SITU, PERFUSION 0.5 mm SLICES
37 °C 37°C 37°C
i
3 WASHES IN PBS 
x 10 MIN
i
3 WASHES IN EGTA 
x 10 MIN
DIGESTION WITH DIGESTION WITH DIGESTION IN
COLLAGENASE COLLAGENASE/DISPASE COLLAGENASE/DISPASE
x 20 MIN HYALURONIDASE x 20 MIN HYALURONIDASE x 35 MIN
PASS THROUGH GAUZE
i
CENTRIFUGATI0N-30g AND 
RESUSPENDED IN KRHB x 3
TRYPAN BLUE VIABILITY TEST
REAGENTS
1. Ca^+-fre e  Krebs Ringer Phosphate Buffer (KRPB)
NaCl 150 mM
KC1 4.97 mM
KH2P04 1.24 mM
MgS04 0.62 mM
MgCl2 0.62 mM
NaHC03 3.73 mM
Na2HP04 4.84 mM
2. Ca— free Krebs Ringer Hydrogencarbonate Buffer (KRHB)
NaCl 142 mM
KC1 4.37 mM
KH2P04 1.24 mM
Mg504 0.62 mM
MgCl2 0.62 mM
NaHC03 24.0 mM
3. Ca^+-  and Mg^+-free  Phosphate Buffered Saline (PBS)
NaCl 200 mM
KC1 2.68 mM
KH2P04 1.47 mM
Na2HP04 ,2H20 20.3 mM
4. 'ETGA* -  PBS + 0.5 mM Ethylene-bis-(B-amino ethyl e th e r)N -N '-te tra  
acetic acid
47.
5. Hank's Basic S a lt S o lu tion  (Hanks BSS)
NaCl 200 mM
KC1 5.36 mM
Na2HP04 0.42 mM
kh2po4 0.44 mM
Glucose 5.56 mM
Solutions 1 -  5 contained phenol red indicator (0.5% solution)
2 m l/L itre  and were s te r i l is e d  by f i l t r a t io n  (0.45 urn f i l t e r ) .
6 . CaCl2 -  769 mM in d is t i l le d  water
7. Enzymes
Collagenase
Dispase
Hyaluronidase
Deoxyribonuclease
PROCEDURES
I I . 3.1 ISOLATION OF HEPATOCYTES FROM RAT LIVER
Hepatocytes were isolated from ra t  l iv e r  by a two-step _in situ  
perfusion technique, modified from that described by Rao e t al_ (1976). 
Buffers were maintained at 37°C and gassed continuously with 95% 02/5% 
C02* 180 -  240 g male rats were k i l le d  by inhalation of excess
diethyl ether. Immediately following expiration, the animal was 
prepared for perfusion. The abdominal cavity was opened and the l iv e r  
exposed. The in fe r ia  vena cava was ligated above the renal veins. 
Cannulae were inserted into the hepatic portal vein and into the 
superior vena cava via the r igh t atrium. The l iv e r  was perfused (v ia  
the hepatic portal vein) with KRPB (40 ml/min) for 10 min. The 
perfusate was discarded. The l iv e r  was then perfused with KRHB (40 
ml/min). Collagenase solution (96 mg collagenase, 1 ml CaCl2 and 
10 ml KRHB) was added to the remaining 200 ml of KRHB and the l iv e r
was perfused (with recirculation) fo r up to 20 min. The l iv e r  was 
then excised, chopped into smaller pieces and teased apart. The 
loosened mass was passed through gauze (125 ^im). The f i l t r a t e  was 
centrifuged a t 300 rpm for 2 min. The resultant ce ll p e l le t  was 
washed in KRHB and sedimented as above three times. The cell p e l le t  
was resuspended in the appropriate buffer/cu lture  medium and the 
v ia b i l i ty  determined by trypan blue dye exclusion ( I I . 4 ) .
11.3.2 ISOLATION OF HEPATOCYTES FROM GUINEA PIG LIVER
Hepatocytes were isolated from the l iv e r  of male guinea pigs in a 
manner identical to that described for the ra t .  However, the b i le  
duct was ligated prior to perfusion.
11.3.3 ISOLATION OF HEPATOCYTES FROM MARMOSET LIVER
Male marmosets were k i l le d  by a single in jection of pentabarbitone 
(60 mg Saggatal) .  The perfusion of the l iv e r  via the hepatic portal 
vein and superior vena cava was identical to that described for the 
ra t .  The b i le  duct was ligated prio r to perfusion. The l iv e r  was 
perfused (50 ml/min) f i r s t  with 500 ml PBS followed by 500 ml EGTA 
solutions and f in a l ly  (with recircu lation) with 200 ml Hanks BSS 
containing dispase (300 mg), collagenase (100 mg), hyaluronidase 
(100 mg) , deoxyribonuclease (10 mg) and CaC^ (700 j i l ) adjusted to pH
7.4 (modified from Maekubo e t al_, 1982). A fter about 20 min the l iv e r  
was removed and the hepatocytes collected by f i l t r a t io n  through gauze 
followed by centrifugation as described for the iso lation of ra t  
hepatocytes.
11.3 .4  ISOLATION OF HEPATOCYTES FROM HUMAN LIVER
The outer capsule of the l iv e r  was removed and the l iv e r  sliced with a 
chloroform-degreased microtome blade into slices of approximately
0.5 mm. 10 gm l iv e r  was incubated (with shaking) in 25 ml PBS in a 250 
ml conical flask (37°C) for 10 min. The PBS was decanted and 2 fu rther
such washes in PBS performed. The l iv e r  slices were washed twice in 
EGTA as above. F ina lly  20 ml Hanks BSS containing dispase (60 mg), 
collagenase (20 mg), hyaluronidase (20 mg), deoxyribonuclease (2 mg) 
and CaCl2 (140 ^il) was added and the slices incubated at 37°C for  
approximately 30 min. The hepatocytes were collected by f i l t r a t io n  
and centrifugation as described for the iso lation of ra t  hepatocytes. 
All solutions contained gentamicin (50 ^ig/ml) .
I I . 4  TRYPAN BLUE DYE EXCLUSION TEST
The v ia b i l i t y  of isolated hepatocytes was assessed by determining the 
percentage of ce lls  excluding the polar dye Trypan Blue.
REAGENTS
Trypan Blue dye: 0.5% (w/v) solution in 0.85% (w/v) saline.
PROCEDURE
Trypan Blue dye (100 j i l ) was added to the hepatocyte suspension (250 
j j l ) and mixed gently. The number of ce lls  excluding the dye and the 
to ta l number of ce lls  were counted using a haemocytometer. Cell 
preparations routinely  had a v ia b i l i t y  of greater than 90%.
H .5  PREPARATION OF MONOLAYER CULTURES OF HEPATOCYTES 
REAGENTS
I .  CL15 Medium
Liebowitz L15 medium containing:
foetal bovine serum 8.3% (v /v)
tryptose phosphate broth 8.3% (v /v ) *
p e n ic i l l in  G 41.3 lU/ml
streptomycin 8.2 yg/ml
Insulin 10“®M
Hydrocortisone 21-semi succinate 10~^M
2. HCL15 Medium -  CL15 medium containing vitamin C (50 mg/Litre)
3. Fibronectin (human) -  1 mg/100 ml d is t i l le d  water
4. SET buffer -  sucrose, 0.25 M )
EDTA, 5 mM ) pH 7 .4 , 4°C 
Tris-HCl, 20 mM )
PROCEDURE
25 cm^  Falcon tissue culture flasks were seeded with 2.x 10^ viable  
ce lls  in 4 ml CL15 medium (ra t )  or HCL15 medium (guinea pig, marmoset 
and human). The flasks used for marmoset and human hepatocyte 
cultures were precoated with fibronectin (3 ml) for 3 hours before use. 
The flasks were incubated at 37°C. Four hours a fte r  seeding the 
spent medium and unattached ce lls  were aspirated and fresh medium was
added. Further medium changes were made at 24, 48 and 72 hours a f te r
seeding. Compounds to be added to the monolayers were dissolved in 
dimethyl formamide (DMF) and added at each 24 hour medium change. 
Addition of DMF never exceeded 10 y} per flask and th is  concentration 
produced no visable cy to tox ic ity . The monolayers were harvested at  
times up to 96 hours a f te r  seeding. The monolayers were harvested in 
the following way: the medium was discarded and the monolayer washed 
twice with 2 ml SET buffer. The ce lls  were removed from the flask by 
scraping into 1 ml SET buffer. The ce lls  were disrupted by sonication 
for 10 seconds in an MSE 150 Watt Ultrasonic Disintegrator with an 
exponential probe of end diamter of 1/8" and stored at -70°C in 
Eppendorf micro tubes (1.5 ml, Eppendorf Geratebau, Hamburg, Germany).
I I . 6 PREPARATION OF SUBCELLULAR LIVER FRACTIONS
Following homogenisation of l i v e r  tissue the isolated organelle types 
were concentrated into separate fractions by d i f fe re n t ia l  
centrifugation.
REAGENTS
1. ST Buffer -  0.25 M sucrose ) pH 7.4
5 mM Tri s-HCl )
2. SET Buffer -  0.25 M sucrose )
5 mm EDTA ) pH 7.4
20 mM Tris-HCl )
PROCEDURE
Animals were sacrificed by cervical dislocation and the l ive rs  rapidly  
excised and weighed. The gall bladder was removed where necessary.
All subsequent operations were carried out at 4°C. The l i v e r  was 
placed in ST buffer (4 ml/gm), scissor-mixed and homogenised (10 
strokes). A motor driven Potter-Elvehjem glass/teflon homogeniser 
with 1/20" clearance was used throughout. The homogenate was passed 
through muslin cloth to remove large debris and unbroken c e l ls .  The 
f i l t r a t e  was centrifuged at 15,000 gav for 15 min at 4°C in a Beckman 
02:21 centrifuge. The resulting 'heavy p e l le t '  (containing nuclei,
lysosomes, mitochondria and peroxisomes) was resuspended by
homogenisation (6 strokes) in ST buffer. The supernatant was further  
centrifuged at 110,000 gav for 1 hour a t 4°C in a Beckman L8-55 
ultracentrifuge. The resulting microsomal p e l le t  was resuspended by 
homogenisation (6 strokes) in SET buffer (1 ml/2 gm of l i v e r ) .  Samples 
of the supernatant (cytosolic) frac t io n , microsomes and heavy p e l le t
were frozen a t -70°C in 1.5 ml Eppendorf tubes.
11.7 ISOLATION OF LIVER MITOCHONDRIA
A subcellular l iv e r  fraction enriched with functionally  viable  
mitochondria, but re la t iv e ly  free from microsomal and cytosolic enzyme 
contamination was prepared by d if fe re n t ia l  centrifugation, essentia lly  
as described by Aldridge(1957).
REAGENTS
1. 0.3 M sucrose
PROCEDURE
Adult male rats and guinea pigs were k i l le d  by cervical dislocation and 
the live rs  rapidly excised, weighed, scissor-mineed and washed in 
ice-cold sucrose. All subsequent procedures were performed a t 4°C.
The l iv e r  mince was homogenised (10 strokes) in sucrose (30 ml/8 gm 
l i v e r ) .  An overhead motor driven Potter-Elvehjem glass/teflon  
homogeniser with 1/20" clearance was used throughout. The homogenate 
was further diluted with sucrose (45 ml/8 gm l iv e r )  and was centrifuged  
at 850 gav for 10 min at 4°C in a Beckman L8-55 centrifuge. The 
resulting supernatant was centrifuged at 10,000 gav for 20 min a t  4°C. 
The p e lle t  containing the mitochondria was resuspended by 
homogenisation (3 strokes) in sucrose (1 ml/gm l i v e r ) .  The functional 
in teg r ity  of the mitochondrial preparation was assessed by 
determination of the P/0 ra tio  ( I 1 .9 ) .  Using pyrurate as substrate, 
preparations having a P/0 ra t io  of less than 2.5 were discarded.
H .8  METABOLISM OF SUBSTRATES BY ISOLATED MITOCHONDRIA
The metabolism of various substrates by isolated mitochondria was 
studied by determining the oxygen consumption polarographically.
REAGENTS
1. Buffer I (Holland and Sherrat, 1973)
KC1
MgCL2
80 mM 
6 mM 
20 mM 
2 mM 
2 .5 mM
pH 7 .0
Tris-HCl
EDTA
Pi*
*100 ml potassium phosphate buffer (25 mM pH 7 .0 ) /L i t r e  Buffer I .
2. Buffer I I  (B a r t le t t  e t  a^, 1981)
Buffer I containing fa tty  acid free bovine serum albumin (10 mg/ml), 
potassium arsenate (5 mM), sodium malonate (5 mM) and 2,4-dinitrophenol 
(20 ^M)
3. Sodium pyruvate (150 mM)/sodium fumarate (15 mM) in buffer I .
4. Disodium succinate (150 mM) in buffer I .
5. Palmitic acid (10 mM) in absolute ethanol.
6 . Palm itoyl-L-carn itine , lauroyl-DL-carn itine, decanoyl-DL-carnitine 
dissolved in (50/50) buffer I/absolute ethanol.
Octanoyl-OL-carnitine and hexanoyl-DL-carnitine, dissolved in 
buffer I .
PROCEDURE
Oxygen consumption was determined polarographically using a Clark type 
oxygen electrode (Yellow Spring Instruments model 5331). Using 
saline washed mitochrondria (Estabrook, 1957) the oxygen content of the 
buffer was determined to be 0.44 j^g atom 0/ml at 37°C (Chappel 1964).
An aliquot of mitochondrial suspension was equilibrated a t 37°C in a 
f ina l volume of 3 ml. Oxygen consumption was recorded both prio r to 
and following addition of substrate to the incubation mixture. Buffer 
I was used for the measurement of pyruvate, succinate, palmitate and 
palm itoyl-L-carn itine oxidation. Buffer I I  was used where the 
metabolism of acyl-carnitines by DNP-uncoupled mitochrondria was 
determined. The pH of the medium was determined following addition of 
substrates. Compounds to be added to the incubations were dissolved in 
DMF and the effects of DMF alone were assessed. Results were 
expressed as ngm atom 0 consumed/minute.
I I . 9 DETERMINATION OF P/0 RATIO IN ISOLATED MITOCHONDRIA
The functional v ia b i l i t y  of isolated mitochrondria! preparations was 
assessed by determination of the P/0 ra tio  using pyrurate as substrate 
(Estabrook, 1967).
REAGENTS
1. Buffer I ( I I .8 )
2. Sodium Pyruvate (150 mM)/sodium fumarate (15 mM) in buffer I
3. Adenosine 5 ‘ -diphosphate, (ADP)-l mmol/10 ml buffer I
PROCEDURE
Mitochondria were isolated from the l ive rs  of male rats and kept on ice
in 0.3 M sucrose. Oxygen consumption due to metabolism of pyrurate
was determined polarographically using a Clark type oxygen electrode. 
Mitochondria (3-5 mg protein) in a f in a l volume of 3 ml incubation 
buffer were incubated at 37°C. Oxygen consumption was recorded 
following addition of pyruvate/fumarate (20j j 1 ). ADP (10 jj! )  was 
added to the incubation mixture and oxygen consumption recorded until  
the resting rate was resumed. The quantity of oxygen consumed during 
ADP-stimulated respiration was determinated and the P/0 ra t io  was 
calculated:
jjmol ADP added
P/0 = pg atom 0 consumed
The theoretical P/0 ra tio  using pyrurate as substrate is 3 so
mitochondria having a P/0 ra t io  of less than 2.5 were discarded.
11.10 OXIDATION OF PALMITIC ACID BY ISOLATED RAT HEPATOCYTES
The production of ^C  acid soluble material and ^ C 02 from 1“^C
palmitic acid was determined (Christiansen et al_, 1976).
REAGENTS
1. 1"^C Palmitic acid 1.0 mM, 2.9 mCi/mmol
(1“^C  palmitic acid and 6.05 mg palmitic acid were dissolved in 2 ml
0.1 M NaOH at 100°C. 3 ml 1^0 (100°C) was added and allowed to cool
to 37°C when albumin (1.005 gm) was added. KHB was added, the pH 
adjusted to 7.4 and the volume adjusted to 25 ml with KHB).
2. L-Carnitine -79 mg/ml in KHB.
3. NaOH 10% (w/v) in H2O.
56.
4. Krebs Hens!eit buffer (KHB).
NaCl 172 mM
KC1 4.83 mM
KH2P04 0.96 mM
MgS04 .7H20 2.13 mM
CaCl2 .2H20 2.52 mM
NaHC03 23.8 mM
5. Perchloric acid, 2 M and 5 M in H20.
6 . Optiphase s c in t i l la n t .
PROCEDURE
Hepatocytes were isolated from ra t  l iv e r  and diluted in KHB to 10 x 10^ 
viable ce lls /m l.  L -carn itine  (10 j j l /m l ,  f ina l concentration 4 mM) was 
added to the ce lls  and they were incubated with shaking at 37°C for 20 
min. 'Centre w ell ' flasks were prepared containing 0.2 ml NaOH and a
folded f i l t e r  paper (in  the centre w e l l ) ,  0 .5 ml 1“^C  palmitate and
1 ml KHB. Flasks were prepared in t r ip l ic a te  for determination of
^C02 and for determination of ^ C  acid soluble m ateria l. The 
reaction was started by addition o f ce ll suspension (0 .5  m l). The 
flasks were stoppered and incubated at 37°C in a shaking water bath. 
Compounds to be added to the ce lls  were dissolved in DMF, which never 
exceeded 5jul per f lask . Control flasks received DMF alone. A fter  
30 min 5 M HC104 (200 ju l) was injected into the flasks and they were
incubated for a further 60 min at 37°C to trap a ll  of the ^ C 0 2 . 1 ml
of cell suspension was removed from the other flasks into 2M HC1Q4 
(500jli1) in Eppendorf tubes. The precip ita te  was centrifuged in an 
Eppendorf Microfuge and 500 pi  o f  the supernatant was counted in 10 ml 
Optiphase. * 4C02 rad ioactiv ity  was determined by dissolving the f i l t e r  
papers in H20 (1 ml) and Optiphase (10 m l). A '« Packard 
Tri-Carb 460 s c in t i l la t io n  counter was used. Results were expressed 
as nmol ^C02 produced/30 min/10^ ce lls  or nmol ^C  acid soluble 
material produced/30 min/10^ c e l ls .  The v ia b i l i t y  of the c e lls  was 
determined at the end of the incubation time by the Trypan Blue dye 
exclusion tes t ( I I .4 ) .
57.
11.11 ESTERIFICATION OF PALMITATE INTO TRIGLYCERIDES BY ISOLATED RAT
HEPATOCYTES
The incorporation of ^C  rad ioactiv ity  into tr ig lycerides  following  
incubation of isolated hepatocytes with 1“^C  palmitic acid was 
determined (Christiansen e t al_, 1976).
REAGENTS
1 . 1"^C  palmitic acid as 11. 10.
2. Krebs Hensleit buffer (KHB) as 11.10.
3. L-Carnitine (79 mg/ml KHB).
4. Chloroform/methanol (30:60).
5. Chloroform.
6 . Methanol.
7. Hexane.
8 . Hexane/diethyl ether/Acetic acid (80:20:1 ).
PROCEDURE
Hepatocytes were isolated from the l iv e r  of male rats and diluted to 10 
x 10  ^ viable ce lls /m l. The cell suspension was incubated with 
carn itine  (10 ^1/ml f in a l concentration 4 mM) for 20 min at 37°C. 25 ml 
conical flasks containing 1“^C  palmitate (0 .5 ml) and KHB (1 .0  ml) 
were equilibrated at 37°C. The reaction was started by addition of
cell suspension (0.5 m l). Compounds to be added to the flasks were
dissolved in DMF and the concentration of DMF never exceeded 5 ;j! per 
flask . The v ia b i l i t y  of the hepatocytes at the end of the incubation 
period (30 min) was determined by Trypan Blue dye exclusion ( 11.4 ) .
1 ml cell suspension was removed into 5.3 ml CHCl3/MeOH (30:60) and 
l ip id s  were extracted for 2 hours. 1.5 ml CHC13 was added and mixed 
w ell .  This was followed by 1.5 ml H20 and thorough mixing. The 
CHC13 layer was separated from the aqueous layer by centrifugation (10 
min, 4°C, 2000 rpm). The CHC13 layer was collected and evaporated 
under a stream of nitrogen. The total l ip id  extract was redissolved 
in hexane (100 p i ) .  A sample (25 ;j! ) of th is  was subjected to thin
layer chromatography on Whatman precoated s i l ic a  gel F-254 plates 
developed in hexane/diethyl ether/acetic  acid (80:20:1 ). The spots were 
visualised with iodine vapour. The areas corresponding to 
tr ig lycerides were scraped from the plates, into p lastic  s c in t i l la t io n  
v ia ls . 4 ml water and 10 ml Optiphase s c in t i l la n t  were added and the 
via ls  l e f t  overnight in the dark. -^C rad ioactiv ity  was determined in 
a Packard Tri-Carb 460 s c in t i l la t io n  counter. Results were
expressed as nmol *^C palmitate incorporated into t r ig ly c e r id e /10  ^
c e lls .
11.12 CYTOCHROME P-450 DETERMINATION
The cytochrome P-450 content of microsomes was determined by 
measurement of the carbon monoxide difference spectrum as described by 
Omura and Sato (1964).
REAGENTS
1. Tris-HCl, 66 mM, pH 7 .4 .
2. Sodium d ith io n ite  (s o l id ) .
3. Carbon monoxide.
PROCEDURE
The microsomes were diluted to protein concentrations of approximately 
1-2 mg/ml in Tris-HCl buffer, and divided equally between two cuvettes. 
A baseline of equal l ig h t  absorbance between 500 and 400 nm was 
recorded using a Beckman Acta VI spectrophotometer. The contents of 
both cuvettes were reduced by addition of Na2$204 ( ~  1 mg). Carbon 
monoxide was bubbled through the sample cuvette only fo r  approximately 
30 sec and the difference spectrum (500 -  400 nm) recorded. Using the 
Beer-Lambert law, cytochrome P-450 concentration was determined using 
an extinction coe ff ic ien t of 91 mM“1cm*'1 (^. A450-490) • The cy t°chrome 
P-450 concentration was expressed as nmol.mg prote in"*.
11.13 LAURIC ACID HYDROXYLASE
Cytochrome P-450-mediated 1 auric acid hydroxylase a c t iv ity  (LAH) was 
assayed in microsomes and in hepatocytes by a modification (K Joseph, 
personal communication) of the method described by Parker and Orton 
(1980).
REAGENTS
1. Tris-HCl, 66 mM, pH 7 .4 .
2. . NADPH, 25 mg/ml in 66 mM Tris-HCl, pH 7.4
3. Diethyl ether
4. Hydrochloric acid, 1 M.
5. 1“*^C sodium laurate , 1.5 mM (10 jjCi/mmol) in 66 mM Tris-HCl,
pH 7 .4 .
PROCEDURE
Microsomal suspension (0.2 -  2 mg protein) or sonicated hepatocytes 
(1 -  2 mg pro te in ), 1“*^C 1 auric acid (170 ju l) and Tris-HCl were placed 
in 10 ml stoppered glass te s t tubes to give a f ina l volume of 2 m l.
The tubes were preincubated at 37°C for 3 min. The reaction was 
in i t ia te d  by addition of NADPH (100j u l ) .  A fter 15 min the reaction  
was stopped by addition of 1MHC1 (500 / j1 ) .  l ’ *^C 1 auric acid and i ts
l"*^C-hydroxylated products were extracted into 5 ml diethyl ether.
The ether layer was separated by centrifugation (2000 rpm x 10 min x
4°C ), aspirated, and evaporated under nitrogen, and f in a l ly  redissolved
in methanol (200 p i ) .  The hydroxylated metabolites were separated 
from 1"*^C 1 auric acid by thin layer chromatography. Further 
separation into 11-hydroxy and 12-hydroxy 1 auric acid required high 
pressure l iqu id  chromatography.
TLC: a sample of the methanol extract was separated by TLC on Whatman
KC18F reversed phase plates developed in methanol:water:glacial acetic  
acid (9 0 :9 .5 :0 .5 ) .  The radioactive areas were localised by 
autoradiography, scraped from the plates and the rad ioactiv ity  
determined by l iq u id  s c in t i l la t io n  counting.
HPLC: 11- and 12-hydroxy lauric  acid were separated on a Technicol
Spherisorb ODS, 5 jj column with methanol/water/glacial acetic acid 
(60:39 .5:0 .5 ) at a flow rate of 1.5 ml/min. After these had eluted  
lauric  acid was eluted with methanol/glacial acetic acid (9 9 .5 :0 .5 ) .  
1”*^C lauric  acid and i ts  1“*4C metabolites were detected with a 
Berthold Radioactivity Detector and quantitated by determination of 
peak areas as a percentage of the total rad ioactiv ity  using a 
Spectra Physics SP4100 computing in tegrator.
11.14 7-ETHOXYCQUMARIN-O-DEETHYLASE ACTIVITY
7-ethoxycoumarin is metabolised by a microsomal monooxygenase system to 
a fluorescent product, 7-hydroxycoumarin (U llr ic h  and Weber, 1972).
I I .14.1 MICROSOMAL ASSAY
REAGENTS
1. Tris-HCl, 66 mM, pH 7 .4 .
2. NADPH, 10 mM in Tris-HCl, pH 7 .4 .
3. 7-Ethoxycoumarin, 1 mM in Tris-HCl, pH 7 .4 .
4. 7-Hydroxycoumarin, 1 mM in Tris-HCl, pH 7 .4 .
PROCEDURE
Microsomal suspension (50 pi or diluted where necessary), 7-ethoxy- 
coumarin (500 p i )  and 66 mM Tris-HCl (to ta l volume 1 ml) where 
mixed together in a cuvette and a stable baseline obtained at 37°C.
The reaction was in i t ia te d  by addition of NADPH (20 | i l ) and the 
time-dependent increase in fluorescene a t 460 nm was recorded using an 
excitation wavelength of 380 nm. A known amount of 7-hydroxycoumarin 
was added as an internal standard for each stamp!e. A c tiv ity  was 
expressed as nmol 7-hydroxycoumarin formed,min"*.mg protein”* .
I I . 14.2 CULTURED HEPATOCYTE ASSAY (Fry e t  a l ,  1978)
REAGENTS
1. Sodium acetate buffer, 0.1 M, pH 4 .5 .
2. B-glucuronidase, 10 mg/ml acetate buffer.
3. 7-ethoxycoumarin, 40 mM in 66 mM Tris-HCl, pH 7 .4 .
4. Diethyl ether.
5. 0.1 M sodium hydroxide/0.1 M glycine, pH 10.4.
6 . 7-hydroxycoumarin in 66 mM Tris-HCl, pH 7 .4 .
PROCEDURE
7-ethoxycoumarin (10 ; j l ) was added to 4 ml medium covering the 
monolayer of hepatocytes and the flasks were incubated at 37°C for 2 
hours. 2 x 1 ml aliquots were removed into stoppered glass tubes 
containing B-glucuronidase (500j j ! )  and incubated overnight a t 37°C. 
Diethyl ether (5 ml) was added to each tube and following a 10 min 
extraction 3 ml of the ether phase was removed into stoppered glass 
tubes containing NaOH/glycine buffer. A fter a 10 min extraction
period the ether layer was discarded. Blanks and standards were
prepared in duplicate and subjected to the same excitation procedure. 
The fluorescence of the samples at 450 nm with an excitation wavelength 
of 370 nm was recorded. The concentration of 7-hydroxycoumarin in the 
samples was determined from the standard curve of F^gg nm versus 
7-hydroxycoumarin nmol/ml.
I I .15 PEROXISOMAL B-OXIDATION
11.15.1 ASSAY IN HEAVY PELLET
Peroxisomal B-oxidation was determined as the palmitoyl-CoA-dependent 
reduction of NAD+ in the presence of cyanide to in h ib it  reoxidation of 
NADH by mitochondria, as described by Bronfman e t al_ (1979) with some 
modifications.
REAGENTS
1. Tris-HCl, 60 mM, pH 8 .3 .
2. Reagent A:
Coenzyme A,
NAD+
Nicotinamide 
D ith io th re ito l  
KCN
Bovine serum albumin
3. Flavin adenine dinucleotide, 14.9 mg/ml 60 mM Tris-HCl.
4. Pal mi toy!-Coenzyme A, 7.54 mg/ml 60 mM Tris-HCl.
5. Triton X-100, 1% (v /v) in 60 mM Tris-HCl.
PROCEDURE
Samples were diluted 1:1 with triton-XlOO and incubated at 37°C for 5 
min prior to assay. Reagent A (2 m l), FAD (20 ju l) and an a liquot of 
heavy p e lle t  ( f in a l protein conc< 0.2  mg/ml) or hepatocyte sonicate 
( f in a l protein cone< 1 0 0  /jg /m l) were added to each of two cuvettes. 
The volume was adjusted to 3 ml with 60 mM Tris-HCl, the components
75 juM )
555 juM )
141 mM ) In 60 mM T r is -
4.2 mM ) HC1 pH 8.3
3 mM )
0.225 mg/ml )
mixed and equilibrated at 37°C. A baseline was recorded a t 340 nm. 
Following addition of palmitoyl-CoA (20 jjI ) to the sample cuvette the
time-dependent A A34Qnm was recorded. Peroxisomal B-oxidation was
+ 1 1expressed as nmol NAD reduced.min"1 .mg protein" 1 using an extinction
c oeff ic ien t o f 6.22 mM"*cm"* for NADH.
I I . 15.2 ASSAY IN HEPATOCYTES
In preliminary experiments with cultured hepatocytes the 
spectrophotometric assay described above was used. Subsequently, 
however, a radiochemical assay was developed by Lazarow (1981) which 
measures the 1"*^C acid soluble material released from 1"*^C pal mi toy! 
CoA by peroxisomal B-oxidation. The substrate concentration suggested 
by Lazarow was found to be in s u ff ic ie n t  to permit a l in ear  rate of 
reaction and was adjusted accordingly.
REAGENTS
1. Tris  HC1, 50 mM pH 8 .0 .
2. NAD 
D ith io thereito l  
BSA
Tri ton X-100 
CoASH 
FAD
Palmi toy1 CoA 
1"*^C pal mi toy! CoA
3. Perchloric acid, 6% (v /v ) .
PROCEDURE
Samples were analysed in t r ip l ic a te  at two protein concentrations. An
aliquot of the sample was pipetted into an Eppendorf tube on ice . The
volume was made up to 300 pi  with Tris-HCl buffer. 200 ^1 of reagent A
was added, and the tubes placed in a water bath at 37°C. A fter 11 min
500 jjM ) REAGENT A
2.47 mM )
187.5 jjg/ml )
25 /jg/ml ) in 50 mM Tris-HCl,
250 jtiM ) pH 8.0
25 juM )
25 pV[ )
2 ^iCi/50 ml )
the reaction was terminated by addition of perchloric acid (250 p i ) and 
the tubes l e f t  for 1 hour at 4°C. The tubes were then centrifuged for  
2 min in an Eppendorf microfuge and 500 ul of the supernatant pipetted  
into p lastic  s c in t i l la t io n  v ia ls .  10 ml of Optiphase was added and 
the **C rad ioactiv ity  determined by s c in t i l la t io n  counting. T r ip lic a te  
blanks were prepared containing 300 i^il buffer and 200 pi  reagent A, and 
the perchloric acid-soluble *^c rad ioac tiv ity  was subtracted from the 
sample counts. Peroxisomal B-oxidation was expressed as nmol palmitoyl 
CoA metabolised .min"* mg protein"*.
11.16 MITOCHONDRIAL -GLYCEROPHOSPHATE DEHYDROGENASE
Mitochondrial ©(-glycerophosphate dehydrogenase (oCGPDH) was determined 
by the method of Lee and Lardy (1965) which measures the 
glycerol-3-phosphate-dependent reduction of a r t i f i c i a l  electron  
acceptors in the presence of cyanide.
REAGENTS
1 . Potassium phosphate buffer, 125 mM, pH 7 .5 .
2. Solution A: 5 mM KCN in potassium phosphate buffer (125 mM, 
pH 7 .5 ) .
3. Solution B: 150 mM sodium <x-glycerophosphate/5 mM KCN in 
potassium phosphate buffer (125 mM, pH 7 .5 ) .
4. PMS-INT solution. 40 mg INT (2-p-iodo-phenyl-3-p-nitrophenyl-5-  
phenyl-monotetrazolium ch lo r id e ), 10 ml 0.05 M potassium phosphate 
buffer, pH 7 .5 . [Prepared fresh by warming gently to 56°C to 
dissolve. Covered in fo i l  at a l l  times to protect from l i g h t . ]  
Immediately before use 25 mg PMS (phenazine methosulphate) was 
added.
5. Trichloroacetic acid, 10% (w /v).
6 . Ethanol, 95% ( v /v ) .
PROCEDURE
Samples of 'heavy p e l le t '  or hepatocyte sonicates were diluted with 
d is t i l le d  water to 2 -  4 mg protein/ml. Each sample was assayed in 
t r ip l ic a te  -  3 ' te s t '  tubes and 3 'blank' tubes. Solution A (20 p i ) 
was added to each 'blank' tube and solution B (20 p i )  to each ' te s t '  
tube. D is t i l le d  water (20 / j l ) was added to a ll  tubes. The tubes 
were equilibrated at 37°C for 10 min. D is t i l le d  water (20 /j1 ) and 
INT-PMS (40 p i ) were added to each tube and the samples were incubated 
at 37°C for 15 min. The reaction was terminated by addition of TCA 
(20 j j l ) followed by ethanol (1 m l). Protein was removed by 
centrifugation for 30 sec in an Eppendorf Microfuge. The optical 
density of the samples at 500 nm was recorded against a d is t i l le d  water 
blank in a Beckman 35 spectrophotometer. The mean OD^qq^ for the 
'blank' tubes was subtracted from the mean 0D5QQnm of the ' te s t '  tubes 
to account for the ©c-glycerophosphate dependent reaction. <x -GPDH 
a c t iv ity  was expressed as A0D.min."*mg protein"*.
11.17 CATALA5E ACTIVITY
Catalase a c t iv ity  was determined by measuring the rate of decomposition 
of hydrogen peroxide, as described by Beers and Sizer (1952).
REAGENTS
1. Sodium potassium phosphate buffer, 50 mM pH 7.0 .
2. Hydrogen peroxide 30 mM (prepared fresh).
3. Triton X-100, 0.5% (v /v) in phosphate buffer, 50 mM (pH 7 .0 ) .  
PROCEDURE
The optical density of the substrate solution at 240 nm was adjusted to 
between 0.55 and 0.50 at 25°C by d ilu tion  with phosphate buffer.
Samples were diluted approximately 1:100 with tr i to n  X-100 solution  
immediately before use. H202 (2.9 ml) was placed in a quartz cuvette
and a stable baseline obtained at 240 nm (25°C) against a phosphate 
buffer blank. 100 p i of diluted sample was added and the decrease in 
^240 W 1 * ^  t i n i e  w a s  r e c o r d e d  immediately. The enzyme was diluted to 
obtain a decrease in ^ 0  over the in i t i a l  15 sec period of not greater 
than 0.1 and not less than 0.02. The curve obtained was extrapolated 
back to t  = 0 and the f i r s t  order rate constant, k ,  determined from:
Catalase a c t iv i ty  was expressed as k sec"* mg protein"*.
I I . 18' SUCCINATE DEHYDROGENASE ASSAY
Succinate dehydrogenase (SDH) was determined by measuring the A  A55Qnni 
due to the reduction of added cytochrome C in the presence of cyanide 
(Green e t cH, 1955).
REAGENTS
1. Sodium phosphate buffer, 0.1 M, pH 7 .4 .
2. Bovine serum albumin, 100 mg/ml.
3. Cyotchrome C (oxidised, horse heart), 10 mg/ml.
4. Potassium cyanide, 20 mM.
k; = 2.3 
15
log
5. Sodium succinate, 0.1 M.
PROCEDURE
The following additions were made to each of two 1 ml cuvettes:
}rt FINAL CONCENTRATION
0.1 M phosphate buffer 100 10 mM
Albumin 100 10/mg/ml
KCN 50 1 mM
H20 595
Tissue Extract 5
Cytochrome C 100
The cuvette contents were mixed, equilibrated at 20°C and a stable 
baseline recorded at 550 nm. The reaction was started by addition of 
succinate (50 jj! ) and the time-dependent A A ^ q^  recorded for 2-3 min. 
Using the Beer-Lambert law the reduction of cytochrome C was determined 
using an extinction coe ffic ien t of 19.7 mM"*.cm"*. Enzymatic a c t iv i ty  
was expressed as jumol cytochrome C reduced.min."* mg prote in"*.
H . * 9  SODIUM DODECYL SULPHATE -  POLYACRYLAMIDE GEL ELECTROPHORESIS 
(SDS-PAGE)
Proteins were solubilised in sodium dodecyl sulphate and separated on 
polyacrylamide gels using a discontinuous buffer system as described by 
Dent e t al_ (1978).
REAGENTS
1. Gel Stock: 30% (w/v) acrylamide containing 0.8% (w/v)
N,N'-methylene bis-acrylamide.
2. Lower Gel Buffer: 1.5 M Tris-HCl (pH 8 .8 ) containing 0.4%
(w/v) SDS
3. Upper Gel Buffer: 0.5 M Tris-HCl (pH 6 .8 ) containing 0.4%
(w/v) SDS.
4. Sample Buffer: 62.5 mM Tris-HCl (pH 6 .8 ) containing 2.3%
(w/v) SDS, 15% (v /v ) g lycerol, 5% (v /v ) 2-mercapto- 
ethanoT and 0.001% (w/v) bromophenol blue.
5. Electrode Buffer: 25 mM Tris-HCl (pH 8.3) containing 0.1%
(w/v) SDS and 192 mM glycine.
6 . Ammonium persulphate 10% (w /v).
7. TEMED -  (N,N,N',N '-tetramethylethylenediamine).
8 . 1.5% (w/v) agarose containing 1.0% (w/v) SDS.
9. Coomasie Blue Stain: Isopropanol/acetic acid/water (25:10:65)
containing 0.05% (w/v) Coomassie blue R-250 dye.
10. Destaining Solution: Isopropanol/acetic acid/water (10:10:80).  
PROCEDURE
A Shandon Southern 613 x 52 vertica l slab apparatus was used. The gels 
(having f in a l dimensions of 170 x 150 x 1.5 mm) were contained between 
glass plates separated by perspex spacers. The plates were degreased 
by successive washing in detergent, d is t i l le d  water and ethanol and 
allowed to dry. The gel compartment was assembled, sealed with 
agarose and clamped in a vertica l position. The lower 7.5% resolving  
gel was prepared by mixing the lower gel buffer (10 m l), the gel stock 
(10 ml) ,  water (20 ml) ,  TEMED (10 ju l) and ammonium persulphate (120 
^ il) .  The solution was immediately poured into the gel compartment and 
d is t i l le d  water was layered on the surface to exclude a i r .  When 
polymerisation was complete (2 hours) the water layer was removed and 
the upper 3% stacking gel, consisting of upper gel buffer (2 .5  m l),
gel stock (1.0 m l), water (6.5 m l), ammonium persulphate (30 jjI ) and 
TEMED (10 p 1 ), was added to the top of the running gel. Immediately a 
perspex comb was placed in the stacking gel to form the sample wells . 
The comb was removed when polymerisation was complete. The lower 
spacer was removed and the gel compartment placed in the 
electrophoresis tank. The electrode buffer was added to the upper and 
lower reservoirs and a i r  bubbles trapped under the gel were removed 
with a syringe. Sonicated hepatocyte cultures were diluted with 
sample buffer to a f ina l concentration of 1 mg protein/ml and placed in 
a boiling water bath for 3 min. The samples were cooled and 30 -  50 jjg 
protein was applied to the stacking g e l. A standard containing proteins 
of known molecular weights was treated s im ila r ly .  A constant current 
of 30 mA was used and electrophoresis was continued until the front  
running bromophenol blue was within 1 cm of the end of the g e l . The gel 
was removed from the glass compartment and stained in Coomassie blue 
dye overnight. The gel background was destained by repeated washings 
in destaining solution. The gel was stored in 30% glycerol. The 
mobility of resolved proteins was compared with that of marker proteins 
of known molecular weights.
11.20 COENZYME A DETERMINATION
Coenzyme A was determined by the c a ta ly t ic  phosphotransacetylase method 
described by Michal and Bergmeyer (1975). In addition to free  
coenzyme A, the assay determines oxidised coenzyme A (CoAS-SCoA) and 
acetyl-CoA.
REAGENTS
1. 0.2 M triethanol amine-HCl containing 15 mM L(-)m alic  acid 
(pH 8 .0 ) .
2. 15 mM NAD+/50 mM acetyl phosphate (potassium lithium s a l t ) .
3. Mai ate dehydrogenase (MDH), 1400 U/ml in 3.2 M ammonium sulphate.
4. Phosphotransacetylase (PTA) 1000 U/ml in 3.2 M ammonium sulphate.
5. C itra te  synthase (CS) 140 U/ml in 3.2 M ammonium sulphate.
6 . Standard Coenzyme A solution, 10 jug/ml in-f^O.
7. Perchloric acid, 1M and 5M.
8 . Potassium carbonate, 5M.
9. D ith io th re i to l , 20 mM.
Solutions 1, 2 and 9 were prepared fresh each day, and the others
stored at 4°C for up to 6 months.
PROCEDURE
Sample preparation:
Hepatocyte monolayers were harvested in Krebs Hensleit bu ffe r  and 
assayed for coenzyme A content immediately. To 1 ml of hepatocyte 
sonicate was added 5N HCIO4 (200 ju l) .  The samples were centrifuged at  
2000 rpm (4°C) for 10 min and the supernatant collected. The p e lle t  
was washed in 1M HCIO4 and centrifuged as above. The supernatant was 
collected and pooled. The pH of the supernatant was adjusted to 
pH 4.6 -  6 by addition of K2CO3 .
Assay:
Sample (x / i l ) ,  water (1800 -x j i l ) ,  malate (500 ^il) and d ith io th re ito l  
(50 jjl.) were mixed in a cuvette and incubated at 25°C for 15 min.
NAD/AP (200 ju l) ,  MDH (15 / i l ) and PTA (15 / j l ) were added, mixed and 
equilibrated for 5 min a t 25°C. A fter ensuring that no change in A34Q 
was observed, CS (20 ju l) was added. A fter 1 min the A A34Q with time 
was recorded for approximately 10 min. 50 jil of CoASH standard was
treated s im ila r ly . The reaction rate (A A 34Q/min) is proportional to 
the quantity of CoASH. The CoASH content of the sample, C, is  
therefore given by:
^ 3 4 0 / mi*s a m p  1 e
C = Cstand  ______  [nmole/ml]
( ^  ^ 34o/mi n ^  standard
where Cs^and = concentration of Standard [nmol/ml].
Results are expressed as nmol CoASH mg protein"*.
11.21 PROTEIN ASSAY
Protein was determined by the method of Lowry et (1951) using bovine 
serum albumin standards.
REAGENTS
1. Bovine serum albumin standard, 1 mg/ml 0.05 M NaOH.
2. Sodium potassium ta r t ra te ,  2% (w /v).
3. Sodium hydroxide, 0.05 M.
4* Copper sulphate. 5H2O, 1% (w /v).
5. Sodium hydroxide, 0.05 M containing anhydrous sodium carbonate,
2% (w /v).
6 . Folin-Ciocalteau reagent; 25% (v /v) in d is t i l le d  water.
PROCEDURE
A range of standards was prepared from the stock albumin solution,
0 -  250 jjg/ml", in 0.05 M NaOH. Samples were diluted as appropriate in 
0.05 M NaOH. Sodium carbonate, copper sulphate and sodium potassium
potassium ta r t ra te  were mixed in the ra tio  100: 1:1 (by volume) 
immediately before use. 5 ml of th is  reagent was added to 0.5 ml of 
the samples, standards and 0.05 M NaOH blank. The tubes were mixed 
immediately and allowed to stand at room temperature for 15 min.
0.5 ml of Folin-Ciocalteau reagent was added to each tube and mixed 
immediately. A fter 35 min the optical density was recorded at 700 nm 
against a d is t i l le d  water blank in a Pye Unicam SP6-500 
spectrophotometer. The concentration of protein was determined from 
the standard curve of Ajqq versus BSA /jg /m l.
11.22 ELECTRON MICROSCOPY
All electron microscopy was performed by the Pathology Section,
Imperial Chemical Industries PLC, Central Toxicology Laboratory. The 
procedures used are standard in that Laboratory and w i l l  not be 
described in depth here. Sections of whole l iv e r  were fixed in 
formaldehyde/glutaraldehyde and 1 mm slices post-fixed in osmium 
tetraoxide. A fter dehydration and embedding in 'A ra ld ite ' 1 /jm slices  
were stained with toluidine blue and areas selected for electron  
microscopy. U ltrath in  (70 -  90 nm) slices were stained with uranyl 
acetate and lead c i t ra te  and electron micrographs were recorded at  
x24,900 magnification in a JE0L/100/CX electron microscope.
Morphometric analysis of peroxisomes was performed according to the 
method of Weibel e t al_ (1969) using a 320 point tes t grid . For 
electron microscopy of hepatocyte cultures the monolayers were fixed  
with glutaraldehyde in the flasks. A fter  post-fixation  in osmium 
tetraoxide and dehydration, the monolayers were embedded in 'A r a ld i te ' .  
Sections of 1 jim were cut e ither  longitudinally  or transversely to the 
plane of the monolayer, and were stained in lead c i t ra te  and uranyl 
acetate and examined as above.
11.23 OIL RED 0 STAIN FOR LIPID
Neutral l ip id  was visualised by staining with Oil Red 0 ( L i l l i e  and 
Ashburn, 1943).
REAGENTS
1. NaCl, 0.9%.
2. Formal saline - 10% formaldehyde (v./v) in phosphate buffered 
saline.
3. Oil Red 0 solution (made f re s h ) :
4 ml d is t i l le d  water was added to 6 ml saturated Oil Red 0 in 
isopropanol. This was allowed to stand for 10 min and then 
f i l t e r e d .
4. H arris 's  Haematoxylin in d is t i l le d  water
5. 'Apathys' mounting medium (R A Lamb, Waxes & General Laboratory 
Supplies, London, UK).
PROCEDURE
The culture medium was discarded and the base of the tissue culture  
flask removed. The monolayer was then washed thoroughly in saline to 
remove traces of culture medium and fixed in formal saline solution  
(20 min). The ce lls  were then stained with Oil Red 0 solution for 20 
min. A fter rinsing with tap water (5 min) the nuclei were 
counterstained with Harris 's  haematoxylin solution (3 min) and washed 
in tap water (5 min). The ce lls  were visualised a fte r  mounting in 
'Apathy's' medium in an Olympus TO! inverted microscope.
11.24 STATISTICS
S ta tis t ic a l comparisons between groups were carried out using student's 
t  te s t .  A level o f significance of P<0.05 (tw o-ta iled) was chosen. 
All values are expressed as mean + SD (n) where n represents e ither  the 
number of animals (in  vivo experiments) or the number of flasks (in  
v itro  experiments).
CHAPTER I I I
HEPATIC EFFECTS OF DI-(2-ETHYL HEXYL)PHTHALATE IN THE RAT
AND THE MARMOSET MONKEY
I I I . l  INTRODUCTION
Di- ( 2-ethyl hexyl)phthalate (DEHP), a commonly used p la s t ic is e r ,  has 
been shown to be an hepatic peroxisome p ro life ra to r  (Lake e t  al_, 1975; 
Moody and Reddy, 1978b) and hepatocarcinogen in rodents (NTP 1982). A 
number of other hepatic peroxisome pro!itera tors  have been shown to 
produce an increased incidence of hepatocellular carcinomas in rodents 
(Reddy and Rao, 1977; Reddy and Qureshi, 1979; Svoboda and Azarnoff, 
1979; Reddy e t aV, 1979;) and i t  has thus been proposed (Reddy e t  
aV, 1980) that hepatic peroxisome pro life ra tors  represent a novel class 
of chemical carcinogens. However, lim ited evidence is available  
suggesting that peroxisome p ro life ra t io n  is peculiar to rodents and may 
be a species-specific phenomen, that is ,  administration of these agents 
to non-rodent species does not resu lt in p ro life ra t io n  of peroxisomes 
in the l i v e r  (Svoboda e t al_, 1967; Blane and P in a ro li ,  1980; Holloway 
et a l , 1982a ,k ) .  In general these studies were lim ited in scope using 
only small numbers of animals (in  many cases one or two) and as such 
are frequently rejected as inconclusive.
In the l ig h t  of the apparent correlation between peroxisome 
p ro life ra tio n  and hepatocarcinogenesis there is a need for data to 
substantiate or disprove this ‘ species-specific1 hypothesis. The aim 
of this study was to compare the effects of a known rodent peroxisome 
p ro life ra to r  on the l iv e r  of the ra t  and a subhuman primate, the 
marmoset (C a l l i th r ix  jaccus) . The study was designed to (a) provide a 
conclusive comparison of the subacute effects of o ra lly  administered 
DEHP in a rodent and non-rodent species and (b) through using a 
primate species, to better evaluate the effects  of DEHP in man. DEHP 
was administered o ra lly  (2000 mg/kg/day) for 14 consecutive days to 
male rats and marmosets and the e ffec t  on hepatic peroxisomes 
determined. The effects of DEHP on serum l ip id  levels and a number o f  
hepatic enzyme a c t iv i t ie s  (which had previously been shown to be 
affected by DEHP and other peroxisome pro !itera tors  in rodents) were 
examined.
I I I . 2 METHODS
Adult male rats (150-190 g) were dosed with DEHP (2 g/kg) suspended in 
corn oil (10 ml/kg) by gavage for 14 days. Control animals received 
corn oil alone. Adult male marmosets (250-400 g) were dosed 
s im ila r ly ,  but the volume of liq u id  that could be dosed to the marmoset 
prevented the administration of DEHP in corn o i l .  A fter  14 days the 
animals were k i l le d  by inhalation of excess fluothane (ra ts ) or carbon 
dioxide (marmosets). Immediately following death the l iv e r  was removed 
and weighted. A sample of l iv e r  was prepared for electron microscopy, 
and morphometries, and a second sample was fractionated into heavy 
p e l le t ,  microsomal and cytosolic fractions by d i f fe re n t ia l  
centrifugation. Cytochrome P-450 content, 7-ethoxycoumarin 
-o-deethylase a c t iv ity  (ECOD) and 1 auric acid hydroxylase a c t iv i ty  
(LAH) were determined in the microsomal fraction . Cyanide-insensitive  
palmitoyl-CoA oxidation (PCO), mitochrondrial oc.-glycerophosphate 
dehydrogenase (ot-GPDH) and succinate dehydrogenase (SDH) were 
determined in the heavy p e lle t  frac tio n . Catalase a c t iv i ty  and protein  
content were determined in a l l  fractions. A blood sample was 
collected by cardiac puncture and the cholesterol and tr ig lyc e r id e  
content determined by the C lin ical Chemistry Section, Biomedical 
Sciences, Central Toxicology Laboratory, Imperial Chemical Industries  
PLC.
I I I . 3 RESULTS
Oral administration of DEHP (2 g/kg/day for 14 days) to the ra t  
resulted in severe hepatomegaly and a lowering of blood tr ig lyc e r id e  
and cholesterol levels (Table 111.1 ) .  In contrast no changes in l i v e r  
weight or blood cho les tero l/tr ig lyceride  levels were noted in marmosets 
treated with DEHP (Table I I I .  1 ) .
Morphometric analysis of electron micrographs revealed a s ig n if ic an t  
increase in the volume of the cytoplasm occupied by peroxisomes in the 
l iv e r  of rats treated with DEHP (Table I I I . 2 ) .  No s ig n if ic an t change 
was observed in the l iv e r  of marmosets treated with DEHP.
TABLE I I I . l
THE EFFECT OF DEHP ON THE LIVER WEIGHT AND BLOOD LIPID CONTENT OF THE
RAT AND THE MARMOSET
SPECIES LIVER WEIGHT CHOLESTEROL TRIGLYCERIDE
[% OF BODYWEIGHT) (mg/100  ml) (mg/100 ml)
CONTROL 4.9 + 0.2 (10) 39 + 3 (8 ) 109 + 3 1  (9)
RAT
DEHP 8.3 + 0.4 (10)* 27 + 6 ( 10)* 54 + 17 (10 )*
CONTROL 4.3 + 0.5 (5) 170 + 13 (5) 194 + 39 (5)
MARMOSET
DEHP 5.2 + 1.4 (5) 162 + 20 (5) 199 + 52 "(5.1
Values are mean + SD (n)
^sign ificantly  d if fe re n t  from respective control p< 0 .05.
TABLE I I I . 2
THE EFFECT OF DEHP ON PEROXISOME VOLUME DENSITY AND PEROXISOMAL 
B-OXIDATION IN THE LIVER OF THE RAT AND MARMOSET
SPECIES PEROXISOMES PALMITOYL-
% CYTOPLASMIC VOLUME CoA OXIDATION3
RAT
CONTROL 2.53 + 0.66 (10) 8.26 + 1.36 (9)
DEHP 20.25 + 3 .5 3  (10)* 35.02 + 3 .6 8  (10 )*
MARMOSET
CONTROL 0.09 + 0.13 (5) 2.42 + 0.64 (5)
DEHP 0.44 + 0.41 (5) 2.51 h- 0.98 (5)
a-nmol NAD+ reduced/min/mg protein
*s ig n if ic a n t ly  d if fe re n t from control p <  0.05.
These morphometric analyses were confirmed by measurement of a marker 
* peroxisomal enzyme a c t iv ity  -  PCO. PCO was enhanced 4 -fo ld  in the 
l iv e r  of rats and unchanged in the l iv e r  of marmosets treated with DEHP 
(Table I I I . 2 ) .  However, in DEHP-treated rats catalase (another
peroxisomal enzyme) exhibited a decrease in specific a c t iv i ty  in the 
heavy p e l le t  fraction (Table I I I . 3 ) .  To ascertain whether th is  
decrease was due to leakage of the catalase from peroxisomes damaged 
during homogenisation, catalase a c t iv ity  was determined in a l l  
subcellular fractions. Catalase a c t iv ity  increased 4 -fo ld  in the 
cytosolic fraction and surprisingly 12- fo ld  in the microsomal frac tio n .  
Similar subcellular analysis of catalase a c t iv ity  in the l iv e r  of the 
marmoset revealed a small but s ta t is t ic a l ly  s ign if ican t increase in the
heavy p e l le t  frac tion , but no change in the microsomal or cytosolic
fraction in DEHP-treated animals.
Microsomal cytochrome P-450 content was increased in the l iv e r  of rats  
treated with DEHP (Table I I 1 .4 ) .  Cytochrome P-450 content could not 
be determined re liab ly  in the microsomal fractions obtained from
marmoset l iv e r  because of the poor spectra recorded. Determination of
cytochrome P-450 mediated monooxygenase a c t iv i t ie s  revealed a small 
increase in ECOD (Table I I I . 4) and a much larger increase in LAH (Table
111.5) in DEHP-treated ra ts . No differences in ECOD or LAH were 
observed in microsomes from DEHP-treated marmosets (Table I I I . 4 and
111.5 ) .  The overall 10-fold increase in tota l LAH (sum of 11 + 12 
hydroxylauric acid) in DEHP treated rats resulted from a 13-fo ld  
increase in the c^-oxidation pathway (C12 oxidation of laur ic  acid) and 
a 6- fo ld  increase in theoa-l oxidation pathway (C ll  oxidation of lau r ic  
acid) (Table I I I . 5 ) .  The contribution of the u>- and u - 1  pathways 
was not determined in marmoset microsomes as no increase in to ta l LAH 
a c t iv ity  was found.
The e ffec t  of DEHP on two hepatic mitoch ondrial enzymes -o(GPDH and 
SDH -  is shown in Table I I I . 4 and o<GPDH a c t iv ity  was elevated 4 -fo ld  
and SDH a c t iv i ty  was markedly reduced in rats treated with DEHP.
Neither enzyme a c t iv ity  was affected in marmosets treated with DEHP.
I I I . 4 DISCUSSION
The aim of this study was to compare the effects of a high dose of DEHP 
(2 g/kg/day for 14 days) on the l iv e r  of the ra t  and the marmoset
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TABLE I I I . 5
EFFECT OF ORAL ADMINISTRATION-OF DEHP ON HEPATIC CYTOCHROME P-450- 
MEDIATED LAURIC ACID HYDROXYLASE ACTIVITY IN RATS AND MARMOSETS
SPECIES
LAURIC ACID HYDROXYLATION (nmol/min/mg)
TOTAL CO-OXIDATION uo-1 OXIDATION 
(C11-+ C12) (C12) (C l l )
RAT
CONTROL
DEHP
2.6 + 0.7 (9) 1.4 + 0.4 (8) 1.2 + 0.3 (8) 
2 5 . 8 + 7 . 2  (1 0 )*  18.1 + 4 . 1  ( 9 ) *  6.8 + 3.7 (9) *
MARMOSET
CONTROL
DEHP
0.7 + 0.4 (5) ND ND 
0.7 + 0.2 (5) ND ND
Values are mean + SD (n)
*s ig n if ic a n t ly  d if fe re n t  from control p <  0 .05.  
ND = not determined
monkey. Oral adm inistration of DEHP to male rats resulted in 
hepatomegaly, serum hypolipidaemia and changes in hepatic u lt ra ­
structure and enzyme a c t iv it ie s . Marmosets receiving the same high 
dose of DEHP showed no hepatomegaly, no serum hypolipidaemia, and no 
changes in hepatic u ltrastructure  or the enzyme a c t iv it ie s  measured. 
These effects  observed in the ra t are ty p ic a l, following adm inistration  
of a peroxisome p ro life ra to r  (Chapter 1 .2 ).
The administration of DEHP to rats resulted in an 8- fo ld  increase in 
the volume of the l iv e r  ce ll cytoplasm occupied by peroxisomes. In 
marmosets receiving DEHP, though comparison of the group mean values 
suggested an increase in the peroxisomal volume th is was not 
s ta t is t ic a l ly  s ig n ific a n t. The morphometric analyses were, however, 
confirmed by measurement of a marker peroxisomal enzyme a c tiv ity  (PCO). 
A 4 -fo ld  increase in PCO was noted in the heavy p e lle t  frac tion  
obtained from the liv e rs  of DEHP treated ra ts . Hepatic PCO a c t iv ity  
was unchanged in marmosets receiving DEHP.
The specific  a c t iv ity  of a second peroxisomal enzyme-catalase-was 
decreased in the heavy p e lle t frac tio n  from the live rs  of DEHP-treated 
ra ts . Catalase a c tiv ity  has consistently been shown to increase 
coincident with peroxisome p ro life ra tio n  (Hess e t al ,^ 1965; Moody and 
Reddy, 1975; Moody and Reddy, 1978a ,^ ) .  I t  has been suggested th a t  
as i t  is a soluble matrix enzyme i t  may easily  be released from 
peroxisomes damaged during the homogenisation process. A 4 -fo ld  
increase in catalase a c tiv ity  in the l iv e r  cytosol of DEHP-treated rats  
was demonstrated which appears consistent with th is  hypothesis.
However, a 13-fo ld  increase in catalase a c t iv ity  in the microsomal 
fraction  from the live rs  of DEHP-treated rats was also noted. The 
specific  a c t iv ity  o f microsomal catalase was comparable with that in 
the heavy p e lle t fraction  and thus i t  is un like ly  that i t  was due 
solely to contamination by peroxisomal enzyme leakage. I t  is  also 
plausable that th is  high specific  a c t iv ity  was due to the presence of 
newly synthesised catalase, although such catalase is l ik e ly  to be 
c a ta ly t ic a lly  inactive u n til assembled w ithin the peroxisome (Lazarow 
and de Duve, 1973). I t  is  also noteworthy that the assay fo r catalase  
measures simply the disappearance of H2O2 and i t  is  conceivable th a t  
other microsomal (or cytosolic) reactions involving H2O2 are 
contributing to the 'cata lase' a c t iv ity , eg glutathione peroxidase. An 
unequivocal id e n tific a tio n  of native catalase enzyme in the subcellu lar
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fractions is c r it ic a l to an understanding of these resu lts . Sim ilar 
changes in subcellular d is trib u tio n  of catalase have been noted with 
other peroxisome p ro !ite ra to rs  (Moody and Reddy, 1976; Hayashi e t a l , 
1981b; Leighton e t al_, 1975; Berge and Bakke, 1981). I t  has also been 
demonstrated th a t extra-peroxisomal forms of catalase e x is t (Holmes 
and Masters, 1969, 1970) and the observed red is trib u tio n  of c e llu la r  
catalase a c tiv ity  may therefore not have been a rte fa c tu a l. Further 
characterisation of these changes was, however, beyond the scope of 
th is  study. DEHP adm inistration to marmosets resulted in a small 
(1 .3 -fo ld ) increase in peroxisomal catalase a c tiv ity  but no change in 
its  subcellular d is tr ib u tio n .
DEHP adm inistration to rats produced a small increase in the to ta l 
microsomal cytochrome P-450 content. This has been noted previously 
(Lake e t al_, 1975). Furthermore, DEHP has previously been shown to 
produce minor e ffects  on many cytochrome P-450-mediated monooxygenase 
a c tiv it ie s  (Lake e t aT, 1975, 1984a , b; Zucc.ato-et.aT_, 1980; Mangham 
et aV, 1981; Agarwal e t a l , 1982). A small (3 -fo ld ) increase in ECOD 
a c tiv ity  was demonstrated in th is  study. A second cytochrome 
P-450-dependent enzyme -  LAH -  was determined as th is  p a rticu la r  
monooxygenase a c tiv ity  had been shown to be increased following  
adm inistration of hypolipidaemic drugs to rodents, but the e ffe c t of 
DEHP on LAH had not been previously determined. In rats treated  with 
DEHP we noted a 10-fo ld  increase in microsomal LAH a c t iv ity . The 
microsomal LAH system of ra t l iv e r  oxidises saturated medium chain 
length fa tty  acids a t the terminal end to the carboxyl group ie  C12,
C ll fo r la u ric  acid (Preis and Bloch, 1964; Wada et aV, 1968;
Bjorkhem, 1970; E ll in  e t a l ,  1972). We were in terested to determine 
whether the increase in to ta l LAH a c tiv ity  was due to a specific  
enhancement of e ith e r the co - or u > -l pathways as had been noted with 
the hypolipidaemic drugs (Parker and Orton, 1980). In the ra t  DEHP 
treatment enhanced the ca-1 oxidation of la u ric  acid 6- fo ld  and the 
co-oxidation of la u ric  acid 13 -fo ld . I t  appears that the hepatic 
effects  of DEHP and the hypolipidaemic drugs are remarkably s im ilar - 
not only in the p ro life ra tio n  of peroxisomes but also in the induction  
of a novel cytochrome P-450. Unfortunately the role of LAH in the 
l iv e r  is  not known and the endogenous substrate(s) not id e n tif ie d .
Thus, the relationship of LAH induction to peroxisome p ro life ra tio n  is  
at present e lus ive , though subsequent investigations in th is  Laboratory 
(C Elcombe, unpublished data) have revealed that the two events are 
undoubtedly re la ted . Microsomal cytochrome P-450 content could not be 
determined in marmoset l iv e r  microsomes due to technical d i f f ic u lt ie s  
but determination of monooxygenase a c tiv it ie s  revealed th a t oral 
adm inistration of DEHP had no e ffe c t on e ith e r ECOD or LAH.
Lake e t al_ ( 1975) reported that DEHP produced a decrease in the 
a c tiv ity  of a marker mitoch ondrial enzyme -SD H . In th is  study we 
have confirmed th is  observation; SDH is reduced to 38% of the a c t iv ity  
in control l iv e r .  This decrease in specific  a c t iv ity  may p artly  
re fle c t  the d ilu tio n  of the mitoch ondrial protein aris ing  from the 
increased peroxisomal prote in . The e ffe c t of DEHP on a second 
m itoch'ondrial enzyme, ocGPDH, has not previously been determined, 
although i t  has been demonstrated that o(GPDH is  markedly enhanced 
following adm inistration of hypolipidaemic drugs to rodents (Hess et 
a l , 1965; Holloway and Orton, 1979). This enzyme a c t iv ity  was 
markedly enhanced in rats treated with DEHP. Induction of ecGPDH is  a 
marker fo r thyroid hormone action (Lee e t al_, 1959). Indeed I t  has 
been proposed by P la tt  and Thorp1 (1966) that the induction of tfGPDH in 
the l iv e r  by c lo fib ra te  resulted from a hyperthyroid e ffe c t brought 
about by the structural s im ila r ity  of c lo fib ra te  and thyroxine. DEHP, 
however, bears no structural s im ila r ity  to thyroxine, and th is  (and 
other peroxisome p ro !ite ra to rs  which we have tested) markedly enhanced 
GPDH a c t iv ity . Also hyperthyroidism leads to mild hepatic 
peroxisome p ro life ra tio n  (Fringes and Reith, 1982)). We have thus 
proposed (M itchell e t al_, 1984) th a t peroxisome p ro life ra tio n  and 
induction of o<GPDH are closely re la ted  and that tfGPDH may play a ro le  
in the reoxidation of NADH generated by the peroxisome. In contrast to 
the findings in the ra t SDH and «GPDH a c t iv it ie s  were unaffected by 
administration of DEHP to the marmoset.
The e ffects  of oral adm inistration of DEHP on the l iv e r  of the ra t  and 
the marmoset are summarised in Table I I I . 6 : a c lear species-difference
in response is  apparent. I t  is  important to know whether th is  
difference in response is  due simply to a tox icokinetic  d iffe ren c e , ie  
a difference in the rate o f absorption/metabolism/excretion or is  due 
to a toxicodynamic d ifference, ie  an inherent difference in the tissue
TABLE 111.6
COMPARISON OF THE EFFECTS OF ORAL ADMINISTRATION OF DEHP 
(2G/KG/DAY X 14 OAYS) ON THE LIVER OF THE RAT AND MARMOSET
RAT MARMOSET
LIVER WEIGHT —
PEROXISOME VOLUME DENSITY * —
PCO * -
CATALASE
P450 CONTENT t -
ECOD ♦ —
LAH * -
*  GPDH -
SDH * —
T  increase 
^  decrease 
— no change
s e n s itiv ity  to peroxisome p ro !ite ra tio n . Prelim inary studies in th is  
Laboratory have indicated that a large percentage ( ~  80%) of o ra lly  
administered DEHP is  excreted unchanged in the faeces by the marmoset. 
Thus i t  is  not c lear i f  a s u ffic ie n t quantity of DEHP were absorbed by 
the marmoset, whether peroxisome p ro life ra tio n  would occur in the 
l iv e r .  However, the hypolipidaemic drug c lo fib ra te , which is  rapid ly  
absorbed and reaches equivalent plasma concentrations in both the ra t  
and the marmoset fa i ls  to e l i c i t  peroxisome p ro lite ra tio n ' in the l iv e r  
of the marmoset (Thorpe, 1962; Holloway e t a ly l9 8 2 a ).
I I I . 5 CONCLUSION
The data presented describes the e ffe c t o f oral adm inistration of DEHP 
(2 g/kg/day for 14 days) on the l iv e r  of the ra t and the marmoset.
Oral adm inistration of DEHP to the ra t resulted in hepatomegaly, a 
lowering of serum cholesterol and trig lycerid es  and p ro life ra tio n  of 
peroxisomes in the l iv e r .  A number o f peroxisomal, mitochrondrial and 
microsomal enzymes were also affected . Oral adm inistration of DEHP to 
the marmoset produced no hepatomegaly, no e ffects  on serum lip id  
le ve ls , no p ro life ra tio n  of peroxisomes and no e ffe c t on any of the 
enzyme a c tiv it ie s  measured. A c lear species difference in response of 
the ra t and marmoset to oral administration of DEHP (2 g/kg/day fo r 14 
days) was observed.
CHAPTER IV
PEROXISOME PROLIFERATION IN CULTURED RAT HEPATOCYTES
IV .1 INTRODUCTION
Primary hepatocyte maintenance cultures maintain d iffe re n tia te d  
hepatocyte functions and preserve the in d u c ib ility  observed in vivo fo r  
a number of days po st-iso la tion  (Bissel e t al_, 1973; Chapman e t  a l l  5 
1973; Bonney e t al ,^ 1974; Michalopoulos and P ito t , 1975; Laishes and 
W illiam s, 1976). This model thus represents a useful system for the 
study of the 1ive r in v it r o . The objective of the present work was to 
determine the s u ita b ility  of primary hepatocyte cultures as an in v itro  
model fo r the phenomenon of peroxisome p ro life ra tio n . The potential 
of such a system fa r  exceeds its  most immediately obvious use as a 
screen for detecting peroxisome p ro !ite ra to rs . In p a rticu la r i t  has 
considerable advantages for studying the underlying mechanisms involved 
in th is  phenomenon. To achieve th is  requires a knowledge of the 
m etabolite(s) responsible fo r causing peroxisome p ro life ra tio n  and of 
the mechanism(s) by which such metabolites e l i c i t  peroxisome 
p ro life ra tio n  in the rodent l iv e r .  Such data is  more easily  
obtainable in a d e licate ly  controlled in v itro  system than in the 
complex and continually changing environment of the animal. I t  has 
been proposed th a t chemically-induced peroxisome p ro life ra tio n  is  a 
species-specific phenomenon (Chapter 1 .3 ) . As hepatocytes may be 
isolated from many species, including man, i t  is  possible using primary 
cultures to compare interspecies effects  d ire c tly .
The a b il i ty  of three s tru c tu ra lly  and pharmacologically d iffe re n t  
agents, c lo f ib r ic  acid, mono-(2-ethyl hexyl)phthalate and 
trich lo ro ace tic  acid (which are proximate p ro !ite ra to rs  derived from 
c lo fib ra te  (Thorpp, 1962), d i-(2 -e th y l hexyl)phthalate (Lake et al_, 
1975) and trichloroethylene {El combe e t al_, 1982) respectively to 
induce peroxisome p ro life ra tio n  in cultured ra t hepatocytes was 
investigated. Evaluation of peroxisome p ro life ra tio n  in  the 
hepatocyte cultures was assessed by both electron microscopic 
examination and e ffects  on in vivo biochemical markers.
IV .2 METHODS
Hepatocytes were isolated from male rats (180-220 g) by jm s itu  l iv e r  
perfusion and cultured in a serum containing Liebowitz medium (CLI5 
medium) at 37°C. 4, 24, 48 and 72 hours a fte r  seeding freshly isolated
ce lls  in the flasks the spent medium and unattached c e lls  were 
aspirated and fresh medium was supplied. In su lin , hydrocortisone and 
steroid hormones were added as indicated. Test chemicals c lo f ib r ic  
acid (CPIB) ,  mono-(2-ethyl hexyl)phthalate (MEHP) and tr ic h lo ra c e tic  
acid (TCA) were dissolved in DMF and added to the culture medium at 
each 24 hour medium change as indicated. Additions of DMF never 
exceeded 10 ^il per flask and th is  concentration produced no visable  
cyto tox ic ity  and had no e ffe c t on any of the parameters measured. At 
various times, as indicated, the monolayers were fixed in s itu  with  
glutaraldehyde and prepared for electron microscopy. A lte rn a tiv e ly , the 
ce lls  were harvested by scraping from the flask into SET b u ffe r, 
disrupted by sonication and assayed immediately for Coenzyme A content 
or stored a t -70°C. Assays fo r cyanide-insensitive palmitoyl-CoA 
oxidation (PCO), mitochondrial oc-glycerophosphate dehydrogenase 
(oc-GPDH), catalase, protein and sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis (SDS-PAGE) were performed on freshly thawed 
sonicates.
IV .3 RESULTS
IV .3.1 ISOLATION AND CULTURE OF RAT HEPATOCYTES
Hepatocytes were isolated from male rats by a two step in s itu  
perfusion technique which routinely  yielded 30 x 10  ^ v iable c e lls  per 
gram liv e r  as determined by trypan blue dye exclusion (Figure IV .1 ).
The hepatocytes were maintained as monolayer cultures, attaching to the 
polystyrene flasks within 4 hours and becoming fla ttened  and polyhedral 
in shape by 24 hours (Figure IV .2 ) . The ce lls  maintained th is  
appearance during the 4 days in cu ltu re . Cell v ia b i l i ty  during th is  
period was established by trypan blue dye exclusion, visual examination
FIGURE I V . 1
ISOLATED RAT HEPATOCYTES
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Hepatocytes were iso la ted from ra t  l i v e r  and stained with trypan 
blue dye. Non-viable ce l ls  are c le a r ly  d is tingu ishable ( ).
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FIGURE I V . 2
PRIMARY CULTURES OF RAT HEPATOCYTES
Hepatocytes iso la ted from ra t  l i v e r  were maintained as monolayer 
cu ltu res. The hepatocytes attached to the flasks and became 
f la ttened  and polyhedral in shape. During the 96 hours in 
cu ltu re  the c e l ls  maintained th is  appearance.
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and by the maintenance of th e ir  a b il i ty  to induce peroxisomal enzymes 
following cl o fib r ie  acid exposure (Table IV . l ) .  Toxicity  of added 
compounds was determined v isu a lly  by monitoring the loss of ce ll 
monolayer structure, rounding up, 1blebbing' and detachment of ce lls  
from the flasks (Figure IV .3 )•  The concentrations of CPIB (0-1 mM), 
MEHP (0 -0 .5  mM) and TCA (0-5 mM) used were those showing no visable  
signs of c y to to x ic ity .
IV .3.2 PEROXISOME PROLIFERATION IN CULTURED RAT HEPATOCYTES
Exposure of cultured ra t hepatocytes to cl o fib r ie  acid (1 mM) fo r 72 
hours resulted in a 3 .5 -fo ld  increase in PCO (Table I V . l ) .  The 
magnitude of th is  induction was smaller than indicated by in vivo 
experiments (Lazarow and de Duve, 1976; Mannaerts et al_, 1979;
Watanabe and Suga, 1980). Determination of oc-GPDH a c t iv ity , markedly 
enhanced by c lo fib ra te  adm inistration 1_n vivo (Hess e t aT, 1965), 
showed a decrease in specific  a c t iv ity  in hepatocytes exposed to 
c lo fib r ie  acid in v itro  (Table IV . l ) .  I t  has been claimed that 
mitochon drialc<GPDH is a marker enzyme for thyroid hormone action (Lee 
et al ,^ 1959) and i t  had recently been demonstrated in primary cultured  
ra t hepatocytes that a much greater induction of otGPDH a c t iv ity  was 
observed when the culture medium was supplemented with in s u lin 1and 
hydrocortisone (Wilson and McMurray, 1980). The culture medium used 
routinely in th is  Laboratory did not contain insu lin  or hydrocortisone. 
Experiments were set up to assess the impact of these hormones on 
c lo fib r ic  acid-induced e ffec ts . When supplemented with these two 
hormones (10"^M and 10"^M respectively) a 17-fo ld  increase in PCO and a 
3 -fo ld  increase in ocGPDH was observed in the c e lls  a fte r  72 hours 
exposure to CPIB (1 mM). In teres tin g ly  supplementation of the medium 
with insu lin  alone (10“^M) had no e ffe c t on CPIB-induced PCO a c t iv ity  
while supplementation of the medium with hydrocortisone alone ( 10“% )  
markedly enhanced the CPIB-induced PCO a c t iv ity . (This information is  
summaried in Table I V . l . )  Although i t  would appear from th is  
observation that the enhancing e ffe c t on PCO induction is due to 
hydrocortisone per se, we have observed that in the presence of
FIGURE I V . 3
TOXICITY IN CULTURED RAT HEPATOCYTES
Hepatocytes maintained as monolayer cu ltures were exposed to cu ltu re  
medium containing various agents. C y to to x ic ity  was frequently  
observed as ' b lebbing1, where the cytoplasm of the ce l l  protrudes 
through the damaged ce ll  membrane. ( ^  J* )
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hydrocortisone alone and potent p ro !ite ra to rs  the ce lls  showed
premature signs of decreased v ia b i l i t y .  This was not observed when the
medium was cosupplemented with in su lin . For th is  reason insu lin  (ICT^M) 
and hydrocortisone (10"^M) were subsequently routinely included in the 
medium. In teres ting ly  a s im ilar permissive e ffe c t may be demonstrated 
by other hormones having glucocorticoid a c t iv ity  (Table IV .2 ).
Three s tru c tu ra lly  d iffe re n t rodent peroxisome p ro !ite ra to rs  (CPIB,
MEHP and TCA) were used to evaluate th is  in v itro  model fu rth e r. 
Addition of CPIB (0 -lm M ), MEHP (0 -0 .5  mM) and TCA (0-5 mM) to cultured  
ra t hepatocytes resulted in a dose-dependent increases in PCO a c tiv ity  
(Figure IV .4 ) . c< GPDH a c tiv ity  showed s im ilar dose-related  
increases following exposure to CPIB and MEHP (Figure IV .5) fo r 72
hours. In contrast in control cultures both PCO and GPDH decreased
with time in culture (Figure IV .6 ) .  This decrease in a c t iv ity ,  
however, was not associated with a loss of the a b il i ty  to respond to 
p ro !ite ra to rs . Even a fte r  72 hours in culture exposure to CPIB (1 mM) 
s ig n ific a n tly  increases PCO. The greatest induction of PCO a c tiv ity  
was observed with three daily  additions of CPIB (1 mM) (Table IV .3 ) .
The increases in peroxisomal enzyme a c tiv ity  (PCO) were p a ra lle lle d  by 
the increases in the peroxisome volume density as determined by 
electron microscopy. P ro lite ra tio n  of smooth endoplasmic reticulum  
was also prominent in treated cultures. Morphometric analysis 
revealed time-dependent increases in the cytoplasmic volume occupied by 
peroxisomes in hepatocytes treated with CPIB (1 mM) and TCA (2 .5  mM) 
(Table IV .4 ) .
A second peroxisomal enzyme a c tiv ity  was determined -  catalase.
Exposure of cultured ra t hepatocytes to MEHP (0 .5  mM) or CPIB (1 mM) 
for 72 hours resulted in marked increases in to ta l catalase a c t iv ity  
(Table IV .5 ) .  A time-dependent increase in CoASH content was noted in 
hepatocytes treated with CPIB (1 mM) (Figure IV .7 ) . SDS-PAGE of 
sonicated hepatocytes revealed an in ten s ifie d  protein band of mwt 
76-78,000 in ce lls  exposed to CPIB (1 mM) fo r 72 hours (Figure IV .8 ) .
TABLE IV .2
THE EFFECT OF 'GLUCOCORTICOID HORMONES' ON THE RESPONSE OF PRIMARY 
RAT HEPATOCYTE CULTURES TO CLOFIBRIC ACID
ADDITIONS TO CULTURES CN”-INSENSITIVE PALMITOYL-CoA
OXIDATION 
(nmol NAD+ reduced/min/mg protein)
None (co n tro l) 1.0  + 0.2 (3)
C lo fib ric  acid 3.1 + 0.8 (3)
Progesterone and c lo f ib r ic  acid 6.8  + 1.2 (3)
17-Hydroxyprogesterone and
c lo fib r ic  acid 11.8 + 0.6 (3)
Corticosterone and c lo fib r ic  acid 19.3 + 1.7 (3)
Hydrocortisone and c lo fib r ic  acid 15.0 + 1.8 ( 2 )
Prednisolone and c lo fib r ic  acid 23.8 + 1.1 (3)
Betamethasone and c lo fib r ic  acid 24.0 + 3 .6 (3)
V
Increasing
glucocorticoid
potency
(Wicks, 1974)
Rat hepatocytes were cultured in the presence of insu lin  (10”^M) and 
the steroid hormones (10“^M) stated above. A fter 24 hr in culture  
c lo fib r ic  acid (1 mM) was added to the medium. Every 24 hr the medium 
was replenished. A fter 72 hr exposure to c lo f ib r ic  acid the c e lls  
were harvested and enzymatic a c t iv it ie s  were determined in ce ll 
sonicates.
Values are Mean + SD (n)
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FIGURE IV.4
EFFECT OF CLOFIBRIC ACID, MQNOETHYLHEXYLPHTHALATE, AND
TRICHLOROACETIC ACID ON CYANIDE-INSENSITIVE 
PALMITOYL-CoA OXIDATION IN CULTURED RAT HEPATOCYTES
2000 r
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Cultured ra t hepatocytes were exposed to medium containing CPIB, MEHP and 
TCA for 72 hours. A fter th is  time the ce lls  were harvested and peroxi­
somal B-oxidation determined. Values are expressed as % a c t iv ity  in  
untreated cultures, and are mean + SD (n = 5 -6 ).
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THE EFFECT OF MONO-(2-ETHYL HEXYL)PHTHALATE AND CLOFIBRIC ACID ON
MITOCHONDRIAL oC-GLYCERQPHOSPHATE DEHYDROGENASE ACTIVITY IN
CULTURED RAT HEPATOCYTES
MEHP
% Control
500
400
300
200
100
I
!
CPIB
i /
i
I71
4 *
0 0.25 0.50 0.75 1.00
CONCENTRATION (mM)
Rat hepatocytes were isolated and cultured. A fter 24 hours the cultured  
ce lls  were exposed to culture medium containing c lo f ib r ic  acid (CPIB) and 
mono-(2-ethyl hexyl)phtfialate (MEHP) fo r 72 hours. A fter th is  time the 
cells  were harvested and « -glycerophosphate dehydrogenase a c t iv ity  was 
determined. Values are expressed as % a c t iv ity  in untreated cultures and 
are mean + SD (n = 5 -6 ).
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n a u K E .  1V . D
TIME-DEPENDENT DECREASE IN CYANIDE-INSENSITIVE PALMITOYL-CoA OXIDATION
AND MITOCHONDRIAL o<-GLYCEROPHOSPHATE DEHYDROGENASE ACTIVITY IN CULTURED
Rat hepatocytes were isolated and maintained as primary.monolayer cultures. 
The culture medium was replenished every 24 hours. A t.the  times indicated  
hepatocytes were harvested and cyanide-insensitive palmitoyl CoA oxidation  
and o<-glycerophosphate dehydrogenase a c t iv ity  were determined. Values are 
mean + SD (n = 4 ).
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TABLE IV .3
THE EFFECT OF TIME OF ADDITION OF CLOFIBRIC ACID TO CULTURED RAT 
HEPATOCYTES ON CN’ -INSENSITIVE PALMITOYL-CoA OXIDATION
TIME OF ADDITION OF 
CLOFIBRIC ACID 
(HRS AFTER SEEDING)
CN"-INSENSITIVE PALMITOYL-CoA 
OXIDATION 
(nmol NAD+ reduced/min/mg protein)
Control (no c lo f ib r ic  acid) 
24, 48 and 72 
48 and 72 
72
1.13'+  0.46 (4) 
11.96 + 2.1 (7 )*  
8.76 + 1.26 (8 ) *  
3 . 1 8 + 0 .5 8 ( 8 ) *
Hepatocytes were isolated from male rats and primary monolayer cultures  
were established. C lo fib ric  acid (1 .0  mM) was added a t the times 
indicated. The c e lls  were harvested 96 hr a fte r  seeding and CN“-  
insensitive palmitoyl-CoA oxidation determined in ce ll sonicates.
Values are mean + SD (n)
*S ig n ific a n tly  d iffe re n t from control values, p <  0.05
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TABLE IV .4
THE EFFECT OF CLOFIBRIC ACID AND TRICHLOROACETIC ACID 
ON THE FRACTIONAL PEROXISOMAL VOLUME OF CULTURED RAT HEPATOCYTES
HRS IN 
CULTURE
ADDITIONS TO CULTURES
NONE (CONTROL) CLOFIBRIC ACID TRICHLOROACETIC
ACID
1% FRACTIONAL PEROXISOMAL VOLUME)
24 2.4 + 1.5 ( 6 )
48 1.3 + 1 .0  (5) 4.2 + 2.1 (5) 3.4 + 2 .8  (4)
72 1.4 + 2.2 (4) 5.3 + 4 .6  (5) 3.1 + 1.4 (8 )
96 0.9 + 0.5 ( 6 ) 7.7 + 2.7 (5) 3.8 + 2.3 ( 6 )
Hepatocytes were isolated from male rats and primary monolayer 
cultures were established. A fter 24 hr in culture c lo f ib r ic  acid 
(1 mM) and trich lo ro ace tic  acid (2 .5  mM) were added. Media and 
compounds were renewed each day. A fter various times of exposure the 
ce lls  were fixed in s itu  in glutaraldehyde and examined by electron  
microscopy.
Values represent % of cytoplasmic volume occupied by peroxisomes and 
are mean + SD (n) where n is the number of representative areas 
examined.
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TABLE IV .5
THE EFFECT OF CLOFIBRIC ACID AND MEHP ON CATALASE ACTIVITY 
IN CULTURED RAT HEPATOCYTES
ADDITIONS TO CULTURE MEDIUM CATALASE ACTIVITY 
KS~*.mg protein"* x 10^
None
C lo fib ric  acid (1 mM) 
MEHP (0 .5  mM)
39.2 + 1 .0  (4) 
252.7 + 30.2 (4 )*  
261.5 + 6 3 .3  (4 )*
A fter 24 hours in cu ltu re , hepatocytes were exposed to culture medium 
containing c lo f ib r ic  acid (1 mM) or MEHP (0 .5  mM) fo r 72 hours. A fter  
th is  time the ce lls  were harvested and catalase a c tiv ity  was determined 
in ce ll sonicates.
Values are mean + SD (n)
^ S ig n ifican tly  d iffe re n t from control p < 0 .05
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EFFECT OF CLOFIBRIC ACID ON THE COENZYME A CONTENT OF CULTURED RAT
HEPATOCYTES
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+->OS-Q.
O Vs
zcLO<coo
0.6
CPIB
0.5
0.4
0.3
0.2 CONTROL
0.1
0
0 24 48 9672
HOURS IN CULTURE
Hepatocytes were maintained as primary monolayer cultures. A fte r 24 hours 
in culture the ce lls  were exposed to culture medium containing c lo f ib r ic  
acid (1 mM) fo r 72 hours. A fter th is  time the c e lls  were harvested and 
acid soluble Coenzyme A was determined. Values are mean + SD (n = 3 ).
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FIGURE IV .8
SODIUM DODECYLSULPHATE-POLY ACRYLAMIDE GEL ELECTROPHORESIS OF RAT 
HEPATOCYTE SONICATES AFTER EXPOSURE TO CLOFIBRIC ACID
Rat hepatocytes were maintained as monolayer cultures. A fte r 24 hours 
in culture the c e lls  were exposed to medium containing c lo f ib r ic  acid 
(1 mM) for 72 hours. A fter th is  time the ce lls  were harvested and 
disrupted by sonication. 37.5 jug ce ll protein was applied to each 
w ell. Resolved proteins were stained with Coomassie Blue R-250.
1. C lo fib ric  acid-treated hepatocytes. 2. Control hepatocytes.
1 1 2  2
©
78,000 Daltons
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IV .4 DISCUSSION
Three s tru c tu ra lly  d is tin c t rodent hepatic peroxisome p ro !ite ra to rs  
MEHP (Lake e t al_, 1975), CPIB (Hess e t al_, 1965; Thorpe, 1962) and TCA 
(El combe e t a l ,  1982) have been shown to induce p ro life ra tio n  of 
peroxisomes in cultured ra t hepatocytes. This peroxisome 
p ro life ra tio n  was demonstrated by.an increase in the percentage of the 
cytoplasm occupied by peroxisomes, an induction of marker peroxisomal 
enzym esPCO and catalase -  and was accompanied by other c e llu la r  
changes: induction of mitochrondrial <xGPDH; increased c e llu la r
Coenzyme A content and induction of a marker 76-78,000 mwt protein . 
(This data is  summarised in Table IV .6 . )
The a b il i ty  of c lo f ib r ic  acid to induce peroxisome p ro life ra tio n  in 
culture was greatly  enhanced by supplementation of the culture medium 
with hydrocortisone. This permissive e ffe c t was not due to 
hydrocortisone s p e c ific a lly  but could be reproduced to d iffe re n t  
extents with other steroid hormones having glucocorticoid a c tiv ity  
(Table IV .2 ) . In te res tin g ly  the magnitude of PCO induction with CPIB 
closely followed the glucocorticoid potency of the steroid as suggested 
by Wicks (1974). The ro le  of glucocorticoid a c tiv ity  in th is  respect 
is unclear. I t  does not appear that glucocorticoids are necessary to 
maintain the functional v ia b i l i ty  of the hepatocyte as cytochrome P-450 
induction by phenobarbitone is unaffected by hydrocortisone 
supplementation of the culture medium (G L Parker, CR El combe, 
personal communication). Glucocorticoids have been shown to be 
required for the maximal induction of other enzymes in cultured ra t  
hepatocytes (Wilson and McMurray, 1980; L i n ' e t ^ ,  1982). This 
permissive e ffe c t may be re lated simply to the improved maintenance of 
morphology of hepatocytes in culture by glucocorticoids (Laishes and 
W illiam s, 1976). I t  is  feasib le  th a t the permissive e ffe c t of 
glucocorticoids on the induction of PCO may be re lated  to the promotion 
of in tra c e llu la r  l ip id  accumulation (Dich e t a l , 1983) which we have 
since suggested to be the tr ig g e r fo r peroxisome p ro life ra tio n . Our 
understanding of th is  phenomenon a t present is complicated by the lack 
of knowledge regarding the effects  of glucocorticoids on the l iv e r .
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TABLE IV .6
EFFECTS'OF PEROXISOME PROLIFERATORS ON THE LIVER 
IN VIVO : IN VITRO COMPARISON
IN VIVO 
LIVER
IN VITRO 
PRIMARY CULTURED 
RAT HEPATOCYTES
PEROXISOMAL VOLUME DENSITY 4
PEROXISOMAL B-OXIDATION
CATALASE i
MITOCHONDRIAL ocGPDH ♦
COENZYME A CONTENT ♦
80,000 MWT PROTEIN *
i■ -Increase
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In cultured ra t hepatocytes the control enzyme a c tiv it ie s  -  PCO and 
c* GPDH -  declined with time in cu ltu re . This is  a common observation 
in cultured l iv e r  ce lls  and presumably re fle c ts  adaptation of the l iv e r  
cell to its  new environment. This is , however, an important 
observation. The weak peroxisome p ro !ite ra to r TCA produced a 3 -fo ld  
increase in PCO above control levels  at 96 hours but th is  did not 
exceed the PCO in freshly isolated hepatocytes. Such an increase 
could be regarded as a maintenance of a c t iv ity  rather than an 
induction. However, the in d u c ib ility  of PCO in the c e lls  even a fte r  
72 hours in culture favours induction rather than maintenance. I t  is  
not feasib le  with compounds such as TCA, which bind strongly to serum 
proteins, to predict the acce s s ib ility  of the agent to the c e l l .  The 
b io a v a ila b ility  of such compounds is not re flected  by the concentration 
in the medium. The potent in vivo peroxisome p ro life ra to r  c lo f ib r ic  
acid induced PCO to levels  greatly  exceeding the a c t iv ity  in freshly  
isolated l iv e r  c e lls . A s im ila r phenomenon was observed with induction 
of cxgpdh.
That PCO is a good marker fo r peroxisome p ro life ra tio n  in the l iv e r  i_n 
vivo has been demonstrated (Lazarow, 1977; Lalwani e t al_, 1983a) . The 
induction of th is  peroxisomal enzyme a c tiv ity  closely followed the 
increases in fractiona l peroxisomal volume in cultured hepatocytes 
(Figure IV .9 ) . Preparation of hepatocyte cultures fo r electron  
microscopy and morphometric analysis is  an extremely time-consuming and 
expensive process and and i t  was expedient therefore, having 
established th is  correlation  to measure peroxisomal enzyme a c tiv ity  
routinely as a marker fo r peroxisome p ro life ra tio n .
A second peroxisomal enzyme, catalase, has consistently been shown.to 
be elevated in the l iv e r  following adm inistration of peroxisome 
p ro life ra to rs  to rodents (Lalwani e t al_, 1983a) .  A large increase in 
catalase a c tiv ity  (6 .7 -fo ld  and 6 .4 -fo ld  respectively) was observed in 
cultured ra t hepatocytes exposed to MEHP (0 .5  mM) or CPIB (1 mM) fo r 72 
hours. Such large increases in catalase a c t iv ity  are not observed in 
the l iv e r  in vivo. However, i t  is l ik e ly  that in control hepatocytes
110.
CORRELATION BETWEEN PEROXISOMAL VOLUME DENSITY AND CYANIDE-INSENSITIVE 
PALMITOYL CoA OXIDATION IN CULTURED RAT HEPATOCYTES
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Hepatocytes were maintained as primary monolayer cultures. A fte r 24 
hours in culture the ce lls  were exposed to culture medium containing  
c lo fib r ic  acid (1 mM). At the times indicated (days p o s t-iso la tio n ) the 
cells  were harvested and palmitoyl-CoA oxidation determined or fixed  
and examined by electron microscopy fo r determination of peroxisome 
volume density. Control c e lls  (O)* C lo fib ric  ac id-treated c e lls  (□) 
Values are mean + SD (n -  4 -6 ),
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cultures catalase a c tiv ity  decreases with time in cu ltu re , thus 
magnifiying the fo ld  induction. I t  is also noteworthy that 
determination of catalase a c tiv ity  in ce ll sonicates should be compared 
with determination of catalase a c tiv ity  in l iv e r  homogenates as 
subcellular red is trib u tio n  of catalase or leakage from broken 
peroxisomes cannot be disregarded.
CPIB, MEHP and TCA produced dose- and time-dependent increases in 
m itochondrial otGPDH a c tiv ity  in cultured ra t hepatocytes. ocGPDH 
a c tiv ity  has been shown to be increased in the liv e r  of rodents treated  
with c lo fib ra te  (Hess e t a^, 1965; Holloway and Orton, 1979). otGPDH is  
claimed to be a marker enzyme fo r thyroid hormone a c tiv ity  (Lee e t al_, 
1959). Indeed i t  has been suggested th a t the observed induction of 
o( GPDH activity is  a response to a disturbance in thyroid hormone status 
brought about by the structural s im ila r ity  of thyroxine and c lo f ib r ic  
acid.
COOH
HO CH2—CH Thyroxine
n h 2
Cl
c h 3
I
o — C —COOH Clofibric acid
c h 3
Such a mechanism is , however, un like ly  to explain the induction of 
«GPDH a c t iv ity  by MEHP and TCA, since these compounds bear no 
structural s im ila r ity  to thyroxine. In cultured ra t hepatocytes we
have consistently found <xGPDH a c tiv ity  to be induced with agents that 
cause peroxisome p ro life ra tio n . Furthermore, the magnitude of 
GPDH induction correlates closely with the magnitude of PCO 
induction (Figure IV .10).
I t  would appear therefore that induction of cxGPDH is an event closely  
re lated to peroxisome p ro life ra tio n . cxGPDH forms an un idirectional 
shuttle system fo r the transfer of reducing equivalents ( NADH) across 
the mitochrondrial membrane (from the cytosol to the m a tr ix ). The 
coinduction of peroxisomal B-oxidation and *GPDH may indicate that the 
NADH generated by the peroxisome is  reoxidised by transmitochrondrial 
membrane shuttling  involving in p a rtic u la r the dihydroxycetone 
phosphate/oc-glycerophosphate redox p a ir.
In te re s tin g ly , hyperthyroidism i t s e l f  e l ic i ts  mild hepatic peroxisome 
p ro life ra tio n  in rodents (Fringes and Reith, 1979) and though compounds 
s tru c tu ra lly  s im ilar to thyroxine, such as cl o fi b ra te , may act via a 
thyroid hormone mediated-mechanism the observed induction of ocGPDH in  
vivo may be a marker fo r peroxisome p ro life ra tio n  rather than thyroid  
hormone a c t iv ity .
A number of peroxisome p ro !ife ra to rs  have been shown to markedly 
increase the content of coenzyme A in the l iv e r  In vivo (Savolainen e t 
a l,  1977; Shindo e t a l , 1978; Bakke and Berge, 1982; Halvorsen, 1983). 
Physiological stresses such as starvation , chemically-induced diabetes 
and feeding of high fa t  d ie ts , where mild peroxisome p ro lite ra tio n  is 
observed (Horie e t al_, 1981, Neat e t al_, 1980; Is h ii e t al_, 1980a , b) ,  
also confer an increase in hepatic coenzyme A content (Christiansen et 
a l , 1979; Tubbs and Garland, 1964). Increases in acetyl CoA and free  
CoASH in p a rtic u la r are common (Bakke and Berge, 1982; Skrede and 
Halvorsen, 1979; Savolainen e t al_, 1977). In cultured ra t  hepatocytes 
exposure to c lo f ib r ic  acid (1 mM) produced a time-dependent increase in  
c e llu la r  CoASH content (acetyl CoA and CoASH). The ro le  of th is  change 
in the phenomenon of peroxisome p ro life ra tio n  is not understood.
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CORRELATION BETWEEN CYANIDE-INSENSITIVE PALMITOYL-CoA OXIDATION
AND MITOCHONDRIAL <X-GLYCEROPHOSPHATE DEHYDROGENASE ACTIVITY IN
CULTURED RAT HEPATOCYTES
<v
4->Os_
CL
O CDo  £a . \■ c
oE£
24
20
16
12
8
4
0
.08 .12 
ocGPDH (AOD/min/mg protein)
.16.040
Cultured ra t hepatocytes were exposed to culture medium containing 
c lo fib r ic  acid (1 .0  mM] or trich lo ro ace tic  acid (2 .5  mM) fo r up to 72 
hours. At the times indicated (days p o st-iso la tion ) the ce lls  were 
harvested and PCO and«-GPDH a c tiv ity  were determined. Control ce lls  
( • ) } c lo fib r ic  acid-treated ce lls  (■) and TCA-treated ce lls  (A).
.Values are mean + SD (n -  4 -6 ).
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I t  has been suggested that the observed increase in hepatic coenzyme A 
content following administration of c lo f ib ra te  or i ts  analogues to 
rodents, is intim ately associated with the observed hypolipidaemia, by 
driving more acyl groups through mitoch ondrial B-oxidation (Halvorsen, 
1983).
SDS- PAGE of sonicated hepatocyte cultures revealed an increase in a 
protein of 76-78,000 Daltons following exposure to CPIB (1 mM) for 72 
hours. Similar observations have been made following administration  
of peroxisome pro life ra to rs  to rodents (Reddy and Kumar, 1977; Is h i i  
and Suga, 1979; Is h i i  et aV, 1980a ; Lalwani et al ,^ 1981a; Reddy et al_, 
1981^; Kawashima et al_, 1984). The induced protein is believed to be 
the bifunctional enoyl CoA hydratase/3-hydroxy acyl-CoA dehydrogenase 
(Osumi and Hashimoto, 1979; Reddy e t  al_, 1981).
IV .5 CONCLUSION
The s u ita b i l i ty  of primary r a t  hepatocyte cultures as an i_n v itro  
system for the study of peroxisome pro life ra tio n  has been investigated. 
Three s tru c tu ra lly  unrelated compounds CPIB, MEHP and TCA, have been 
shown to p ro l ife ra te  peroxisomes in cultured r a t  hepatocytes. The 
presence of hydrocortisone in the culture medium was found to be 
essential for maximal p ro life ra t io n  of peroxisomes and induction o-f 
marker enzymes. A mitoch. ondrial enzyme - otGPDH - was shown to be a 
marker for peroxisome p ro lite ra t io n . Further v e r if ic a tio n  of the system 
was demonstrated by: an increase in the peroxisomal volume density, an 
increase in catalase a c t iv ity ;  an increase in c e l lu la r  Coenzyme A 
content, and an induction of a marker 76-78,000 mwt protein. The
dose- and time-dependency of these effects were demonstrated. The
overall response to peroxisome pro life ra to rs  observed in cultured ra t  
hepatocytes was comparable to the response of the l iv e r  in vivo (Table
IV .6 ) .
Hence from both biochemical and morpholigical c r i te r ia  primary cultures  
of ra t  hepatocytes appear to o ffe r  a suitable v itro  system for  
investigating the phenomenon of peroxisome p ro life ra t io n .
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CHAPTER V
PEROXISOME PROLIFERATION IN CULTURED RAT, GUINEA PIG, MARMOSET
AND HUMAN HEPATOCYTES
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V .l INTRODUCTION
A number of chemical agents have been shown to cause p ro life ra t io n  of 
peroxisomes in the l iv e r  of rodents (Hess e t  al_, 1965; Reddy e t al_, 
1973; Lake et al_, 1975; Reddy and Krishnakantha, 1975; El combe e t a l ,  
1982). Subsequently, a number of these agents have also been shown to 
enhance the incidence o f hepatocellular carcinoma in rodents (Reddy and 
Rao, 1977; Reddy and Qureshi, 1979; Svoboda and Azarnoff, 1979).
This correlation has lead to the proposal that rodent peroxisome 
pro lifera tors  as a class are carcinogenic (Reddy et al_, 1980). These 
agents have shown a lack of overt genotoxic potential in a number of in 
v itro  te s t  systems (Warren e t al_, 1980; Fitzgerald e t  a l ,  1981; Warren 
et al_, 1982; Reddy et al ,^ 1982^) and i t  is suggested that the sustained 
increase in peroxisomal enzyme a c t iv ity  leads to an increased steady 
state H2O2 concentration, and this elevated H2O2 potentiates the 
carcinogenic mechanism (Reddy e t  al_, 1979; Reddy e t al ,^ 1980; Warren 
et al_, 1980, Warren et al_, 1982).
Early studies by Svoboda e t al_ (1967) had revealed that the 
hypolipidaemic drug c lo f ib ra te  did not e l i c i t  hepatic peroxisome 
pro lite ra tio n  in a number of species. Subsequently a number of other 
agents (which are pro life ra tors  in rodents) have fa i le d  to e l i c i t  
peroxisome p ro life ra t io n  in the l iv e r  of non-rodent species (Blane and 
P in aro li ,  1980; Holloway e t al_, 1982a , b; Osumi and Hashimoto, 1978). 
I t  has thus been suggested that hepatic proxisome p ro life ra t io n  is  
unique to rodents. More importantly, i t  follows that i f  peroxisome 
pro life ra tio n  is a prerequisite event in th is  carcinogenic mechanism 
then induction of hepatocarcinogenesis by these agents is also l ik e ly  
to be unique to rodents.
In the e a r l ie r  studies only small numbers of animals were used and 
peroxisome p ro life ra t io n  in the l iv e r  was assessed merely by subjective  
evaluation of electron micrographs and thus these studies have 
frequently been rejected as inconclusive. However, in recent studies 
using clobuzarit (Orton et al_, 1984) and DEHP (Chapter I I I )  sizeable  
groups of animals were used and quantitative morphometric analysis of 
peroxisomal changes was complemented by determination of a number of
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biochemical markers. No peroxisome pro life ra tio n  was observed in the 
l iv e r  of dogs or marmoset monkeys used in these studies. Reddy et al_ 
(1984) have demonstrated that c ipro fib ra te  (a potent p ro !ite ra to r  in 
the rodent) produced peroxisome p ro lite ra t io n  in the l iv e r  of the cat, 
chicken, pigeon, Rhesus and Cynamolgus monkeys and concluded that  
peroxisome p ro life ra t io n  "is a dose-dependent and not a species 
specific phenomenon".
Despite the frequent occurrence of peroxisome pro !ite ra tion  as a 
toxicological e ffe c t  in rodents, i t  is  a t present unclear whether i t  is  
inducible in the l iv e r  of non-rodent species a t ' .a l l ,  or whether i t  is 
merely a dose-dependent phenomenon to which rodents are exceptionally  
sensitive.
I t  has been shown that peroxisome pro life ra tio n  can be induced in 
primary ra t  hepatocyte cultures (Chapter IV; Gray aT, 1982; 1983). 
Hence the aim of th is  work was to investigate the "species difference"  
phenomenon by exposing primary cultures of ra t ,  guinea pig, marmoset 
and human hepatocytes to a range of known peroxisome p ro !ife ra to rs .
Such experiments allow the d irect comparison of the effects of these 
agents on the hepatocytes of d if fe re n t  species, and in particu la r  on 
human hepatocytes, providing a simple means of assessing the e ffects  of 
these agents in man.
V.2 METHODS
Hepatocytes were isolated from male ra ts , male guinea pigs and male 
marmosets by perfusion of the l iv e r  i_n situ  and from human l iv e r  wedge 
biopsy samples by incubation of l iv e r  slices in enzyme-containing 
buffer. The procedures used for cell isolation vary s i ig h t ly  for each 
species and are described in deta il in METHODS. The hepatocytes were 
suspended in CL 15 medium. Vitamin C (50 m g /l it re )  was included in the 
medium for the guinea pig, marmoset and human hepatocyte cultures  
(HCL15 medium). Primary monolayer cultures were prepared by seeding 
25 cm^  Falcon tissue culture flasks with 2 x 10^ viable ce lls  in 4 ml 
culture medium. Flasks for human hepatocytes were precoated with
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human fibronectin to aid cell attachment. The flasks were incubated 
in a i r  at 37°C. 4, 24, 48 and 72 hours a f te r  seeding the spent medium
and any unattached ce lls  were aspirated and fresh medium supplied.
Test compounds c lo f ib r ic  acid (CPIB), mono-(2-ethyl hexylTphthalate 
(MEHP) and tr ich lo roacetic  acid (TCA) were dissolved in DMF and added 
to the fresh culture medium at 24, 48 and 72 hours post-seeding. A fter  
96 hours in culture the cells  were harvested by scraping into SET 
buffer, disrupted by sonication and stored at -70°C. Cyanide- 
insensitive palmitoyl CoA oxidation (PCO) was assayed in the freshly  
thawed sonicates e ither  as the pal mi toy!-CoA-dependent reduction of 
NAD+ (spectrophotometric assay) or as the production of ^C  
acid-soluble material from 1“^ C  palmitoyl-CoA (radiolabelled assay). 
The radio!abelled assay was developed subsequently to the 
spectrophotometric assay and was found to be of greater s e n s it iv ity  and 
r e l ia b i l i t y  when measuring peroxisomal B-oxidation in hepatocytes from 
non-rodent species. Cytochrome P-450 mediated 1 auric acid 
6j-hydroxylase a c t iv ity  (LAH) was measured in freshly thawed sonicates 
of cultured hepatocytes. Protein was determined by the method of 
Lowry et al_ (1951). The v ia b i l i t y  of the cell cultures was assessed 
by determining the induction of cytochrome(s) P-450 by phenobarbitone 
(PB). The cultures were exposed to PB (2 mM) for 72 hours, when 
7-ethoxycoumarin-o-deethylase a c t iv ity  (ECOD) was determined. Induction 
of ECOD, which requires a complex anabolic response, was assumed to 
indicate the metabolic competence and hence v ia b i l i t y  of the cell 
cultures.
Y.3 RESULTS
Hepatocytes isolated from ra ts , guinea pigs, marmosets and humans were 
maintained as primary monolayer cultures for 96 hours. The e ffic iency  
of attachment of the human and marmoset ce lls  to the flasks was less 
than for ra t  and guinea pig ce lls  but was greatly enhanced by 
precoating of the flasks with human fibronectin . In a l l  cultures the 
hepatocytes attached to the polystyrene flasks and became fla ttened and 
polyhedral in shape within 6 -  8 hours ( ra t  and guinea pig c e lls )  or 12 
-  24 hours (marmoset and human). During the four days of culture the 
cells  maintained this appearance (Figure V . l ) .
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FIGURE V .l
GUINEA PIG HEPATOCYTES IN PRIMARY MONOLAYER CULTURE
MARMOSET HEPATOCYTES IN PRIMARY MONOLAYER CULTURE
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FIGURE V .l 
(Continued)
HUMAN HEPATOCYTES IN PRIMARY MONOLAYER CULTURES
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Hepatocytes were iso la ted  from guinea p ig , marmoset and human l i v e r ,  
and cultured in  HCL15 medium. Human l i v e r  ce l ls  were seeded on 
fibronectin-precoated f lasks . The c e l ls  maintained th is  appearance 
during the four days of cu ltu re .
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CP1B (0 -  1.0 mM), MEHP (0 -  0.5 mM) and TCA (0 -  5 mM) produced a 
dose-dependent increase in PCO in cultured ra t  hepatocytes following 72 
hours exposure (Figure V.2 -  V.4 ) .  Primary guinea pig, marmoset and 
human hepatocyte cultures were exposed to equivalent, and in many cases 
much higher concentrations of these agents (Figure V.2 -  V.4 ) .
Induction of PCO as observed in cultured ra t  hepatocytes, was not 
observed in cultured guinea pig, marmoset or human hepatocytes. In 
cultured guinea pig hepatocytes small but s ta t is t ic a l ly  s ign if ican t  
increase «  2 -fo ld )  in PCO was observed following 72 hours exposure to 
c lo f ib r ic  acid (5 mM). In cultured marmoset hepatocytes s im ilar
small increases in PCO were observed following 72 hours exposure to
c lo f ib r ic  acid (0.25 -  1.0 mM) and MEHP (0.05 -  0.25 mM) but no 
dose-response relationship was observed. In cultured human 
hepatocytes no increases in PCO were observed with any of the agents 
tested. The effects on PCO were confirmed by electron microscopy of 
the hepatocyte cultures (Figure V .5 ) .  LAH-a second enzyme associated 
with peroxisome pro life ra tio n  in ra t  l iv e r  (Parker and Orton, 1980; 
Orton and Parker, 1982; Gibson et al ,^ 1982; Okita and Chance, 1984)
was determined following exposure to MEHP (0.5 mM) and CPIB (1 mM) for
72 hours (Table V . l ) .  Neither compound affected LAH in human 
hepatocyte cultures. A small increase in LAH was observed in marmoset 
hepatocytes exposed to MEHP (0.5 mM) (Table V . l ) .  This change was very
small when compared to that observed in ra t  hepatocytes (14-fo ld )
exposed to MEHP (0.5 mM).
Where possible the v ia b i l i t y  of the cultured hepatocytes was assessed 
by determination of ECOD following exposure to phenobarbitone (2 mM) 
for 72 hours. In cultured ra t ,  guinea pig and human hepatocytes a 
s ign if icant increase in ECOD a c t iv i ty  was noted indicating the
functional v ia b i l i ty  of the ce lls  (Table V .2 ),
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EFFECT OF CLOFIBRIC ACID ON CYANIDE-INSENSITIVE PALMITOYL—CoA OXIDATION
IN CULTURED RAT, GUINEA PIG, MARMOSET AND HUMAN HEPATOCYTES
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Primary ra t ,  guinea pig, marmoset and human hepatocyte cultures were 
exposed to medium containing c lo f ib r ic  acid fo r  72 hours. A fter  th is  
time the cells  were harvested and PCO determined. Values are mean + 
SD (n = 3 -7 ).
•k
S ign ificantly  d if fe re n t  from control, p <  0.05 
aDetermined by spectrophotometric assay 
^Determined by radio!abelled assay
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I J. U W I N L  V •
EFFECT OF M0N0-(2-ETHYL HEXYL)PHTHALATE ON CYANIDE-INSENSITIVE PALMITOYL- 
CoA OXIDATION IN CULTURED RAT, GUINEA PIG, MARMOSET AND HUMAN HEPATOCYTES
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Primary ra t ,  guinea pig, marmoset and human hepatocyte cultures were 
exposed to medium containing MEHP for 72 hours. A fter  th is
time the cells  were harvested and PCO determined. Values are mean + 
SD (n = 3 -8 ).
■k
Sign ificantly  d if fe re n t  from control, p <  0.05 
determined by spectrophotometric assay 
^Determined by radiolabelled assay
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FIGURE V.4
EFFECT OF TRICHLOROACETIC ACID ON CYANIDE-INSENSITIVE PALMITOYL-CoA
OXIDATION IN CULTURED RAT, GUINEA PIG, MARMOSET AND HUMAN HEPATOCYTE
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Primary ra t ,  guinea pig, marmoset and human hepatocyte cultures were 
exposed to medium containing TCA for 72 hours. A fter  this
time the cells  were harvested and PCO determined. Values are mean
+ SD (n = 3 -3 ).
*
S ign ificantly  d if fe re n t from control, p< 0.05. 
determined by spectrophotometric assay.
Determined by radiolabelled assay.
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ELECTRON MICROGRAPHS OF CULTURED HUMAN HEPATOCYTES:
EFFECT OF CLOFIBRIC ACID
(a) Control hepatocytes
W m m k
(b) C lo f ib r ic  acid treated hepatocytes
Human hepatocyte cultures were exposed to c lo f ib r ic  acid (1 mM) fo r  72 
hours. Comparison of electron micrographs of these ce lls  revealed no 
increase in peroxisomes
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TABLE V . l
EFFECT OF MONO-(2-ETHYL HEXYL)PHTHALATE AND CLOFIBRIC ACID ON LAURIC 
ACID HYDROXYLASE ACTIVITY IN CULTURED RAT, MARMOSET AND HUMAN
HEPATOCYTES
ADDITIONS TO CULTURE LAH
nmol/hour/mg protein
Rat None 2.4 + 1.5 (8 )
MEHP (0.5 mM) 34.7 + 8.4 (4 )*
Marmoset None 8.4 + 0.9 (8 )
MEHP (0.5 mM) 14.1 + 1 . 3  (4 ) *
CPIB (1.0 mM) 11.4 + 1.8 (4)
Human None 6.9 + 0.7 (3)
MEHP (0.5 mM) 8.3 + 1.0 (3)
CPIB (1.0 mM) 6.5 + 1.4 (3)
Values are mean + SD (n)
* S ta t is t ic a n y  d iffe re n t from control p <  0.05
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TABLE V.2
INDUCTION OF ECOD BY PHENOBARBITONE IN CULTURED 
RAT, GUINEA PIG AND HUMAN HEPATOCYTES
ADDITIONS TO MEDIUM ECOD
nmol/hour/mg protein
Rat None
Phenobarbitone
2.55 + 0.51 (4 )a 
13.10 + 2.52 {4 )a*
Gru.me.Q_
f ‘9
None
Phenobarbitone (2 mM)
8.17 + 0.29 (3) 
23.57 + 1.99 (3 )*
Human None
Phenobarbitone (2 mM)
0.66 + 0.05 (3) 
2.93 + 0 .2 4  (3 )*
Values are mean + SD (n)
^ S ta t is t ic a l ly  d if fe ren t from control p < 0 . 0 5  
anmol/hour/10  ^ ce lls
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V.4 DISCUSSION
A number of agents have been shown to e l i c i t  p ro life ra t io n  of 
peroxisomes in the l iv e r  of rodents. Limited studies have indicated  
that these agents do not e l i c i t  peroxisome p ro life ra t io n  in the l iv e r  
of some species, such as the guinea pig and the marmoset monkey 
(Svoboda e t aV, 1967; Osumi and Hashimoto, 1978; Holloway e t a ^ ,  
1982a ,b; Orton et al_, 1984). I t  is not c lear whether th is  
difference is due merely to metabolism or b io a v a i la b i l i ty  differences  
or whether i t  is  indicative of an inherent difference in the response 
of the l iv e r  of these species to such agents.
C lo fib r ic  acid, MEHP and TCA are the principal metabolites derived from 
c lo f ib ra te , DEHP and trichloroethylene respectively and have been shown 
to be responsible for the effects of the parent compounds (Thorpe,
1962; Lake e t aV, 1975; El combe e t al_, 1982). These agents have 
also been shown to produce peroxisome p ro life ra t io n  in cultured ra t  
hepatocytes (Chapter IV, Gray e t  al_, 1982, 1983). This suggests tha t  
peroxisome pro life ra tio n  results from the d irect e ffec t of these agents 
on the hepatocyte, and is unlikely to be mediated iji vivo by a systemic 
stimulus. (However, the culture medium used does contain serum and 
the involvement of contaminating hormones etc can not be completely 
excluded.) Hence, peroxisome pro !ite ra tion  may be s im ila r ly  assessed 
in primary cultures of hepatocytes from other species. More 
importantly, as hepatocytes may be isolated from human l i v e r ,  human 
hepatocyte cultures represent a useful means of determining whether 
peroxisome p ro life ra t io n  occurs or not and thus of extrapolating more 
accurately the carcinogenic risk of these agents to man.
CPIB, MEHP and TCA produced dose-related increases in PCO in primary 
ra t  hepatocyte cultures. No such dose-related effects  on PCO were 
observed in cultured guinea pig, marmoset or human hepatocytes exposed 
to comparable concentrations of CPIB, MEHP or TCA for 72 hours. A small 
but s ta t is t ic a l ly  s ign if icant increase in PCO a c t iv ity  was observed in 
cultured marmoset hepatocytes exposed to CPIB or MEHP or cultured  
guinea pig hepatocytes exposed to CPIB (5 mM) for 72 hours.
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I t  is relevant here to point out that the results shown are 
'representative' of a number of experiments performed. The s ta t is t ic a l  
increases in PCO observed were not consistently reproducible. This 
inconsistency is also indicated by the lack of dose-dependency of the 
effec ts . However, wherever increases in PCO were recorded the degree 
of induction was minimal and never approached that observed in ra t  
l iv e r  c e l ls .  Whether these minor changes are of toxicological 
importance is questionable. I t  is  plausible that measurement of PCO 
is not a suitable marker for peroxisome p ro life ra t io n  in the l i v e r /  
hepatocytes of a l l  species. However, lack of peroxisome p ro l ife ra t io n  
in these cultured hepatocytes has been confirmed by electron microscopy 
and the lack of induction of a non-peroxisomal enzyme (LAH) which is  
concomittantly induced by peroxisome pro!ifera tors  in ra t  l iv e r  in vivo
(Orton and Parker, 1982; Gibson et al_, 1982; Lake et al_, 1984; Okita
and Chance, 1984) and in cultured ra t  hepatocytes (Lake e t al_, 1983; 
Mitchell e t £ [ ,  1985).
From these observations i t  is  suggested that peroxisome p ro life ra t io n  
as observed in the l iv e r  of the ra t  does not occur in the l iv e r  of a l l
species. We have noted an increase in PCO above control levels in
guinea pig and marmoset hepatocytes exposed to MEHP and CPIB for 72 
hours. These increases were very small, not dose-related and were not 
always reproducible. Furthermore i t  is  not c lear a t present whether 
the small increases in PCO resu lt from a 'maintenance' of the a c t iv i ty  
in isolated ce lls  or an 'induction' above the levels observed in 
isolated c e lls .  In the context of 'p ro l i fe ra t io n ' of peroxisomes th is  
requires investigation. As y e t, however, the small samples o f human 
l iv e r  received and the less e f f ic ie n t  methods used for ce ll iso la tion  
and culture have not yielded a s u ff ic ie n t ly  large number of rep licate  
flasks to allow these important investigations to be made.
I t  is suggested, then, that agents such as c lo f ib ra te  and DEHP w il l  not 
produce p ro life ra t io n  of peroxisomes in the l iv e r  of the guinea pig, 
the marmoset or man a fte r  short term exposure, and that the difference  
in response between the ra t  and these species is not explainable on 
metabolism differences alone but results from an inherent difference in 
the susceptib ility  of the hepatocytes of these species to peroxisome 
p ro life ra t io n .
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CHAPTER VI
IDENTIFICATION OF THE PROXIMATE PEROXISOME PROLIFERATORS 
DERIVED FROM D I - ( 2-ETHYL HEXYL)PHTHALATE
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V I .1 INTRODUCTION
Despite the large number of chemicals which have been shown to e l i c i t  
peroxisome p ro life ra t io n  in the l iv e r  of rodents (Chapter 1 .2 .)  and the 
proposed link  between peroxisome pro life ra tio n  and hepatocarcinogenesis 
(Reddy et a l , 1980), surprisingly l i t t l e  attention has been paid to 
determining the mechanisms(s) by which these agents act. A knowledge 
of the mechanism(s) involved in peroxisome p ro life ra t io n  is c r i t ic a l  to 
our appreciation of the role of the peroxisome in the normal 
intermediary metabolism of the l iv e r ,  and the ro le , i f  any, of a 
perturbation in this metabolic status in hepatocarcinogenesis. Also, 
the speculated species s p e c if ic ity  in peroxisome p ro life ra t io n  (Svoboda 
et al ,^ 1967; Blane and P in aro li ,  1980; Holloway et crt, 1982a , b;
Orton e t a t ,  1984; Osumi and Hashimoto, 1978) are best approached 
through a knowledge of the mechanism(s) by which these agents act in 
rodents. Investigation of such mechanisms is dependent on the prior  
id en tif ic a t io n  of the metabolite species responsible for e l ic i t in g  
pro life ra tio n  of peroxisomes. In this Chapter the use of a primary 
ra t  hepatocyte culture system to id en tify  the proximate peroxisome 
p ro !ife ra to r(s )  derived from d i-(2 -e th y l hexyl)phthalate (DEHP) is  
described. DEHP was selected as the compound for study because of the 
demonstrated species difference phenomenon (Chapter I I I )  and the vast 
amount of other published data available on the hepatic e ffects and 
metabolism of DEHP in many species (Lake e t af[, 1975; Moody and Reddy, 
1978; EHP, 1982; NTP, 1982; Albro e t a l ,  1973; Albro and Moore,
1974; Albro et a l , 1982a , b) .  The f i r s t  phase of this work was to 
co llect urine from rats treated with DEHP and to id en tify  and iso la te  
the metabolites. The major metabolites were then added to cultured ra t  
hepatocytes and the e ffec t  on c e l lu la r  markers for peroxisome 
pro!ite ra tion  determined.
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V I .2 METHODS
7’ ^C-DEHP was administered o ra lly  by gavage (500 mg/kg/day for 3 days) 
to male ra ts . Urine was collected over a period of 4 days to obtain 
s u ff ic ie n t  recoveries of metabolites. The metabolites were isolated  
by reversed phase HPLC and id e n tif ie d  by cap il la ry  gas chromatography/ 
mass spectrometry. The methods used for the preparation of DEHP 
metabolites are described in deta il by Lhuguenot e t a l  (1985). A 
large quantity (1 gm) of metabolite VI (metabolite Vis) was prepared by 
chemical synthesis.
Hepatocytes were isolated from male ra ts , male guinea pigs, male 
marmosets and from human l iv e r  biopsy samples. Monolayer cultures  
were prepared and maintained for 96 hours post iso la tion . 4, 24, 48, 
and 72 hours a f te r  seeding the spent medium and any unattached ce lls  
were aspirated and fresh medium supplied. DEHP metabolites were added 
to the culture medium at each 24 hour medium change. A range of 
concentrations was chosen based on the cytotoxic ity  of MEHP iji v itro  
(0 -  0.5 mM).
At the times indicated the monolayers were harvested by scraping from 
the flasks into SET buffer, disrupted by sonication and were e ith er  
assayed for coenzyme A content immediately or frozen at -70°C for assay 
of peroxisomal B-oxidation (PCO), cytochrome P-450-mediated 1 auric acid 
hydroxylase a c t iv ity  (LAH) and protein content. Other monolayers were 
fixed in s itu  in glyceraldehyde and examined by electron microscopy.
V I .3 RESULTS
1~^C DEHP was administered o ra lly  to rats and the urine collected.
The major metabolites (which accounted for approximately 85% of the 
dose) were isolated in s u ff ic ie n t  quantity and purity for use in the in 
v itro  experiments, and are indicated in Figure V I . 1. The metabolites 
are numbered according to Albro e t al (1981).
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FIGURE V I . 1 
STRUCTURE OF DEHP AND ITS METABOLITES
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Cultured ra t  hepatocytes were exposed to culture medium containing 
MEHP, 2-EH and metabolites IX , V I,  V and I .  At concentrations 
exceeding 0.5 -  1.0 mM the ce lls  showed visable signs of cy to tox ic ity .  
In hepatocytes exposed to MEHP, metabolite IX and metabolite VI for 72 
hours a dose-related increase in PCO was noted (Figure V1.2 ) .
Metabolite I yielded a small but s ta t is t ic a l ly  s ig n if ican t increase in 
PCO a fte r  72 hours exposure. Metabolite V and 2-EH had no e ffe c t  on 
PCO in cultured ra t  hepatocytes. The changes in PCO were confirmed by 
exami nation of electron micrographs of control and phthalate-treated  
cultures (Figure V I . 3 ) .
MEHP (0 -  0.5 mM) and metabolite VI (0 -  1.0 mM) produced marked 
dose-dependent increases in LAH a f te r  72 hours exposure (Figure V I .4 ) .  
Metabolites V and I a t high concentrations (1.0 mM) produced small 
increases in LAH a f te r  72 hours exposure. In comparison with the 
25-fo ld increase in LAH a c t iv ity  produced by metabolite VI (1 .0  mM) 
these changes are probably of l i t t l e  significance.
Similar s tru c tu re -a c tiv ity  relationships were observed for e ffects  on 
coenzyme A content of cultured ra t  hepatocytes. MEHP, metabolite IX 
and metabolite VI (0.5 mM) produced s ign if icant time-dependent 
increases in c e l lu la r  coenzyme A content whilst exposure to metabolite 
V had no e ffe c t  (Figure V I .5 ) .
The a b i l i t y  of the synthetic metabolite (metabolite Vis) to produce 
p ro lite ra tio n  in cultured ra t  hepatocytes was examined. Metabolite  
Vis was a less potent peroxisome p ro l i te ra to r ,  producing maximal 
induction of PCO at a concentration of 2.0 mM (Figure V I . 6 ) .  However, 
though the concentration of metabolite Vis required to produce 
p ro life ra tio n  was s ig n if ican tly  higher than required for authentic 
metabolite VI the degree of p ro !ite ra tion  obtained was comparable. 
Metabolite Vis was thus used to investigate 'species differences' in 
peroxisome p ro !ite ra t io n . Cultured guinea pig, marmoset and human 
hepatocytes were exposed to metabolite Vis for 72 hours and the e f fe c t  
on PCO determined. No increase in PCO was observed in human 
hepatocytes but metabolite Vis produced a s lig h t (<T2-fold) increase in 
PCO in cultured guinea pig and marmoset hepatocytes (Figure V I . 7 ) .
These effects  showed no dose-dependency.
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FIGURE V I ;2
THE EFFECT OF DEHP METABOLITES OH CYANIDE-INSENSITIVE
PALMITOYL-COA OXIDATION IN CULTURED RAT HEPATOCYTES
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Cultured ra t  hepatocytes were exposed to medium containing 0 -  0.5 mM 
MEHP, metabolite IX, metabolite V I,  metabolite I ,  metabolite V and 
2-ethyl hexanol for 72 hours. A fter this time the ce lls  were 
harvested and peroxisomal B-oxidation determined. Values are 
expressed as % a c t iv ity  of untreated cultures and are mean + s d  
(n = 4 ) .
★
S ig n if ic a n t ly  d if fe re n t  from c o n tro l, p <  0 .05 .
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FIGURE V I .3
ELECTRON MICROGRAPHS OF CULTURED RAT HEPATOCYTES 
EXPOSED TO DEHP METABOLITES
(a) Control
(b) MEHP (0.5 mM)
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FIGURE V I .3 
(Continued)
(d) M etabo lite  VI (0.5 mM)
(e) Metabolite V (0.5 mM)
Cultured ra t hepatocytes were exposed to medium containing 0.5 mM MEHP, 
metabolite VI and metabolite V fo r  72 hours. A fte r th is  time the 
c e l ls  were examined by electron microscopy and the e f fe c t  on 
peroxisomes ( ) f )  determined. Hepatocytes exposed to MEHP and 
metabolite VI contained more peroxisomes (per f ie ld  of view) than 
control c e l ls  or c e l ls  exposed to metabolite V.
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FIGURE V I.4
THE EFFECT OF DEHP METABOLITES ON CYT0CHR0ME-P450-MEDIATED
LAURIC ACID HYDROXYLATION IN CULTURED RAT HEPATOCYTES
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Monolayer cultures of ra t  hepatocytes were exposed to culture medium 
containing MEHP, metabolite V I,  metabolite V, and metabolite I fo r  72 
hours. A fter this time the ce lls  were harvested and LAH determined. 
Values are expressed as nmol hydroxyl auric acid formed.hr .mg protein
■k .
Significantly  d if fe re n t from control, p <  0.05.
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FIGURE V I .5
THE EFFECT OF DEHP METABOLITES ON COENZYME A CONCENTRATION
IN CULTURED RAT HEPATOCYTES
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Monolayer cultures of ra t  hepatocytes were exposed to medium containing 
MEHP, metabolite IX, metabolite V I, and metabolite V for 24, 48 and 72 
hours. A fter these times the ce lls  were harvested and perchloric  
acid-soluble coenzyme A was determined.
★
S ig n if ic a n t ly  d i f fe re n t  from c o n tro l,  p <  0 .05 .
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FIGURE V I .6
COMPARISON OF THE EFFECTS OF AUTHENTIC METABOLITE VI AND SYNTHETIC 
METABOLITE VI ON PEROXISOMAL B-OXIDATION IN CULTURED RAT HEPATOCYTES
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Authentic metabolite VI and 'synthetic metabolite VI' re fe r  to the 
metabolite isolated from the urine of DEHP treated rats and the 
chemically synthesised metabolite respectively. Cultured ra t  
hepatocytes were exposed to medium containing e ither authentic 
metabolite VI (0 -  0.5 mM) or synthetic metabolite VI (0 -  2.0 mM) for  
72 hours. After th is  time the ce lls  were harvested and peroxisomal 
B-oxidation determined.
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FIGURE V I .7
EFFECT OF METABOLITE VI ON PEROXISOMAL B-OXIDATION IN CULTURED 
GUINEA PIG, MARMOSET AND HUMAN HEPATOCYTES
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Cultured guinea pig, marmoset and human hepatocytes were exposed to 
medium containing metabolite Vis (0 -  2.0 mM) for 72 hours. A fter  
this time the ce lls  were harvested and peroxisomal B-oxidation 
determined.
S ig n if ic a n t ly  d if fe re n t  from c o n tro l,  p <  0 .05 .
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V I . 4 DISCUSSION
Following oral administration of DEHP to the ra t ,  DEHP is cleaved in 
the in testine and the monoester (MEHP) and the cleaved side chain 
(2-ethyl hexanol) are absorbed (Albro and Thomas, 1973; Lake e t al_, 
1977; White e t  a l ,  1980). MEHP has been shown to be a potent 
peroxisome p ro !ite ra to r  in the l iv e r  in vivo (Lake et al_, 1975) and in 
primary hepatocyte cultures (Gray et a]_, 1983) 2-EH has also been shown 
to be a peroxisome p ro l i te ra to r  i_n vivo and i t  has been suggested that  
the 2-EH moiety is responsible for the observed hepatic effects of DEHP 
(Moody and Reddy, 1978^). However, on a molar basis s ig n if ica n tly
higher doses of 2-EH than MEHP are required to e l i c i t  an equivalent 
degree of peroxisome p ro lite ra t io n  (C R Elcombe, unpublished data) and 
as the remaining 2-EH side chain is not cleaved from MEHP during 
metabolism then MEHP must also be a peroxisome p ro lite ra to r  in 
rodents.
MEHP is extensively metabolised in the l iv e r  in vivo (Albro e t  a^,
1973) and by primary hepatocyte cultures (Lhuguenot e t al_, 1985). Thus 
the peroxisome p ro life ra t io n  observed in cultured ra t  hepatocytes 
exposed to MEHP (Chapter IV) may be due to i ts  metabolism to an 
'ac tive ' metabolite. The sim plified pathway of MEHP metabolism is 
shown in Figure V I .8 .
The urinary metabolites of DEHP are indicative of oxidation of MEHP at  
three points: the to-carbon atom, the to-l-carbon atom and the ethyl
side chain. The to- and to-l-carbon oxidation products account for  
over 85% of the metabolites (Albro e t  al_, 1973; ■Albro et.art, 1981; 
Lhuguenot e t aT, 1985). Addition of the co-l oxidation products 
(metabolites IX and VI) to cultured ra t  hepatocytes produced a 
dose-related increase in peroxisomal B-oxidation, mirroring that  
produced by MEHP i t s e l f .  Of the to-oxidation products metabolite I 
produced a s l ig h t ,  but s ta t is t ic a l ly  s ign if ican t increase in 
peroxisomal B-oxidation. 2-EH was inactive a t the concentrations used 
in this study but has been shown (a t  high doses) to be a peroxisome 
p ro lite ra to r  in vivo (Moody and Reddy, 1978^1
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FIGURE V I.8
PROPOSED ROUTE OF MEHP META80LISM IN THE RAT
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As MEHP is extensively metabolised by primary ra t hepatocyte cultures 
(Lhuguenot e t al_, 1985) i t  is  not possible to conclude from th is  data 
whether MEHP i t s e l f  is  a peroxisome p ro life ra to r  or i f  the effects  are 
due to the metabolism of MEHP to metabolites IX and/or V I. Information 
on th is  point may be derived by determining the e ffects  of blocking the 
metabolism of MEHP. MEHP is believed to be metabolised by a 
cytochrome P-450-dependent system (Albro et al_, 1973, 1981). However, 
supplementation of the culture medium with metyrapone or SKF 525A 
(P-450 in h ib ito rs ) had no e ffe c t on the induction of PCO by MEHP (data 
not shown) but i t  is  well known that such in h ib ito rs  are subsequent 
inducers o f P-450 in cultured ra t hepatocytes and do not in h ib it  a ll 
forms of P-450. Thus conclusive blockage of MEHP metabolism must be 
demonstrated before any conclusions can be drawn from th is  experiment. 
That MEHP i t s e l f  may be a peroxisome p ro life ra to r  was suggested by the 
s im ila r ity  in dose response curves between MEHP and metabolites IX and
V I. I f  metabolism of MEHP is required to e l i c i t  peroxisome 
p ro lite ra tio n , then one might expect fa r  less of the 'a c tiv e ' agent to 
be required to e l i c i t  a s im ilar response to MEHP. When MEHP (0 .5  mM) 
was added to cultured ra t hepatocytes the concentration of t* i- l  
metabolites produced reached a maximum concentration of approximately 
150 ^M (Lhuguenot e t al_, 1985). Though a s ig n ifican t increase in PCO 
was observed a t th is  concentration of metabolite IX or V I, th is  was 
small in comparison to the e ffe c t obtained by MEHP i t s e l f  (0 .5  mM).
This discrepancy may be due to differences in b io a v a ila b ility  of the 
m etabolites. This p o s s ib ility  has not ye t been examined.
The e ffects  of the DEHP metabolites on two fu rther markers of 
peroxisome p ro life ra tio n  were investigated to ve rify  the e ffe c t on PCO 
in cultured ra t hepatocytes - microsomal LAH and c e llu la r  coenzyme A 
content. Both of these have been shown to be markedly affected by 
peroxisome p ro lite ra to rs  in cultured ra t hepatocytes (Chapters IV and
V) and in the l iv e r  i_n vivo (Orton and Parker, 1982; Gibson e t al_, 
1982; Lake e t aj[, 1984a; Okita and Chance, 1984; Bakke and Berge,
1982; Savolainen e t a l , 1977; Halvorsen, 1983; Shindo e t a l , 1978).
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Exposure of cultured ra t hepatocytes to 0.5 mM MEHP, m etabolite IX or 
metabolite VI fo r 72 hours resulted in a time-dependent increase in 
c e llu la r  coenzyme A (acid so lub le). S im ila rly , exposure of 
hepatocytes to MEHP and m etabolite VI produced a marked increase in LAH 
a c t iv ity . The o -oxidation products had no e ffe c t on coenzyme A 
content and only a small e ffe c t on LAH a t high concentrations (1 .0  mM). 
The effects  of DEHP-metabolites on cultured ra t hepatocytes are 
summarised in Table V I .1.
A comparison of the e ffe c t of DEHP metabolites a t equimolar 
concentrations demonstrates th a t MEHP and its  u - l  oxidation products 
are potent peroxisome p ro !ite ra to rs  in cultured ra t hepatocytes. Also 
m etabolite I produced a small induction of PCO in cultured ra t  
hepatocytes while 2-EH has been shown to be a peroxisome p ro life ra to r  
in the l iv e r  in vivo . The hepatic peroxisome p ro life ra tio n  observed 
following oral administration of high doses of DEHP may represent the 
cumulative effects  of these m etabolites. The a b il i ty  of each 
metabolite to e l i c i t  peroxisome p ro life ra tio n  in the l iv e r  is  
presumably dictated by its  concentration and duration in the l iv e r .  The 
greater s e n s itiv ity  of hepatocytes to the u -1 oxidation products of 
MEHP suggests th a t these metabolites are l ik e ly  to play an important 
ro le in peroxisome p ro life ra tio n  i_n vivo.
More importantly a metabolite of DEHP which is  not fu rther metabolised 
(Lhuguenot e t al_, 1985) has been id e n tif ie d  as a potent peroxisome 
p ro lite ra to r . This metabolite has been synthesized in large quantities  
(1 gm) to enable its  use in fu rther in v itro  experiments. The a b il i ty  
of th is  synthetic metabolite (m etabolite Vis) to produce peroxisome 
p ro life ra tio n  in cultured ra t hepatocytes was examined. Compared to 
the authentic metabolite VI extracted from the urine o f DEHP-treated 
rats th is  synthetic m etabolite was a less potent peroxisome 
p ro life ra to r  in cultured ra t hepatocytes. Metabolite VI possesses an 
o p tic a lly  active centre and may ex is t as two stereoisomers (Figure
V I .9 ) . Subsequent analysis of the synthetic metabolite (D Moore, 
personal communication) has revealed the presence of two isomers in 
approximately equal concentrations (50 :50 ). However, analysis of the 
authentic urinary metabolite has revealed that though
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TABLE V I .1
SUMMARY OF THE EFFECTS OF DEHP METABOLITES ON MARKERS FOR
PEROXISOME PROLIFERATION IN CULTURED RAT HEPATOCYTES
AGENT PCO LAH CoASH
MEHP
IX
VI
V
I
2-EH
+++
+++
+++
— +
+++
ND
+++
— +
ND
+++
+++
+++
ND
ND
— /+++ Strongly negative/positive
--+  Weakly positive at high concentrations
ND Not determined
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FIGURE V I .9 
STEREOISOMERS OF METABOLITE Vis
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two isomers are present, the ra tio  is 85:15. Attempts are being made 
at present to separate these two isomers so that th e ir  individual 
a b il ity  to induce PCO in cultured ra t hepatocytes may be assessed.
Following the id e n tific a tio n  of specific  metabolites of DEHP as 
'p ro life ra to rs ' important differences in the metabolism of DEHP 
suggested a possible explanation for the observed lack of peroxisome 
p ro life ra tio n  in the l iv e r  of some species.
1. MEHP is barely metabolised by the guinea pig and is  excreted 
almost exclusively as MEHP-glucuronide (Albro e t al_, 1982a).
2. Though re la tiv e ly  large amounts of the u > -l-o x id a tio n  products 
(metabolites IX and VI) are excreted by the monkey, these 
metabolites are conjugated with glucuronic acid and not ' f r e e 1 
metabolites as in ra t urine (Albro e t al_, 1981; 1982a).
The lack of peroxisome p ro life ra tio n  in these species follow ing oral 
administration of DEHP could be explainable, thus, by the lack of 
production of the 'ac tive  agent' (in  the guinea pig) or rapid removal 
of th is  'ac tive  agent' by conjugation (in  the monkey). Exposure of 
cultured guinea p ig , marmoset and human hepatocytes to m etabolite Vis 
for 72 hours did not lead to an induction of PCO. Though rapid  
conjugation of metabolite Vis may protect the hepatocytes of these 
species, experiments revealed th a t less than 30% of metabolite Vlw as  
conjugated by the guinea pig hepatocyte and the remaining free
metabolite concentration was s u ffic ie n t to produce s ig n ific a n t
p ro life ra tio n  in ra t  hepatocytes (data not shown).
V I .5 CONCLUSION
In conclusion, th is  work has demonstrated that the metabolites produced
by oxidation of the co-l carbon atom of MEHP (and perhaps MEHP i t s e l f )
lead to peroxisome p ro life ra tio n  in ra t hepatocytes. Peroxisome 
p ro life ra tio n  was not, however, observed in guinea pig, marmoset or 
human hepatocytes exposed e ith e r to MEHP (Chapter V) or th is  'a c tiv e '
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m etabolite. This data suggests that the lack of peroxisome 
p ro life ra tio n  in the l iv e r  in v ivo , following oral adm inistration of 
DEHP to the guinea pig and marmoset is not explainable simply in terms 
of metabolism differences but appears to resu lt from in tr in s ic  species 
differences in s e n s itiv ity  to peroxisome p ro life ra tio n . Furthermore, 
the response observed in human hepatocytes mimicked those in the guinea 
pig and marmoset and not the ra t.
CHAPTER V II
INVESTIGATION OF THE MECHANISM(S) INVOLVED IN 
HEPATIC PEROXISOME PROLIFERATION
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V I I . 1 INTRODUCTION
Despite the im plication of the involvement of peroxisome p ro life ra tio n  
in hepatocarcinogenesis in rodents, surprisingly l i t t l e  atten tion  has 
been paid to the understanding of this toxicological e ffe c t . The study 
of peroxisome p ro life ra tio n  is  a t present phenomenology, th a t is ,  
merely measurement of an increased number of peroxisomes or an 
induction of peroxisomal enzymes in the l iv e r  of rodents. Further 
accumulation of such data does not provide any understanding of the 
significance of th is  hepatic e ffe c t or o ffe r  any means of assessing the 
potential hazard of rodent peroxisome p ro lite ra to rs  to man.
I t  is  envisaged that the elucidation of the mechanisms involved in 
peroxisome p ro life ra tio n  is  c r it ic a l to our understanding of the role  
of the peroxisome in the intermediary metabolism of the l iv e r ,  the 
importance ( i f  any) of an a lte ra tio n  in th is  metabolic state and the 
contribution ( i f  any) of peroxisome p ro life ra tio n  to hepatocarcino­
genesis. Understanding the mechanisms operative in the rodent l iv e r  
is  also necessary fo r ra tio n a lis in g  the observed species differences in  
peroxisome p ro life ra tio n .
Establishing the mechanism(s) involved in peroxisome p ro life ra tio n  and 
consequential carcinogenesis comprises three facets: f i r s t ly ,  the 
id e n tific a tio n  of the in i t ia l  reaction (primary biochemical lesion) of 
the agent with the hepatocyte; secondly, id e n tif ic a tio n  of the 
mechanisms involved in the regulation and control of peroxisome 
biogenesis and peroxisomal enzyme synthesis; and th ird ly , the 
mechanisms involved in in it ia t io n  and development of carcinogenesis.
The structural d ivers ity  of the chemicals which have been shown to  
e l ic i t  peroxisome p ro life ra tio n  in the rodent l iv e r  suggests th a t a 
single mechanism of action is un like ly  to account fo r a ll of these 
agents. The mechanism by which Di- ( 2-ethyl hexyl)phthalate (DEHP) 
induces peroxisome p ro life ra tio n  in the l iv e r  of the ra t has been 
investigated here. DEHP was selected because of the substantial body 
of lite ra tu re  availab le  on its  hepatic e ffe c ts , metabolism, species 
differences and carcinogenicity.
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When administered o ra lly  to the ra t ,  DEHP is cleaved extensively in the 
in testin e  to the monoester mono-( 2-ethyl hexyl)phthalate (MEHP) and 
2-ethyl hexanol, which are subsequently absorbed (Albro and Thomas, 
1973; Lake, 1977; White et al_, 1980). As oral adm inistration of 
e ith e r MEHP or 2-ethyl hexanol produces peroxisome p ro life ra tio n  in the 
l iv e r  in v ivo , both of these agents have been suggested to be 
responsible fo r the effects  of DEHP (Lake et al ,^ 1975; Moody and 
Reddy, 1978^). However, we have recently demonstrated, using primary 
ra t hepatocyte cu ltures, that specific  metabolites of MEHP produced by 
oxidation of the co-1 carbon atom are the l ik e ly  p ro !ite ra to rs  (Chapter
V I) .  However, the ro le  of these metabolites in the peroxisome 
p ro life ra tio n  produced by DEHP in vivo can only be approached with a 
knowledge of the mechanism(s) involved in the development o f  th is  
toxicological e ffe c t .
DEHP, in common with other hepatic peroxisome p ro lite ra to rs , produces a 
p ro file  of changes in the l iv e r  which are suggestive of a perturbation  
of normal l ip id  metabolism -  induction of hepatic enzymes involved in 
l ip id  metabolism (peroxisomal B-oxidation, carn itine  acyl transferase, 
lau ric  acid hydroxylase) and increase in hepatic Coenzyme A, ca rn itin e  
and fa tty  acid binding protein content (Chapter 1 .2 ) . We have formed 
a hypothesis which implicates in trahepatic  l ip id  accumulation as an 
event preceeding peroxisome p ro life ra tio n  (Figure V I I . 1 ) . In theory 
th is  l ip id  accumulation could be brought about in a varie ty  of ways 
such as decreased oxidation of fa t ty  acids, increased/decreased 
e s te r if ic a tio n  of fa tty  acids, or increased denovo synthesis of fa t ty  
acids fo r example.
The objective of the work described in th is  Chapter was to id e n tify  the 
primary biochemical lesion caused by MEHP/metabolite V I(s ) in the 
hepatocyte. The effects  o f MEHP and metabolite VI on hepatic l ip id  
metabolism have been investigated, and the ro le of these e ffec ts  in the 
ensuing peroxisome p ro life ra tio n  is  discussed.
FIGURE V I1.1
PEROXISOME PROLIFERATION: LIPID ACCUMULATION HYPOTHESIS
LESION
AGENT
LESIONLESION LESION
INTRAHEPATIC LIPID 
ACCUMULATION
PEROXISOME
PROLIFERATION
LESION - Increased de novo fa t ty  acid synthesis 
Decreased B-oxidation of fa t ty  acids 
Increased/Decreased e s te r if ic a tio n  of fa t ty  acids 
Agent is of fa t ty  acid nature 
Other
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V I I . 2 METHODS
The effects  of MEHP and its  metabolites on fa tty  acid metabolism were 
determined in isolated ra t hepatocytes. Hepatocytes were isolated  
from male rats and incubated in the presence or absence of DEHP 
metabolites: the oxidation of 1~^C palm itate to 1~^C 02 and 1“^C
acid soluble m ate ria l, the e s te r if ic a tio n  of 1“^C  palm itate and 7"^C  
MEHP in to  trig lycerid es  and the free Coenzyme A levels were 
determined.
Isolated ra t hepatocytes were maintained as primary monolayer cultures  
and the e ffe c t of supplementation of the culture medium with 
pantothenic acid on the induction of peroxisomal B-oxidation by MEHP 
was determined.
Primary monolayer cultures of ra t ,  guinea pig and human hepatocytes, 
exposed to culture medium containing DEHP-metabolites, were fixed  in  
formal saline and stained with Oil Red 0 fo r v isua lisation  of 
in tra c e llu la r  neutral l ip id .  The concentrations of DEHP metabolites  
used were those determined to produce maximum peroxisome p ro life ra tio n  
in cultured ra t hepatocytes without visable cy to to x ic ity  (Chapter V I) .
Subcellular fractions enriched with mitochondria were iso lated from ra t  
and guinea pig l iv e r  by d iffe re n tia l centrifugatio n . The metabolism 
of substrates was recorded by measurement of oxygen consumption 
polarographically, and the e ffects  of metabolite Vis were determined.
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VI 1 .3 RESULTS
V H .3 . 1 EFFECT OF MEHP ON THE INTRACELLULAR LIPID CONTENT OF 
CULTURED RAT HEPATOCYTES
Cultured ra t hepatocytes were exposed to medium containing MEHP 
(0 .5  mM) for 72 hours. At in terva ls  monolayers were fixed in  s itu  
with formal saline and stained with Oil Red 0 fo r v isua lisation  of 
in tra c e llu la r  neutral l ip id .  The l ip id  content of control c e lls  did 
not change noticeably during the 96 hours in culture (Figure V I I . 2 ) .  
However, in hepatocytes exposed to MEHP a marked increase in 
in tra c e llu la r  l ip id  was noted which reached a maximum a t 32 -  48 hours 
exposure (Figure V I I . 2 ) .  A fter th is  time the l ip id  content returned 
to control leve ls .
V I1.3 .2  EFFECT OF DEHP METABOLITES ON PALMITIC ACID OXIDATION IN 
ISOLATED RAT HEPATOCYTES
The oxidation of 1“^C  palm itic  acid by isolated ra t hepatocytes was 
determined in the presence or absence of DEHP m etabolites: MEHP
(0.5  mM) and m etabolite VI (0 .5  mM) caused a s ig n ific a n t decrease in 
the oxidation of 1”^C  palm itate (Figure VI 1 .3 ) . Metabolite V 
(0 .5  mM) produced a much sm aller, but s ig n ific a n t decrease in the 
oxidation of 1"^C palm itate by isolated ra t hepatocytes (Figure  
V I I . 3 ) . Metabolite V I(s ) (the chemically synthesized m etabolite) has 
been shown to be a less potent inducer of peroxisomal B-oxidation in 
cultured ra t hepatocytes than the authentic metabolite VI iso lated  from 
ra t urine (Chapter V I) .  The effects  of authentic m etabolite VI and 
metabolite V I(s ) on the oxidation of l '^ C  palm itate by iso lated  ra t  
hepatocytes were thus compared. Both agents decreased the to ta l
oxidation of 1"^C palm itate by isolated ra t hepatocytes (Figure 
V I I . 4 ) .  The in h ib itio n  of palm itate oxidation by both metabolites  
resulted from a decrease only in the production of l ’ ^C  acid soluble 
material (acetate , ketone bodies), 1“^ C 02 production was unaffected.
156.
FIGURE V I I . 2
OIL RED 0 STAINING OF NEUTRAL LIPID IN CULTURED RAT HEPATOCYTES:
EFFECT OF MEHP
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FIGURE V I I . 2
(Conti nued)
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FIGURE VI 1 .2
(Continued)
Cultured ra t hepatocytes were exposed to medium containing MEHP 
(0 .5  mM) fo r up to 72 hours. At in tervals  (as indicated) the ce lls  
were fixed i_n s itu  and stained with Oil Red 0 fo r v isua lisation  of 
in tra c e llu la r  l ip id .  A marked'increase in in tra c e llu la r  neutral l ip id  
was seen in hepatocytes exposed to MEHP fo r 32 -  48 hours. This 
in tra c e llu la r  l ip id  disappeared a fte r  56 hours exposure to MEHP.
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EFFECT OF MEHP, METABOLITE VI AND METABOLITE V ON THE OXIDATION OF
V 14C PALMITATE BY ISOLATED RAT HEPATOCYTES
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Isolated ra t hepatocytes (5 x 10 ) were incubated in Krebs Hensleit 
buffer c o n t a i n i n g  l “ *^c palm itic acid (0.25 mM) a t 37°C. MEHP, 
metabolite VI and m etabolite V were added to the flasks a t a f in a l  
concentration of 0.5 mM. A fter 30 min 1"^ C 02 and 1".^C acid 
soluble m aterial was determined. Values are mean + SD (n = 3 flasks)
aSum of 1~^4C02 and 1~^4C acid soluble material 
^ S ign ifican tly  d iffe re n t from control, p < 0 .0 5
THE EFFECT OF AUTHENTIC METABOLITE VI AND METABOLITE Vis ON THE 
OXIDATION OF 1"14C PALMITATE BY ISOLATED RAT HEPATOCYTES
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Isolated ra t hepatocytes (5 10 ) were incubated in Krebs Hensleit bu ffer
containing 1-14c palm itic  acid (0.25 mM) at 37°C. Metabolite VI and 
metabolite Vis were added to the flasks . A fter 30 min 1"^C0£ and 1“^  
acid soluble m aterial were determined. Values are mean + SD (n = 3-4 
f la s k s ).
S ig n if ic a n t ly  d if fe re n t  from co n tro l P < 0 .0 5 .
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V I I . 3.3 EFFECT OF DEHP METABOLITES ON INCORPORATION OF PALMITIC
ACID INTO TRIGLYCERIDES BY ISOLATED RAT HEPATOCYTES
The e ffe c t of MEHP (0 -  0.5 mM) and metabolite Vis (0 -  2.0 mM) on 
the e s te r if ic a tio n  of l '^ C  palm itate into 14C trig lyce rid es  was 
compared in isolated ra t hepatocytes. Metabolite Vis produced a 
s ig n ifica n t decrease in the incorporation of palm itic  acid into  
trig lycerid es  (Figure V I I . 5 ) . A s im ilar decrease was also observed 
with MEHP (0.1 mM). However, a t a higher concentration (0 .5  mM) MEHP 
caused a s lig h t increase in the incorporation of l “^C -p al irritate into  
tr ig lyc e rid e s .
V I I .3 .4  EFFECT OF MEHP ON ACID SOLUBLE COENZYME A IN ISOLATED 
RAT HEPATOCYTES
Isolated ra t hepatocytes were incubated with MEHP (0 -  0.5 mM) fo r  
30 min. MEHP produced a concentration-dependent decrease in the acid 
soluble CoASH content of the c e lls  (Figure V I I . 6 ) .
V I I . 3.5 EFFECT OF PANTOTHENIC ACID ON THE INDUCTION OF PEROXISOMAL
B-OXIDATION BY MEHP IN CULTURED RAT HEPATOCYTES
In cultured ra t hepatocytes supplementation of the culture medium with 
pantothenic acid (a biosynthetic precursor of CoASH) s ig n ific a n tly  
decreased the induction of peroxisomal B-oxidation by MEHP (0 .5  mM) 
(Figure V I I . 7 ).
V I I . 3 .6  EFFECTS OF METABOLITE Vis ON RAT LIVER MITOCHONDRIA
Metabolite Vis a t concentrations exceeding 1.0 mM affected the 
respiratory control o f the mitochondria: The P/0 ra tio ,u sing  pyruvate
(10 mM) as substate, was not measurable ( ie  approached zero) as the 
concentration of metabolite Vis approached 2.0 mM (Figure V I I . 8 ) .  
Metabolite Vis (0 -  2.0 mM) in h ib ited  the metabolism o f palm itic  acid  
(50 uM) by. iso lated ra t l iv e r  mitochondria in a concentration dependent 
manner (Figure V I I . 9 ) . The metabolism of p a lm ito y l-L -carn itin e  
(60 urn) however, was unaffected by m etabolite Vis (Figure V I I . 10 ).
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FIGURE V I I . 5
EFFECT OF MEHP AND METABOLITE Vis ON THE INCORPORATION OF 1~14C PALMITATE
INTO TRIGLYCERIDES BY ISOLATED RAT HEPATOCYTES
3 6 r
32
03
w
*3
o
<0
O  28
T"
s
o
£
c
24
MEHP
f
\
»  —
2 0 *» I
i
± j
36
32
28
24
20
Metabolite Vis
\
i'-"*
\
L
0*5 0
Concentration (mM)
2*0
Isolated ra t hepatocytes (5 x 1 0 )  were incubated in Krebs Hens l e i t  
buffer containing 1~ p a l m i t i c  acid (0.25 mM) at 37°C. MEHP or 
m etabolite Vis were added to the flasks . A fter 30 min to ta l l ip id  
was extracted from the ce lls  and the tr ig lyc e rid e  frac tio n  separated 
by th in  layer chromatography. The ^C  ra d io a c tiv ity  in the t r ig ly c ­
eride frac tio n  was determined. Values are mean + SD (n = 3 f la s k s ).
•k
S ig n ifica n tly  d iffe re n t from contro l, p < 0 .0 5
anmol 1 -14C palm itate incorporated into trig lycerid e /10^  c e lls /3 0  min
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FIGURE V I1 .6
EFFECT OF MEHP ON THE COENZYME A CONTENT OF ISOLATED RAT HEPATOCYTES
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Isolated ra t hepatocytes (10 % 10 ) were incubated in Krebs Hensleit 
buffer (4 ml) a t 37 C. MEHP ( 0 -  0.5 mM) was added to the flasks . 
A fter 30 min perchloric-acid  soluble coenzyme A content was determined,
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EFFECT OF PANTOTHENIC ACID ON THE INDUCTION OF CYANIDE-INSENSITIYE
PALMITOYL CoA OXIDATION BY'MEHP IN CULTURED RAT HEPATOCYTES
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Isolated ra t hepatocytes were maintained as primary monolayer cultures  
MEHP (0 .5  mM) and pantothenic acid (0.1 -  1.0 mM) were added to the 
culture medium and a fte r  72 hours exposure the ce lls  were harvested. 
Cyanide-insensitive palmitoyl CoA oxidation (PCO) was determined in 
cell sonicates. At a ll  concentrations of pantothenic acid PCO of 
hepatocytes exposed to MEHP was greater than that of control c e lls ,  
p< 0.05. _
v S ig n ifican tly  d iffe re n t from A, p <  0.05
S ig n ifican tly  d iffe re n t from B, p <  0.05
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FIGURE V I I . 8
EFFECT OF METABOLITE Vis ON THE P/O RATIO OF ISOLATED RAT LIVER
MITOCHONDRIA METABOLISING PYRUVATE
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Rat l iv e r  mitochondria (5 mg protein in 3 ml buffer) were incubated 
a t 37 C. The stim ulation of the ra te  of pyruvate metabolism by ADP 
was determined by following the oxygen consumption polarographically. 
The e ffe c t of addition of m etabolite Vis to the incubations on the 
P/0 ra tio  was determined.
a jjmol ADP added _ P, 
jjg atom 0 consumed
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FIGURE V I I . 9
EFFECT OF METABOLITE Vis ON THE OXIDATION OF PALMITIC ACID BY
ISOLATED RAT LIVER MITOCHONDRIA
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"Mitochondria (5 mg protein} were incubated a t 37°C. The metabolism 
of palm itic acid (50 juM) was determined by measuring the oxygen 
consumption polarographically. Metabolite Vis (0 -  2.0 mM) was added 
1 min la te r  and its  e ffe c t on palm itate metabolism determined.
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FIGURE V I I . Iu
EFFECT OF METABOLITE Vis ON THE OXIDATION OF PALMITOYL-L-CARNITINE
BY ISOLATED RAT LIVER MITOCHONDRIA
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Mitochondria (5 mg protein) were incubated a t 37 C. The metabolism 
of palm itoy!-L -carn itine  (60 / jM) was determined by measuring the 
oxygen consumption polarographically. Metabolite Vis (0 -  2 .0 mM) 
was added 1 min la te r  and its  e ffe c t on palm ito y!-L -carn itine  
metabolism determined.
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V I I . 3.7 EFFECTS OF METABOLITE Vis ON 2,4-DNP-UNCOUPLED RAT
LIVER MITOCHONDRIA
The metabolism of acyl-carn itines  was fu rther investigated in 
2,4-DNP-uncoupled mitochondria. In th is  system the resp iratory chain 
was uncoupled by 2,4-DNP so metabolism proceeded at a maximum ra te . As 
B-oxidation proceeded fu rther metabolism of the acetyl groups generated 
was prevented by the presence of malonate (an in h ib ito r  of succinate 
dehydrogenase). Hence, prelim inary experiments showed that 
metabolites Vis did not a ffe c t the metabolism of palmi to y !-L -  
carn itine  (22 juM) in 2 ,4 - DNP in uncoupled ra t l iv e r  mitochondria 
(Figure V I I . 11).
However, a concentration-dependent in h ib itio n  of octanoyl-DL-carnitine  
metabolism (82juM) was observed (Figure V I I . 12.) The e ffe c t of 
metabolite Vis on the metabolism of acyl carn itines o f d iffe re n t  
chain lengths was thus investigated. A concentration of 2 mM 
metabolite Vis was u tilis e d  as the loss of respiratory control 
produced in coupled mitochondria a t th is  concentration ( V I I . 3 .6 ) was 
unlikely  to be relevant in DNP-uncoupled mitochondria, and the 
concentration-dependent in h ib itio n  of octanoyl-DL-carnitine was maximal 
at th is  concentration. The metabolism of octanoyl- and 
hexanoyl-DL-carnitine were in h ib ited  severely by metabolite Vis over 
a range o f substrate concentrations (20 -  280 juM) (Figure V I I . 13 ).
The metabolism of palm itoyl- and la u ro y l-c a rn itin e  was stimulated  
s lig h tly  by metabolite Vis (Figure V I I . 13). This data is 
summarised in Figure V I I . 14, where the e ffe c t of metabolite Vis 
(2 .0  mM) on the metabolism of 100 i^M acyl carn itines by ra t  l iv e r  
mitochondria is  described.
K inetic analysis of the metabolism of acyl carn itines revealed th a t 
though the Vmax for the metabolism of the various acyl carn itines was 
essentia lly  s im ila r, the Km varied enormously, increasing with 
decreasing chain length (Table V I I .1 ) .  Furthermore, the e ffe c t of 
metabolite Vis on hexanoyl-DL-carnitine metabolism by hepatic 
mitochondria was suggested, by the Cornish-Bowden p lo t (Figure V I I . 15) 
to indicate 'competitive in h ib it io n 1.
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FIGURE V I I . 11
EFFECT OF METABOLITE Vis ON THE OXIDATION OF PALMITOYL-L-CARNITINE
BY 2,4-DNP-UNCOUPLED RAT LIVER MITOCHONDRIA
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Mitochondria.(5  mg protein) were incubated at 37°C in buffer 
containing 2,4-DNP. The metabolism of p a lm ito yl-L -carn itine  (22 jjM) 
was determined by measuring the oxygen consumption polarographically. 
The e ffe c t of addition of metabolite Vis 1 min p rio r to substrate on 
the rate of pa lm itoy!-L -carn itine  metabolism was determined.
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FIGURE V I I , 12
EFFECT OF METABOLITE Vis ON THE OXIDATION OF OCTANOYL-.DL-CARNITINE 
BY 2,4-DNP-UNCOUPLED RAT LIVER MITOCHONDRIA
metabolite VI
0 1 2 3 4
Time (min)
Mitochondria (5 mg protein) were incubated a t 37°C in buffer  
containing 2,4-DNP. The metabolism of octanoyHH-carnitine (82 uM) 
was determined by measuring oxygen consumption polarographically.
The e ffe c t of addition of metabolite Vis 1 min p rio r to substrate 
on the rate o f octanoyl-DL-carnitine metabolism was determined.
(mM)
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FIGURE V I I .14
THE METABOLISM OF 0-ACYL CARNITINES BY 2,4-DNP-UNCOUPLED RAT LIVER
MITOCHONDRIA: EFFECT OF METABOLITE Vis
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TABLE V I I . 1
METABOLISM OF'-O-ACYL CARNITINES BY 2,4-DNP UNCOUPLED RAT LIVER
MITOCHONDRIA
O-ACYL CARNITINE 
CHAIN LENGTH
Kmapp
[nM]
Vmaxapp 
ngm atom 0/min/mg
C16 266 42
C12 310 48
CIO 2004 30
C6 39600 34
Rat liv e r  mitochondria (5 mg protein) were incubated in buffer 
containing 2,4-DNP at 37°C, The metabolism of acyl carn itines was 
determined by measuring oxygen consumption po larographically . Km and 
Vmax values were obtained from the plots of S/V against V.
174.
FIGURE V I I . 15
INHIBITION OF HEXANOYL-DL-CARNITINE OXIDATION IN 2,4-DNP-UNCOUPLED
RAT LIVER MITOCHONDRIA BY METABOLITE Vis
METABOLITE Vis (mM)
Mitochondria (5 mg protein) were incubated in buffer containing 2,4-DNP 
at 37°C. The metabolism of hexanoyl-DL-carnitine was determined by 
measuring the oxygen consumption polarographically. Metabolite Vis 
was added to the incubations 1 min prior to addition of substrate and 
the e ffec t on the in i t i a l  ve loc ity  (V i) recorded.
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V I I .3 .8  EFFECTS OF METABOLITE Vis ON OCTANOYL-DL-CARNITINE
METABOLISM IN 2,4-DNP-UNCOUPLED MITOCHONDRIA FROM THE 
LIVERS OF MEHP PREDOSED RATS
Interestingly  l iv e r  mitochondria isolated from rats administered MEHP 
(500 mg/kg/day for three days) appeared less sensitive to the 
inh ib ition  of octanoyl carn itine  metabolism by metabolite Vis (Figure
V I I . 16). The concentration ( I 5Q) of metabolite Vis required to cause 
a 50% in h ib it ion  of the rate of octanoyl-carnitine metabolism in 
mitochondria isolated from the l iv e r  of control rats was approximately
0.9 mM. This concentration did not a ffec t  the metabolism of octanoyl 
carn itine  in mitochondria from MEHP-predosed ra ts . This is perhaps 
not a good representation of the difference as octanoyl carn itine  
metabolism in mitochondria from control animals is severely inhib ited  
at concentrations very much lower than the I 50.
V I I . 3.9 EFFECTS OF METABOLITE Vis ON GUINEA PIG LIVER MITOCHONDRIA
The functional in te g r ity  of isolated guinea pig l iv e r  mitochondria was 
not affected by concentrations of metabolite Vis up to 2.0 mM as 
denoted by the constancy of the P/0 ra tio  with pyruvate as substrate 
(Figure./.VI1.17). In 2,4-DNP-uncoupled mitochrondria octanoyl-DL-
carn itine  was oxidised at a much slower rate than by 2,4-DNP-uncoupled 
ra t  l iv e r  mitochondria and metabolite Vis produced a s lig h t  
inh ib ition  of th is  metabolism (Figure V I I . 18). However, the 
inh ib ition  was less marked than in isolated ra t  l iv e r  mitochondria with 
an IgQ >  2.0 mM metabolite Vis.
V I I .3.10 EFFECTS OF MEHP, METABOLITE Vis AND CLOFIBRIC ACID ON THE 
INTRACELLULAR LIPID CONTENT OF CULTURED GUINEA PIG AND 
HUMAN HEPATOCYTES
In cultured guinea pig and human hepatocytes exposed to MEHP (0 .5  mM), 
metabolite Vis (2.0 mM) or c lo f ib r ic  acid (1 .0  mM) for 72 hours, Oil 
Red 0 Staining revealed s ig n if ican tly  greater amounts of in t ra c e l lu la r  
neutral l ip id  than untreated controls (Figure V I I . 19 and V I I . 20 ) .  This 
was most severe with metabolite Vis in both species. Guinea pig 
hepatocytes exposed to MEHP, though showing early signs of 
in tra c e llu la r  l ip id  accumulation, a f te r  72 hours exposure showed marked 
vacuo!ation (Figure V I I . 19).
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HfciUKt: V I I .  16
EFFECT OF METABOLITE Vis ON THE OXIDATION OF OCTANOYL-DL-CARNITINE
BY ISOLATED LIVER MITOCHONDRIA PREPARED FROM CONTROL AND MEHP-DOSED
RATS
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METABOLITE Vis (mM)
Mitochondria were prepared from the livers  of control ( j£ )  and MEHP- 
predosed rats (500 mg/kg/day x 3 days) jQ):.. Mitochondria (5 mg protein) 
were incubated at 37°C in buffer containing 2,4-DNP. The metabolism of 
octanoyl-carnitine (82 juM) was determined by measuring oxygen consumption 
polarographically. Metabolite Vis was added 1 min prio r to the substrate 
and the e ffe c t  on the in i t i a l  ve locity  (V i) was determined.
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FIGURE V I I .17
EFFECT OF METABOLITE Vis ON THE P/O RATIO OF GUINEA PIG LIVER
MITOCHONDRIA METABOLISING PYRUVATE
%
1-0 2-0
Metabolite Vis (mM)
Mitochondria prepared from the l iv e r  of the guinea pig (5 mg protein) 
were incubated at 37°C. The metabolism of pyruvate (10 mM} and i ts  
stimulation by ADP was determined by measuring oxygen consumption 
polarographically. The e ffec t of addition of metabolite Vis to the 
incubation medium on the ADP-stimulated respiration was determined.
jumol ADP added 
jug atom 0  consumed
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EFFECT OF METABOLITE Vis ON THE OXIDATION OF OCTANOYL-DL-CARNITINE BY
2,4-DNP-UNCOUPLED GUINEA PIG LIVER MITOCHONDRIA
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Mitochondria (5 mg protein) isolated from guinea pig l iv e r  were 
incubated in buffer containing 2,4-DNP at 37 C. The metabolism of 
octanoyl carn itine  (82 juM) was determined by measuring oxygen 
consumption polarographically. Metabolite Vis was added to the 
incubations T min prior to addition of substrate and the e f fe c t  on 
the in i t i a l  velocity  (V i) determined.
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FIGURE V I I . 19
OIL RED 0 STAINING OF CULTURED GUINEA PIG HEPATOCYTES:
EFFECT OF MEHP, METABOLITE YIs AND CLOFIBRIC ACID
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FIGURE V I I . 19
(Continued)
(c) M etabolite  V is-Treated
(d) C lo f ib r i c  Acid-Treated
Cultured guinea pig hepatocytes were exposed to cul tu re medium 
containing MEHP (0.5 mM), metaboli te Vis (2.0 mM) and c l o f i b r i c  acid 
(1.0 mM) fo r  72 hours. The monolayers were f ixed in formal sa l ine and 
stained with Oil Red 0 fo r  v isua l isa t ion  of in t r a c e l1u la r  l i p i d  ( ).
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FIGURE V I I . 20
OIL RED 0 STAINING OF CULTURED HUMAN HEPATOCYTES:
EFFECT OF MEHP, METABOLITE Vis AND CLOFIBRIC ACID
(a) Control
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FIGURE V I I . 20
(Continued)
(c) Metabol ite Vis-Treated
(d) C lo f ib r ic  Acid-Treated
fa*. |ils|
Cultured human hepatocytes were exposed to cu l ture medium containing 
MEHP (0.5 mM), metabol ite Vis (2.0 mM) and c l o f i b r i c  acid (1.0 mM) fo r  
72 hours. The monolayers were f ixed in formal sal ine and stained with 
Oil Red 0 fo r  v isua l isa t ion  of i n t r a c e l l u l a r  l i p i d  ( ).
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VI 1 .4 DISCUSSION
We have proposed a hypothesis that implicates in tra c e llu la r  l ip id  
accumulation as the tr igger for peroxisome p ro l ife ra t io n . An increase 
in in tra c e l lu la r  neutral l ip id  was noted in cultured ra t  hepatocytes 
exposed to MEHP. This accumulation of l ip id  was temporary and 
subsequently disappeared presumably as a resu lt of the ensuing 
peroxisome p ro l ife ra t io n . Having id en tif ied  in t ra c e llu la r  l ip id  
accumulation as an event occurring early in the development of 
peroxisome p ro l ife ra t io n , i t  was pertinent to examine effects of MEHP 
on hepatic l ip id  metabolism. Four aspects of l ip id  metabolism, which 
when perturbed could lead to in tra c e llu la r  l ip id  accumulation were 
investigated in isolated ra t  hepatocytes (Figure V I I . 21).
The e ffec t  of MEHP on denovo fa t ty  acid synthesis was determined by 
measuring the incorporation of °H into c e l lu la r  l ip id s  following the 
incubation of hepatocytes in ^ Q -c o n ta in in g  medium. However, the 
results were inconsistent. Rates o f synthesis varied 10-fo ld between 
cell preparations and these experiments were discarded as 
inconclusive.
That MEHP may be of ’ fa t ty  acid' nature is indicated by the metabolic 
pathway which implies co- and B-oxidation (Lhuguenot e t  1985) 
analagous to that of fa t ty  acid metabolism. The incorporation of MEHP 
into tr ig lycer id e  by isolated ra t  hepatocytes was thus investigated  
(data not shown). Hepatocytes were incubated with 7"^C MEHP (0.5 mM) 
for up to four hours but no incorporation of MEHP into tr ig ly c e r id e  was 
observed. I t  is s t i l l  feasib le , however, that the mere presence of 
MEHP (or i ts  metabolites) in the l iv e r  may i n f l i c t  a ' f a t t y  acid 
overload' due to , for example, slow metabolism. Metabolite V, which 
does not e l i c i t  peroxisome p ro life ra t io n  in cultured ra t  hepatocytes 
(Chapter VI) produced a much smaller decrease in the oxidation of 
palmitate. As this metabolite per se is metabolised via a B-oxidation 
type pathway (Lhuguenot et a^, 1985) this inh ib ition  may simply 
represent competition between metabolite V and palmitic acid for  
B-oxidation. However, quantitation of the DEHP metabolites is  
necessary to draw any such conclusions from this data.
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FIGURE V I I . 21
PERTURBATIONS OF FATTY ACID METABOLISM LEADING TO INCREASED
INTRACELLULAR LIPID
Increased denovo fa tty  
acid synthesis
Foreign compound is of 
fa t ty  acid nature
Decreased B-oxidation 
of fa t ty  acids
Increased/decreased 
e s te r if ica t io n  of 
fa t ty  acids
INTRA-HEPATIC 
LIPID ACCUMULATION
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MEHP and metabolite V I/V is  produced a decrease in both the oxidation 
and the es te r if ic a t io n  into tr ig lyce r id e  of 1"^4C palmitate.
Metabolite VI is not further metabolised by the hepatocyte (Lhuguenot 
et al_, 1985) and competition for B-oxidation therefore seems un like ly .  
I t  is not possible from these experiments to designate a s ite  of action 
of metabolite V I, as the reactions investigated involve a complex 
series of coordinated enzyme steps (Figure V I I . 22). I t  was clear  
that a more detailed investigation of these individual steps was 
necessary.
Fatty acid oxidation occurs in three compartments within the 
hepatocyte: the microsomes (co -o x id a t io n ) , the peroxisomes and the
mitochondria (B-oxidation). Only the peroxisomal and mitochondrial 
B-oxidation systems can account for short chain products and ^ € 0 2  
from l ' ^ C  palmitate. Therefore the effects of metabolite Vis on 
fa t ty  acid oxidation were studied in isolated ra t  l iv e r  mitochondria.
At concentrations of metabolite Vis which had no e ffec t  on the 
metabolism of pyruvate, palmitic acid metabolism was inh ib ited .
However, metabolite Vis had no e ffec t  on the metabolism of 
pal mi toy !-L -carn it in e  at these concentrations. The implication of 
these observations is indicated below ( V I I .2 3 ) .  When supplied with 
palmitic acid mitochondria consume oxygen, which indicates metabolism. 
This oxygen consumption is inhib ited by metabolite Vis a t  
concentrations not a ffecting the respiratory control of the 
mitochondria. As the mitochondrial inner membrane is impermeable to 
long chain fa t ty  acids the fa t ty  acid supplied must f i r s t  be activated  
to the corresponding fa tty  acyl-CoA ester, transferred across the inner 
mitochondrial membrane by carn itine  acyl transferase and the electrons 
from the reducing equivalents (NADH2 , FADH2 ) generated during 
B-oxidation and Krebs cycle metabolism passed along the electron  
transport chain whence oxygen consumption is recorded. When 
pal mi toy !-L -carn it in e  was supplied as substrate no in h ib it ion  of oxygen 
consumption by metabolite Vis was observed. Though s u p e rf ic ia lly  
this suggests that metabolite Vis in h ib its  e ither the activation of 
palmitate to palmitoyl-CoA or the outer carnitine acyl transferase, 
such a conclusion would be un justif ied  considering the complicated 
sequence of events preceeding the determination of oxygen consumption.
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FIGURE V I I .22
PATHWAYS INVOLVED IN THE OXIDATION AND ESTERIFICATIQN OF 1
PALMITATE BY ISOLATED RAT HEPATOCYTES
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3. Acyl CoA hydrolase (MIT/MIC)
4. Glycerophosphate acyl transferase (MIT/MIC)
5. Monoacyl glycerol phosphate acyl transferase/ 
phosphatidate phosphohydrolase (MIC/CTY)
6 . Diacyl glycerol acyl transferase (MIC)
7. B-oxidation pathway (MIT/PER)
8 . Tricarboxylic acid cycle (MIT)
9. D-B-hydroxy butyrate dehydrogenase, 
for  example (MIT)
COMPARTMENT ATIOM
CYT = Cytosol 
MIT = Mitochondria 
PER = Peroxisome 
MIC = Microsomes
187.
THE OXIDATION OF PALMITIC ACID BY ISOLATED HEPATIC MITOCHONDRIA
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Furthermore, the presence of organelles other than mitochondria in 
these fractions must be considered. Peroxisomes have s im ilar  
sedimentation characteristics to mitochondria and are pelleted together 
with mitochondria and lysosomes in the centrifugation process used. 
Although dependent on the mitochondria for generation of acyl CoA (or 
ATP) peroxisomes also metabolise fa t ty  acyl CoA (so consuming O2?) and 
may also provide acetate for mitochondrial metabolism. Though 
L-carnitine may stimulate the metabolism of long chain fa t ty  acids by 
isolated mitochondria (as i t  is essential for th e ir  transport across 
the mitochondrial membrane) i t  would appear that i t  is not required for  
metabolism to occur. This discrepancy suggests that the designation of 
oxygen consumption as an indicator of mitochondrial fa t ty  acid 
metabolism alone may be un jus tif ied . Acyl-carnitines, however, are not 
metabolised by the peroxisome and thus the determination of oxygen 
consumption using these substrates is more ju s t i f ie d  as a measure of 
mitochondrial function. The separation of peroxisomes and mitochondria 
was not feasible and a lte rn a tiv e , more d e f in it iv e  methods were 
therefore sought.
In order to investigate further the possible effects  of metabolite 
Vis on mitochondrial fa t ty  acid metabolism, the metabolism of acyl 
carnitines in DNP-uncoupled mitochondria was investigated. As in 
coupled mitochondria the rate of metabolism of long chain 
acyl-carnitines was not inhib ited by metabolite Vis, and was in fac t  
s lig h t ly  enhanced. However, the metabolism of the medium chain acyl 
carnitines (MCAC)-hexanoyl- and octanoyl-carnitine -  was severely 
inhibited by metabolite Vis over a wide range of substrate 
concentrations.
In the metabolism of acyl carnitines by DNP-uncoupled mitochondria 
there are two possible sites where metabolite Vis may exh ib it  th is  
inh ib ition  (Figure V I I . 24). F irs t ly  metabolite Vis may in h ib i t  an 
enzyme of the B-oxidation pathway active on medium/short chain acyl 
CoAs s p e c if ica lly . In teres ting ly , inh ib it ion  of such a B-oxidation 
enzyme, even though specific  to acyl CoA's of 8C or less in fers  that  
oxidation of a l l  acyl carnitines would be inhibited as they are
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FIGURE V I I . 24
SITES OF INHIBITION OF METABOLITE Vis
a r n i t i n eACYL
CAT
CARNITINE
i nn e r
mitochondrial
membrane
CoASH
ACYL-CoA
p
- O X ID A T IO N
C16
C14
C12
C10
I
C8
C6
C4
C2
*  in h ib it ion  of mitochondrial B-oxidation enzyme 
inh ib ition  of carnitine acyl transferase
190.
shortened by B-oxidation. In retrospect this may have been 
investigated simply by determining the e ffec t  of metabolite Vis on 
the tota l oxygen consumption (manometrically) fo r  a known amount of 
substrate in DNP-uncoupled mitochondria, as a quantitative relationship  
exists between oxygen consumption and complete metabolism of substrate 
in this system (Sherrat and Osmundsen, 1976). Using palmitoyl 
carn it ine , for example, a decrease in tota l oxygen consumption, 
indicative of incomplete metabolism would have supported the inh ib ition  
of a B-oxidation enzyme; a lte rn a t iv e ly , metabolite Vis may in h ib it  
the transport of MCAC across the mitochondrial membrane ie  inh ib it ion  
of carn itine  octanoyl transferase (COT). To determine the actual s ite  
of action of metabolite Vis would necessitate tracing the products of 
acyl carn itine metabolism, which, without a U"14C-labelled substrate, 
is 'technically.-extremely d i f f i c u l t . .  This U“^ C -la b e l le d  substrate was 
not availab le .
I f  COT is the s ite  where metabolite Vis acts in the l iv e r  ce ll two 
important questions are raised. F irs t ly  what is the source of MCAC 
within the ce ll and secondly, i f  metabolite Vis in h ib its  MCAC 
metabolism spec if ica lly  how is the inh ib ition  of l~ ^ C - palmitic acid 
oxidation by isolated l iv e r  ce lls  and mitochondria explained? Median 
chain length fa t ty  acids taken up by the l iv e r  are activated to CoA 
esters intramitochondrially. The mitochondrial membrane is permeable 
to these fa t ty  acids and a carn itine  transport system is  not required. 
However, the mitochondrial membrane does contain COT suggesting a role  
in the transport of MCAC/MCACoA1s which are presumably formed elsewhere 
in the c e l l .  COT is located also in the microsomal membran e and in 
the peroxisomal matrix and these are therefore possible sources of 
MCAC. In p articu la r  i t  has been suggested that the products of 
peroxisomal B-oxidation are transferred as acyl carnitines to the 
mitochondrion for further oxidation. Thus, peroxisomal B-oxidation may 
contribute more to hepatic fa t ty  acid metabolism than is suggested by 
i_n v itro  experiments and may generate s ign if ican t quantities of MCAC 
whose main/only fate is mitochondrial oxidation.
I t  is useful a t th is point to re f le c t  on the results obtained so fa r  
and attempt to re la te  these observations to the phenomenon of 
peroxisome p ro !ife ra t io n .
M etabo lite  V is produces:
1. An inh ib it ion  of 1“^ C  palmitic acid oxidation in isolated ra t  
l iv e r  c e l ls .
2. An inh ib ition  of palmitic acid e s te r if ica t io n  into tr ig lycerides  
in isolated ra t  l iv e r  c e lls .
3. An inh ib ition  of mitochondrial MCAC metabolism.
Figure V I I . 25 i l lu s ta te s  the proposed mechanism of action of metabolite 
Vis in producing p ro life ra t io n  of peroxisomes.
Metabolite Vis inh ib its  hepatic fa t ty  acid oxidation e ither  d ire c t ly  
by inh ib it ing  a specific mitochondrial B-oxidation enzyme or COT or 
in d irec tly  by sequestration of essential cofactors such as CoASH/ 
carn itine in median chain length fa t ty  acids. This in h ib it ion  may 
resu lt in hepatic l ip id  accumulation which triggers p ro life ra t io n  o f  
peroxisomes.
The role played by CoASH in this mechanism is suggested by the 
following observations: the hepatic coenzyme A content is known to 
increase in the l iv e r  of rodents treated with peroxisome p ro lite ra to rs ;  
in isolated hepatocytes incubated in the presence of MEHP a decrease in 
short chain/free Coenzyme A is noted, which suggests a red is tr ibution  
of in t ra c e l lu la r  Coenzyme A; supplementation of the culture medium 
with pantothenic acid, a biosynthetic precursor of Coenzyme A, appears 
to in fe r  a 'protection' against the peroxisome p ro life ra t io n  induced by 
MEHP. Superfic ia lly  this suggests that CoASH per se may play an 
in tr ic a te  role in peroxisome p ro life ra t io n  and that by preventing the 
in i t i a l  depletion in free CoASH within the l iv e r  ce ll by MEHP, 
peroxisome pro lite ra tio n  may be s ig n if ica n tly  reduced. Further 
substantiation of a role for CoASH in peroxisome p ro life ra t io n  requires 
determination of free CoASH levels in ce lls  grown in pantothenic 
acid-supplemented medium and the nature of the d istr ibu tion  of CoASH in 
isolated l iv e r  cells  treated with metabolite Vis.
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Having id en tif ie d  a possible lesion in the ra t  l iv e r  i t  was of in teres t  
to investigate the e ffe c t  of metabolite Vis on MCAC metabolism in the 
guinea pig l iv e r ,  as in vivo administration of DEHP, does not lead to 
hepatic peroxisome p ro life ra t io n  (Osumi and Hashimoto, 1978). 
Furthermore metabolite Vis (a potent p ro !ite ra to r  in ra t  hepatocytes) 
did not e l i c i t  peroxisome p ro !ite ra tion  in cultured guinea pig 
hepatocytes (Chapter V I ) .  Metabolite Vis does in h ib it  MCAC metabolism 
in isolated guinea pig mitochondria, though less severely than observed 
in ra t  l iv e r  mitochondria. In terestingly  both palmitic acid and 
octanoyl-carnitine were metabolised at s ig n if ican tly  lower rates in 
isolated guinea pig mitochondria. I f  the competitive in h ib it ion  of 
octanoyl carn itine  metabolism by mitochondria is the causal lesion  
leading to peroxisome p ro life ra t io n  in the l iv e r  of the ra t  in v ivo , 
then basic differences in fa t ty  acid metabolism (such as Kms, chain 
length s p e c if ic it ie s ,  rates of metabolism etc) between species are 
l ik e ly  to be o f extreme importance in determining the effectiveness of 
metabolite Vis (and DEHP?) as a peroxisome p ro !i te ra to r  in these
species. The comparative biochemistry of fa t ty  acid metabolism
between species and even tissues of the same animal has been l i t t l e  
investigated.
With regard to species differences in peroxisome p ro life ra t io n  i t  is 
in teresting that the inh ib ition  of MCAC metabolism is observed in  both 
ra t  and guinea pig l iv e r  mitochondria. Furthermore, in tra c e l lu la r  
l ip id  accumulation was noted in cultured guinea pig ce lls  exposed to 
metabolite Vis. However, th is was not transient as in ra t  hepatocytes 
but continually increased during the 72 hours of exposure. A s im ilar  
pattern of l ip id  accumulation was noted in cultured guinea pig 
hepatocytes exposed to MEHP and c lo f ib r ic  acid and also in human 
hepatocytes exposed to MEHP, metabolite Vis or c lo f ib r ic  acid.
I t  is apparent then that exposure o f hepatocytes of these species to
metabolite Vis and other rodent peroxisome pro !itera tors  does lead to
accumulation of in tra c e llu la r  l ip id  but unlike the ra t  th is  does not 
lead subsequently to p ro life ra tio n  of peroxisomes ie the species 
difference may l i e  not in the occurrence of the in i t i a l  lesion but in 
the adaptive response of the l iv e r  to the accumulation of l ip id .
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V I I . 5 CONCLUSIONS
In summary, the mechanism of action by which DEHP e l ic i t s  p ro life ra t io n  
of peroxisomes in the l iv e r  of the ra t  has been investigated. I t  is  
suggested that metabolite Vis competitively in h ib its  the oxidation 
of MCAC by hepatic mitochondria. This leads to a subsequent 
accumulation of intrahepatic l ip id  the nature of which is unknown. This 
l ip id  accumulation triggers the p ro life ra tio n  of peroxisomes which 
serves to 'burn o f f 1 th is  l ip id .  Furthermore, a change in the 
mitochondrion occurs which reduces the sens it iv ity  to this in h ib it io n .  
I t  is not c lear whether th is  change is deleterious to normal fa t ty  acid 
metabolism. Metabolite Vis also inh ib its  MCAC in isolated guinea 
pig mitochondria although less severely than in ra t  l iv e r  mitochondria. 
However, in guinea pig (and human) hepatocytes the pursuing 
accumulation o f in tra c e l lu la r  l ip id  does not tr igg er p ro l ite ra t io n  of 
peroxisomes and i t  is suggested that the adaptive response expressed by 
the l iv e r  may be d if fe re n t  in d if fe re n t  species.
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CHAPTER V I I I
FINAL DISCUSSION
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Hepatic peroxisome p ro lite ra tio n  in rodents has been recognised as an 
important toxicological phenomenon. In particu lar , a correlation  
exists between peroxisome pro life ra tio n  and hepatocarcinogenesis in 
rodents. The suggestion of species differences in se n s it iv ity  to 
peroxisome prol i te ra t io n  (and hence hepatocarcinogenesis?) has raised 
ju s t i f ie d  concern over the choice of species as a model for assessing 
the hazard of such agents to man. This present controversy is  
unlikely to be resolved until the underlying mechanism(s) associated 
with peroxisome pro life ra tio n  and the ensuing carcinogenesis in the 
rodent l iv e r  are fu l ly  understood. One of the primary objectives o f  
th is  work was to assess the s u i ta b i l i ty  of primary hepatocyte
cultures as an in v itro  system to probe such mechanisms. I t  has
previously been demonstrated that such primary 'maintenance' cultures  
retain many d iffe ren tia ted  hepatocyte functions and the in d u c ib i l i ty  
of these functions observed vn vivo for a number of days. Thus i t  is
feasible to examine the function of the hepatocyte in a f in e ly
controllable environment.
Preliminary experiments indicated that i t  was possible to induce 
p ro life ra tio n  of peroxisomes in cultured ra t hepatocytes and that  
this was greatly enhanced (to levels comparable with those observed 
in v ivo) by supplementation of the culture medium with hydrocortisone 
or other steroid hormones having some glucocorticoid a c t iv i ty .  This 
observation alone was of great significance as i t  indicated tha t the 
e ffec t observed in the l iv e r  iji vivo was l ik e ly  to be brought about 
by the direct interaction of the chemical with the l iv e r  ce ll and was 
not mediated necessarily v^a some systemic influence. Furthermore, 
examination of a number of hepatic effects occurring concomitant 
with peroxisome pro life ra tio n  i_n vivo revealed that a ll  of these were 
inducible vn vi tro (induction of peroxisomal B-oxidation, catalase,
1 auric acid hydroxylase and oc-glycerophosphate dehydrogenase, and 
increase in c e llu la r  coenzyme A content and 80000 mwt p ro te in ). Thus 
the response of the hepatocyte ini v itro  is both q u a lita t iv e ly  and 
quantitatively  sim ilar to the response of the l iv e r  in vi vo.
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As in v itro  alternatives are desperately sought in toxicology to 
replace or reduce the number of experiments on animals, such a system 
may provide a 'screen' fo r  the detection of peroxisome p ro !ife ra to rs .  
This does, however, require careful application.
Trichloroethylene, for example, is a peroxisome p ro l ife ra to r  in the 
mouse l iv e r  (Elcombe et al_, 1982) but not in cultured mouse 
hepatocytes. This is because the 'ac tive ' metabolite, 
tr ich loroacetic  acid, is not produced in su ff ic ie n t quantity as the 
metabolising system involved (cytochrome-P450) fa l ls  to very low 
levels in these ce lls  (Bissel et al_, 1973; Michalopoulos et '.ert,
1976; ' Guzelian-et al ,^ 1977). By bypassing the P450-dependent step 
and adding chloral to the cultures, peroxisome p ro life ra t io n  is  
observed. Thus, without prior knowledge of the metabolism of the 
agent such 'fa lse  negatives' may occur.
A valuable extension of this system is the investigation of species 
differences using 'maintenance' cultures prepared from the l iv e r  of 
various species. In particu lar the effects of these agents on human 
hepatocytes can be examined d irec tly  and need not be extrapolated  
from effects in other species. Our results in cultured hepatocytes 
(Chapter V and V I) have confirmed the lack of peroxisome 
pro life ra tio n  seen in the l iv e r  of the guinea pig and marmoset in 
vivo with c lo fib ra te  and DEHP (Osumi and Hashimoto, 1978; Svoboda et  
al_, 1967; Chapter I I I ) .  With agents such as DEHP which undergo 
extensive metabolism i t  was plausable that the observed species 
differences in peroxisome p ro life ra t io n  were due simply to metabolism 
differences. However, we have demonstrated that even when exposed 
to the 'active metabolites' of DEHP (Chapter V I) no peroxisome 
pro life ra tio n  is observed. Occasional small (but s ta t is t ic a l ly  
s ign if ican t) increases in peroxisomal B-oxidation were noted in 
cultured guinea pig and marmoset hepatocytes exposed to these agents. 
These increases never approached those observed in cultured ra t  
hepatocytes and were not dose-dependent. The significance of these 
effects is not c lear. F irs t ly  i t  is not known in hepatocytes of 
these species, whether th is represents 'maintenance' of peroxisomal 
enzyme a c t iv ity  rather than induction. Secondly, whether such small 
changes are relevant in terms of carcinogenic hazard is  unknown as 
the relationship between degree of peroxisome p ro life ra t io n  and
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tumour incidence in rodents has not been investigated. F in a l ly ,  i t  
cannot be ignored that the hepatocytes of these species for some 
reason may not respond i_n vi tro in a manner analagous to the l iv e r  i_n 
vivo. However, i t  is f e l t  that the induction of monooxygenase 
a c t iv ity  by phenobarbitone, which requires the integration of complex 
biosynthetic reactions, is a most suitable indicator of the 
functional v ia b i l i t y  of such c e lls . Without the id en t if ic a t io n  of a 
'pos it ive ' peroxisome p ro !ite ra to r  in these cells  these 'negatives' 
can not be further validated.
Having established the phenomenology of 'species differences' in 
peroxisome p ro life ra t io n  i t  was pertinent to investigate the 
mechanisms involved: i t  is the elucidation of the mechanistic
differences in response and not the apparent qu a lita t ive  differences  
which w il l  ultimately decide the toxicological relevance of hepatic 
peroxisome p ro life ra t io n  in rodents. S irnplistically  when an agent 
(or i ts  metabolite) interacts with the hepatocyte to produce 
ultim ately a p ro life ra tio n  of peroxisomes a number of sites ex is t  
where a species difference in response may occur which could lead to 
a difference in the occurrence or degree of peroxisome p ro !ite ra t io n  
(Figure V I I I . 1).
A consideration of the structural d iversity  of the agents which have 
been shown to e l i c i t  peroxisome pro life ra tio n  makes a single unifying  
mechanism of action seem unlike ly . However, Reddy has suggested 
that this is indeed the case, and has proposed that peroxisome 
p ro life ra tio n  involves a cytosolic receptor (Reddy and Lalwai, 1983; 
Lalwani et al_, 1983°). I t  is envisaged that these agents in te ra c t  
with a receptor in the cytoplasm of the hepatocyte. This receptor- 
ligand complex then interacts with chromatin to e l i c i t  selective  
increases in transcription of peroxisomal mRNAs. The only evidence 
in support of this receptor is the demonstration of ^H-nafenopin 
binding in the cytosol of ra t l iv e r  and kidney (Lalwani e t al_,
1983C). I t  seems unlikely that a single receptor exists with 
spec if ic ity  for a l l  of the s tructura lly  diverse p ro !ite ra to rs  known. 
Furthermore, the c r i te r ia  for designating such protein binding as a
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FIGURE V I I I . 1
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'receptor' ie  low capacity -  high a f f in i ty  binding, id en t if ic a t io n  of 
an endogenous ligand, correlation with biological response, 
translocation to the nucleus etc are not adequately sa tis fied  by 
the data of Lai warn’ e t al_. For example, by comparison with 
characterised hepatic receptors th is  'receptor' demonstrates low 
a f f in i ty  and high capacity binding (Table V I I I . 1 ). Furthermore, the 
lack of specific binding of ^H-nafenopin in skeletal muscle and heart 
(Lalwani et aV, 1983c ) is  not consistent with the demonstrated 
induction of peroxisomal B-oxidation by nafenopin in these tissues 
(Leighton and Lazo, 1972; Behrens e t aV, 1983).
However, i f  peroxisome pro life ra tio n  is a consequence of a 
receptor-mediated mechanism then the endogenous ligand may maintain 
the levels of peroxisomes and peroxisomal enzymes within the ce ll  
under normal conditions. P ro lifera tio n  of peroxisomes associated 
with physiological stresses such as chemically-induced diabetes, 
starvation and high fa t  d iets , which invoke an increased in flux  of 
fa tty  acids into the l iv e r ,  suggests that this endogenous ligand may 
be a fa t ty  acid per se. By implication a cytosolic protein such as 
fa t ty  acid binding protein (Z protein) may be responsible fo r  the 
observed cytosolic binding of 3h nafenopin. Fatty acid binding 
protein (FABP) demonstrates low a f f in i ty  -  high capacity binding with 
endogenous substrates and exhibits a diverse substrate s p e c if ic ity  
(Ockner e t al_, 1972; Mishkin et a1_, 1972; Mishkin and Turcotte, 
1974; Billheimer and Gaylor, 1980, Table V I I I . 1 ). Furthermore, i t  
has recently been reported that FABP may be involved in the transport 
of fa t ty  acids across the peroxisomal membrane (Appelkvist and 
Dallner, 1980) and the concentration of FABP in the l iv e r  is enhanced 
sign ificantly  following administration of peroxisome pro !ife ra to rs  to 
rodents (Fleischer et al^ 1975; Kawashima et aT, 1983k; Kawashima et  
a^, 1982). Whether FABP per se has any 'receptor' function, 
involving interaction with the nucleus is not known. I f  FABP plays 
a role in peroxisome p ro life ra tio n  i t  may not necessarily be via a 
receptor evoked interaction with DNA. Competition between peroxisome 
pro!iferators  such as nafenopin and endogenous fa t ty  acids for
TABLE V I I I . 1
BINDING PROPERTIES OF HEPATIC 'RECEPTORS'
'RECEPTOR' SUBSTRATE kd CAPACITY 
fmol/mg cytosol 
protein
'STEROID' OESTRADIOL (1) 0.7 x 10“10M 58
' TCDD' TCDD 0.27 x 10"9M 84
'PEROXISOME
PROLIFERATOR'
NAFENOPIN 0.53 x 10“6M 2730
FATTY ACID 
BINDING PROTEIN
FATTY ACID (4 ,5) 0.24 x 10“6M 1,230,000
(1) Eisenfeld et al_, 1976
(2) Poland and Glover, 1976
(3) Lalwani et al_, 1983c
(4) Mi skin and Turcotte, 1974
(5) Kawashima e t a l , 1983—
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binding sites may resu lt in an elevation of the in tra c e l lu la r  free  
(unbound) fa t ty  acid concentration or a redistribution of these fa t ty  
acids in metabolism.
The peroxisomal changes observed in the l iv e r  following  
administration of peroxisome pro lifera tors  are associated with a 
specific increase in the B-oxidation pathway. I t  is however 
feasib le , as the biogenesis of peroxisomes and incorporation of 
proteins is not fu l ly  understood, that the rate of uptake of 
peroxisomal proteins into newly synthesised peroxisomes varies and 
the mRNAs produced when p ro lite ra t io n  is  turned on are 
proportionately s im ilar to the control condition. However, other 
hepatic changes occuring concurrent with peroxisome p ro l ife ra t io n  are 
suggestive of a change in the metabolism of lip id s  by the l i v e r  
(increased hepatic carn itine , Coenzyme A and FABP content, increased 
numbers of peroxisomes, induction of LAH and carnitine acyl 
transferases). Furthermore, that the feeding of high fa t  diets  
results in p ro life ra tio n  of peroxisomes suggests an adaptive role for  
the peroxisome in fa t ty  acid metabolism in the l iv e r .
These observations led us to propose that peroxisome p ro lite ra t io n  is  
triggered by an accumulation of in tra c e llu la r  l ip id ,  perhaps as an 
adaptive response to remove this l ip id .  This implies that these 
structura lly  diverse agents, by a variety of d if fe re n t  mechanisms, 
bring about a single unifying e ffec t ,  that is ,  the accumulation of 
in tra c e llu la r  l ip id ,  and i t  is th is l ip id  that triggers peroxisome 
p ro lite ra t io n . I t  is  also implied here that any agent which gives 
rise to l ip id  accumulation may give rise to peroxisome p ro li fe ra t io n .  
This hypothesis requires further investigation.
The ' l ip id  accumulation' specified is not intended to imply the 
' fa t ty  l i v e r '  synonymous with tr ig lycerid e  accumulation only, but may 
involve accumulation of a particu lar type of l ip id .  Just as the 
mechanisms by which these d if fe ren t agents may bring about l ip id  
accumulation may vary, so may the type of l ip id  vary. I t  is 
necessary then to iden tify  the nature of the l ip id  accumulating prio r  
to peroxisome pro !ite ra tion .
In this respect, the induction of a novel cytochrome P-450 by these 
agents is in teresting. Laurie acid hydroxylase, which shows a high 
s p ec if ic ity  for the co-oxidation of medium chain length fa t ty  acids 
(LAH), is enhanced many-fold in the l iv e r  of rodents treated with 
peroxisome pro !ife ra to rs . The function of this enzyme in c e l lu la r  
metabolism is not known although i t  is believed to play some role in 
assisting the mitochondrial B-oxidation system. With regards to 
peroxisome p ro life ra t io n  i t  is not known whether LAH induction occurs 
simultaneously, prior to or subsequently to peroxisome p ro l ife ra t io n  
(Figure V I I I . 2 ) .  I t  is feasible that LAH induction occurs prio r to a 
peroxisomal response and the excessive production of dicarboxylic  
acids, which are metabolised by the peroxisome (Mortensen e t alI,
1982, 1983) leads to peroxisome pro life ra tio n  (Figure V I I I .2 b ) .  
A lternatively  the medium chain acyl carnitines produced in excess by 
the pro lifera ted  peroxisomes may stimulate LAH a c t iv ity  (Figure
V I I I .2 c ) .  Elucidation of the time course of these hepatic events (in  
particu lar l ip id  accumulation, LAH induction and peroxisome 
pro life ra t io n ) is thus required.
I t  is pertinent, having id e n tif ied  this in tra c e llu la r  l ip id ,  to 
investigate the mechanisms involved in the p ro life ra t io n  of 
peroxisomes. The mechanism of peroxisome biogenesis is not fu l ly  
understood and the c e l lu la r  control factors to ta l ly  unknown.
Whether the l ip id  per se conveys a signal d irec tly  to the nucleus or 
in d irec tly  vi_a sequestration of cofactors which normally act as 
'repressors' is speculative. The se lec tiv ity  of induction of 
various peroxisomal enzymes does suggest, however, that not a l l  are 
coded fo r  in the same 'operon'. A lte rnative ly , the selective  
induction may be misleading and simply a resu lt of k ine tic  
differences in the rates of translation , uptake or assembly of the 
various peroxisomal enzymes. Furthermore, whether the non-peroxisomal 
enzyme changes characteris tica lly  associated with peroxisome 
pro life ra tio n  are the result of this one signal or are brought about 
by some other mechanism(s) is not known.
In hepatocytes of species such as guinea pig, marmoset and man, 
where s ign ificant peroxisome p ro lite ra t io n  does not occur i t  is  
possible to demonstrate increased in tra c e llu la r  l ip id  which greatly
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FIGURE V I I I . 2 .
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exceeds that observed in cultured ra t  hepatocytes. This suggests 
that e ither the type of l ip id  accumulating d iffe rs  q u a lita t iv e ly  in 
these species or that the response to in tra c e l lu la r  l ip id  
accumulation varies in d if fe re n t species. To understand the species 
differences in peroxisome p ro life ra t io n  then i t  is necessary to 
identify  the nature of the l ip id  and to elucidate any basic 
differences in adaptation to in tra c e l lu la r  l ip id .  Further 
investigation of the effects of these agents in hepatocytes of 
non-rodent species is required to determine whether other 'adaptive1 
changes are expressed to eliminate this l ip id .  This ' fa t ty  l i v e r '  
may be of greater importance toxicologica lly  than the mild peroxisome 
p ro life ra tio n  sometimes observed.
In the la s t  twenty years an increasing number of chemicals and drugs 
have been shown to p ro l ife ra te  peroxisomes in the l iv e r  of rodents. 
With many of these agents a correlation exists between the 
observation of peroxisome pro life ra tio n  in the l iv e r  following short 
term exposure and an increased incidence of tumours a f te r  long term 
exposure. Though this is not in i t s e l f  s u ff ic ien t to conclude a 
'causal' re lationship, current opinion has adopted th is  l in e  of 
thought. The peroxisome pro!iferators  tested have almost invariably  
demonstrated a lack of genotoxic potential and i t  is believed that  
these agents produce th e ir  carcinogenic e ffec t via an 'epigenetic' 
mechanism, that is ,  a mechanism whereby the agent (or i ts  
metabolites) does not in teract d irec tly  with DNA. Reddy and 
coworkers have suggested that an imbalance in the H202*-producing 
peroxisomal oxidases ( fa t ty  acyl CoA oxidase) and the H202-degrading 
enzyme, catalase, results in an increased in tra c e l lu la r  H2O2 
concentration which i t s e l f ,  or vi_a generation of reactive oxygen 
species, results in DNA damage (Reddy et aV, 1979; Warren e t  
1980; Warren et al_, 1982). The 'excessive' generation of H2O2 
presumably is dependent on a continuous increased flux of fa t ty  acids 
through the peroxisomal system, though the source of and reason fo r  
this increased substrate is not apparent. Despite the 
attractiveness of this hypothesis l i t t l e  evidence in support of i t  
has been forthcoming. This hypothesis depends largely  on the 
sp ec if ic ity  of catalase as a peroxisomal enzyme. Extra peroxisomal 
catalase has been demonstrated both cytochemically and enzymatically 
in subcellular fractions, though these results are frequently  
discarded as a r te fa c tu a l. Holmes and Masters (1969, 1970), however,
separated f ive  d if fe ren t forms of catalase and proposed an 
in tra c e llu la r  pathway of catalase cycling to re late  the subcellular 
distribution of these forms. Furthermore, i t  has been suggested 
that 'aged' catalase in the cytosol maintains the concentration of 
peroxisomal catalase (Masters, 1982). Clearly the role of catalase 
in H2O2 degradation in the peroxisome/cytosol needs to be c la r i f ie d .
Administration of these agents to rodents produces a number of 
morphological and biochemical changes in the l i v e r .  The segregation 
of peroxisome p ro life ra tio n  as the causative lesion on the basis of 
correlation alone is un justif ied  and i t  is dangerously misleading to 
assess the hazard of these agents to man on such weak evidence. For 
instance, where investigated these agents cause a short wave of 
hyperplasia in the l iv e r  o f rodents (denoted by increased mitosis or 
increased ^H-thymidine incorporation into DNA) (Reddy et a l , 1979; 
Moody and Reddy, 1978; C R El combe, unpublished data). This wave 
of hyperplasia does not continue fo r  the duration of exposure but 
declines to control levels within a few days. I t  is speculative 
that this hyperplasia may be the c r i t ic a l  event in the ensuing 
neoplasia and that carcinogenesis is thereafter inev itab le . The 
sustained peroxisome p ro life ra tio n  may a lte rna tive ly  play some 
secondary role in the development of neoplasia. Exposure of rodents 
to a peroxisome pro !ite ra to r  for the f i r s t  two weeks of adult l i f e  
and the determination of tumour incidence at 1-2 years subsequent to 
this would be an informative experiment.
In conclusion then, that hepatic peroxisome p ro life ra t io n  and 
hepatocarci nogenesis are co rrec ta b le  event in rodents seems c le a r .  
Whether these events are causally re lated, however, requires 
c la r i f ic a t io n .  I t  is  apparent that the effects of these agents in 
all species are not predictable on the basis of effects in rodents. 
Peroxisome p ro life ra tio n  is not observed in the l iv e r  of non-rodent 
species and this is not due solely to differences in metabolism but 
to in tr in s ic  differences in the s e n s it iv ity  of the hepatocytes of 
these species to peroxisome p ro life ra t io n . I f  peroxisome 
p ro life ra tio n  is causally related to carcinogenesis, then these 
agents appear not to present a carcinogenic hazard to man.
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ABBREVIATIONS
ADP -  Adenosine 5 ‘ -diphosphate
ATP .- Adenosine 5 ' -triphosphate
CAT -  Carnitine acetyl transferase
CoA -  Coenzyme A
Co ASH -  Coenzyme A
COT -  Carnitine octanoyl transferase
CPIB -  Cl o f ib r ie  acid
CPT -  Carnitine pal mitoyl transferase
DEHP -  D i-(2 -ethyl hexyl)phthalate
DMF -  Dimethyl formamide
DNP -  2,4-Dinitrophenol
ECOD -  7-Ethoxycoumarin-O-deethylase
EDTA -  Ethylene diaminotetracetic acid
EGTA -  Ethyleneglycol-bis-(B-amino-ethyl etherjNsN'tetraacetic
acid
FABP -  Fatty acid binding protein
FAD -  Flavin adenine dinucleotide
oc GPDH -  oc-Glycerophosphate dehydrogenase
HANKS BSS -  Hanks Basic Salt Solution
LAH -  Laurie acid hydroxylase
MCAC -  Medium chain acyl carnitines
MEHP -  Mono-(2-ethyl hexyl) phthalate
mRNA -  Messenger ribonucleic acid
PB -  Phenobarbitone
PBS -  Phosphate buffered saline
PCO -  Cyanide-insensitive palmitoyl CoA oxidation
SDS-PAGE -  Sodium dodecyl sulphate polyacrylamide gel
electrophoresis 
SDH -  Succinate dehydrogenase
SER -  Smooth endoplasmic reticulum
TCA -  Trichloroacetic acid
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